NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING 2-IMINO GROUP AND PEST CONTROL AGENT INCLUDING THE SAME

Abstract
Provided is a nitrogen-containing heterocyclic derivative having a 2-imino group, which is represented by the following Formula (I).
Description
TECHNICAL FIELD

The present invention relates to a nitrogen-containing heterocyclic derivative having a 2-imino group, and a novel pest control agent using the same.


BACKGROUND ART

Although numerous pest control agents have been discovered so far, novel drugs are still required in view of the problem of reduction in drug sensitivity, long-term efficacy, safety during the use thereof and the like.


In particular, for rice cultivation in East Asia and Southeast Asia, damage by planthoppers that have developed drug resistance against main insecticides including Neonicotinoids represented by imidacloprid is materializing and a specific medicine against planthoppers that have developed drug resistance is expected.


European Patent Application Laid-Open No. 432600(PTL1) discloses a plurality of compounds having the same ring structure as a compound represented by Formula (I), but the compounds are used as herbicides and there is no description about pest control.


European Patent Application Laid-Open No. 268915(PTL2) discloses the structural formula of N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide, but there is no description about the pest control by compounds having other structures.


Japanese Patent Application Laid-Open No. 5-78323(PTL3) discloses a compound similar to the compound represented by Formula (I), but the compound has a structure different from the compound of the present invention, in that R in Formula (I) is an acyl group having a benzene ring, an acyl group having a hetero ring, an alkylsulfonyl group, an alkylaminocarbonyl group and an alkylaminothiocarbonyl group. The biological activity thereof is an insecticidal activity, but the compound of the present invention does not suggest significantly high activity against a wide range of insect species.


International Publication No. 2006/051704(PTL4) discloses a compound similar to Formula (I) of the present invention, but fails to specifically disclose the compound represented by Formula (I) and does not suggest the content of the present invention about pest control activity.


European Patent Application Laid-Open No. 259738(PTL5) discloses a plurality of compounds having a ring structure similar to that of a compound represented by Formula (I), but fails to disclose or suggest a compound having a trifluoroacetic acid imino structure.


CITATION LIST
Patent Literature



  • [PTL 1] European Patent Application Laid-Open No. 432600

  • [PTL 2] European Patent Application Laid-Open No. 268915

  • [PTL 3] Japanese Patent Application Laid-Open No. 5-78323

  • [PTL 4] International Publication No. 2006/051704

  • [PTL 5] European Patent Application Laid-Open No. 259738



SUMMARY OF INVENTION
Technical Problem

The present invention is contrived to provide a novel pest control agent to solve problems which chemicals in the related art have, such as reduction in drug sensitivity, long-term efficacy, safety during the use thereof and the like in the field of pest control.


One of the important problems in the present invention is to provide a chemical which has excellent pest control effects against Nilaparvata lugens, Sogatella furcifera and Laodelphax striatella, which has recently become major pests in the field of rice, exhibits high activity even against drug-resistant planthoppers, reduces the chance that workers are exposed to the chemical during the use thereof such as soil treatment, seed treatment, nursery box treatment and may be safely used.


Solution to Problem

In order to solve the problems, the present inventors have intensively studied, and as a result, have found that a nitrogen-containing heterocyclic derivative having a 2-imino group, which is represented by Chemical Formula (I), has excellent activity as a pest control agent.


That is, according to the present invention, the following inventions are provided.


(1) A nitrogen-containing heterocyclic derivative having a 2-imino group, which is represented by the following Formula (I), or salts thereof.




embedded image


Formula (I)


[in the formula, Ar represents a phenyl group which may be substituted, a 5- to 6-membered heterocycle which may be substituted, or a 4- to 10-membered heterocycloalkyl group,


A represents a heterocycle having a 5- to 10-membered unsaturated bond including one or more nitrogen atoms, and has an imino group substituted with an R group at a position adjacent to the nitrogen atom present on the cycle,


Y represents a hydrogen atom, a halogen atom, a hydroxyl group, a C1 to C6 alkyl group which may be substituted with a halogen atom, a C1 to C6 alkyloxy group which may be substituted with a halogen atom, a cyano group, or a nitro group, and


R represents any one of groups represented by the following Formulae (a) to (e), (y) or (z),




embedded image


[where, R1 represents a hydrogen atom, a substituted C1 to C6 alkyl group, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, or a pentafluorophenyl group,


R2 represents a C1 to C6 alkyl group substituted with a halogen atom, an unsubstituted C3 to C6 branched or cyclic alkyl group, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, a substituted or unsubstituted 5- to 10-membered heterocycle, or a substituted or unsubstituted benzyl group,


R3 represents a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, a substituted or unsubstituted (C6 to C10) aryl (C1 to C6) alkyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkenyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkynyl group, a substituted or unsubstituted phenoxy (C1 to C6) alkyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkenyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkynyl group, a substituted or unsubstituted 5- to 10-membered heterocycle, a substituted or unsubstituted 5- to 10-membered heterocycle (C1 to C6) alkyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkenyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkynyl group, a (C1 to C4) alkoxy (C1 to C5) alkyl group, a (C1 to C4) alkoxy (C2 to C5) alkenyl group, a (C1 to C4) alkoxy (C2 to C5) alkynyl group, a (C1 to C4) alkylthio (C1 to C5) alkyl group, a (C1 to C4) alkylthio (C2 to C5) alkenyl group, or a (C1 to C4) alkylthio (C2 to C5) alkynyl group,


R4 represents a hydrogen atom, a formyl group, a C1 to C18 alkyl group which may be substituted, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, a substituted or unsubstituted (C6 to C10) aryl (C1 to C6) alkyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkenyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkynyl group, a substituted or unsubstituted phenoxy (C1 to C6) alkyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkenyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkynyl group, a substituted or unsubstituted 5- to 10-membered heterocycle, a substituted or unsubstituted 5- to 10-membered heterocycle (C1 to C6) alkyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkenyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkynyl group, a (C1 to C4) alkoxy (C1 to C5) alkyl group, a (C1 to C4) alkoxy (C2 to C5) alkenyl group, a (C1 to C4) alkoxy (C2 to C5) alkynyl group, a (C1 to C4) alkylthio (C1 to C5) alkyl group, a (C1 to C4) alkylthio (C2 to C5) alkenyl group, a (C1 to C4) alkylthio (C2 to C5) alkynyl group, or a group represented by the following Formulae (f) to (n),




embedded image


where, R4a, R4b and R4c represent a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, a substituted or unsubstituted (C6 to C10) aryl (C1 to C6) alkyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkenyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkynyl group, a substituted or unsubstituted phenoxy (C1 to C6) alkyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkenyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkynyl group, a substituted or unsubstituted 5- to 10-membered heterocycle, a substituted or unsubstituted 5- to 10-membered heterocycle (C1 to C6) alkyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkenyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkynyl group, a (C1 to C4) alkoxy (C1 to C5) alkyl group, a (C1 to C4) alkoxy (C2 to C5) alkenyl group, a (C1 to C4) alkoxy (C2 to C5) alkynyl group, a (C1 to C4) alkylthio (C1 to C5) alkyl group, a (C1 to C4) alkylthio (C2 to C5) alkenyl group, or a (C1 to C4) alkylthio (C2 to C5) alkynyl group,


R4d represents a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, or a substituted or unsubstituted 5- to 10-membered heterocycle, and


R4e and R4f each independently represent a hydrogen atom, a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, or a substituted or unsubstituted 5- to 10-membered heterocycle,


R5 represents a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, a substituted or unsubstituted (C6 to C10) aryl (C1 to C6) alkyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkenyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkynyl group, a substituted or unsubstituted phenoxy (C1 to C6) alkyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkenyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkynyl group, a substituted or unsubstituted 5- to 10-membered heterocycle, a substituted or unsubstituted 5- to 10-membered heterocycle (C1 to C6) alkyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkenyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkynyl group, a (C1 to C4) alkoxy (C1 to C5) alkyl group, a (C1 to C4) alkoxy (C2 to C5) alkenyl group, a (C1 to C4) alkoxy (C2 to C5) alkynyl group, a (C1 to C4) alkylthio (C1 to C5) alkyl group, a (C1 to C4) alkylthio (C2 to C5) alkenyl group, or a (C1 to C4) alkylthio (C2 to C5) alkynyl group,


R6 represents a hydrogen atom, a formyl group, a O,O′—C1 to C4 alkyl phosphoryl group, a C1 to C18 alkyl group which may be substituted, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, a substituted or unsubstituted (C6 to C10) aryl (C1 to C6) alkyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkenyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkynyl group, a substituted or unsubstituted phenoxy (C1 to C6) alkyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkenyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkynyl group, a substituted or unsubstituted 5- to 10-membered heterocycle, a substituted or unsubstituted 5- to 10-membered heterocycle (C1 to C6) alkyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkenyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkynyl group, a (C1 to C4) alkoxy (C1 to C5) alkyl group, a (C1 to C4) alkoxy (C2 to C5) alkenyl group, a (C1 to C4) alkoxy (C2 to C5) alkynyl group, a (C1 to C4) alkylthio (C1 to C5) alkyl group, a (C1 to C4) alkylthio (C2 to C5) alkenyl group, a (C1 to C4) alkylthio (C2 to C5) alkynyl group, or a group represented by the following Formulae (o) to (x)




embedded image


where, R6a, R6b and R6c represent a (C1 to C6) alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, a substituted or unsubstituted (C6 to C10) aryl (C1 to C6) alkyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkenyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkynyl group, a substituted or unsubstituted phenoxy (C1 to C6) alkyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkenyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkynyl group, a substituted or unsubstituted 5- to 10-membered heterocycle, a substituted or unsubstituted 5- to 10-membered heterocycle (C1 to C6) alkyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkenyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkynyl group, a (C1 to C4) alkoxy (C1 to C5) alkyl group, a (C1 to C4) alkoxy (C2 to C5) alkenyl group, a (C1 to C4) alkoxy (C2 to C5) alkynyl group, a (C1 to C4) alkylthio (C1 to C5) alkyl group, a (C1 to C4) alkylthio (C2 to C5) alkenyl group, or a (C1 to C4) alkylthio (C2 to C5) alkynyl group,


R6d represents a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, or a substituted or unsubstituted 5- to 10-membered heterocycle,


R6e and R6f each independently represent a hydrogen atom, a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a (C1 to C4) alkoxy (C1 to C5) alkyl group, a (C1 to C4) alkylthio (C1 to C5) alkyl group, a substituted or unsubstituted (C6 to C10) aryl group, a substituted or unsubstituted (C6 to C10) aryl (C1 to C6) alkyl group, or a substituted or unsubstituted 5- to 10-membered heterocycle,


R6g and R6h each independently represent a hydrogen atom, a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, or a substituted or unsubstituted 5- to 10-membered heterocycle, and


R6i, R6j and R6k each independently represent a hydrogen atom, a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, or a substituted or unsubstituted (C6 to C10) aryl group), and


R7 represents a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, a substituted or unsubstituted (C6 to C10) aryl (C1 to C6) alkyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkenyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkynyl group, a substituted or unsubstituted phenoxy (C1 to C6) alkyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkenyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkynyl group, a substituted or unsubstituted 5- to 10-membered heterocycle, a substituted or unsubstituted 5- to 10-membered heterocycle (C1 to C6) alkyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkenyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkynyl group, a (C1 to C4) alkoxy (C1 to C5) alkyl group, a (C1 to C4) alkoxy (C2 to C5) alkenyl group, a (C1 to C4) alkoxy (C2 to C5) alkynyl group, a (C1 to C4) alkylthio (C1 to C5) alkyl group, a (C1 to C4) alkylthio (C2 to C5) alkenyl group, or a (C1 to C4) alkylthio (C2 to C5) alkynyl group,


Y1 and Y2 represent an oxygen atom or a sulfur atom, and may be the same or different, and Ry represents a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, a substituted or unsubstituted (C6 to C10) aryl (C1 to C6) alkyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkenyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkynyl group, a substituted or unsubstituted phenoxy (C1 to C6) alkyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkenyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkynyl group, a substituted or unsubstituted 5- to 10-membered heterocycle, a substituted or unsubstituted 5- to 10-membered heterocycle (C1 to C6) alkyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkenyl group, or a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkynyl group,


Rz represents a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, a substituted or unsubstituted (C6 to C10) aryl (C1 to C6) alkyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkenyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkynyl group, a substituted or unsubstituted phenoxy (C1 to C6) alkyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkenyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkynyl group, a substituted or unsubstituted 5- to 10-membered heterocycle, a substituted or unsubstituted 5- to 10-membered heterocycle (C1 to C6) alkyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkenyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkynyl group, a (C1 to C4) alkoxy (C1 to C5) alkyl group, a (C1 to C4) alkoxy (C2 to C5) alkenyl group, a (C1 to C4) alkoxy (C2 to C5) alkynyl group, a (C1 to C4) alkylthio (C1 to C5) alkyl group, a (C1 to C4) alkylthio (C2 to C5) alkenyl group, or a (C1 to C4) alkylthio (C2 to C5) alkynyl group, and n represents 1 or 2,


here, Ar represents a 6-chloro-3-pyridyl group, A represents a ring represented by the following Formula (A-1), which may be substituted with a methyl group or a halogen atom:




embedded image


where R represents an (a) group in this formula, R1 does not represent a methyl group, a difluoromethyl group, a trifluoromethyl group, a chlorodifluoromethyl group, a chloromethyl group, a dichloromethyl group, a trichloromethyl group, a bromochloromethyl group, a bromomethyl group, a dibromomethyl group, or a pentafluoromethyl group, and where R represents a (b) group of this formula, R2 does not represent an ethyl group, respectively, and


A represents a cycle denoted by the formula (A-1) which may be substituted with a halogen atom, and where R represents an (a) group of this formula, and R1 represents a trifluoromethyl group, Ar does not represent a 2-chloro-5-thiazolyl group, a phenyl group, a 4-chlorophenyl group, a 3-pyridyl group, a 6-chloro-5-fluoro-3-pyridyl group, a 6-fluoro-3-pyridyl group, a 5,6-dichloropyridyl group, a 6-bromo-3-pyridyl group, or a 2-chloro-5-pyrimidyl group.


In addition, the compounds indicated in tables 1 and 2 below are not included.]









TABLE 1









embedded image

















Compound




1H-NMR (CDCl3,

IR (KBr, v,


No.
Ar
R1a
Y
δ, ppm)
cm−1) or MS





P212
6-chloro-3-pyridyl
CF3
H
5.57 (2H, s), 6.92 (1H, td), 7.31 (1H,
m/z = 316






d), 7.80 (1H, td), 7.87 (1H, dd), 7.99
(M + H)






(1H, dd), 8.48 (2H, m)



P213
2-chloro-5-thiazolyl
CF3
H
5.61 (2H, s), 6.93 (1H, dd), 7.68 (1H,
m/z = 322






s), 7.83 (1H, td), 7.97 (1H, d), 8.53
(M + H)






(1H, d)



P214
6-chloro-3-pyridyl
OCH3
H
3.74 (3H, s), 5.40 (2H, s), 6.45 (1H,
m/z = 278






td), 7.29 (1H, d), 7.46 (2H, m), 7.73
(M + H)






(1H, dd), 8.12 (1H, dd), 8.40 (1H, d)



P215
6-chloro-3-pyridyl
CF3
5-Cl
5.53 (2H, s), 7.34 (1H, d), 7.71 (1H,
m/z = 350






dd), 7.87 (1H, dd), 7.94 (1H, d), 8.49
(M + H)






(1H, d), 8.55 (1H, s)



P216
6-chloro-3-pyridyl
CF3
5-F
5.54 (2H, s), 7.34 (1H, d), 7.70 (1H,
m/z = 334






m), 7.80 (1H, m), 7.88 (1H, dd), 8.48
(M + H)






(1H, d), 8.64 (1H, m)



P217
6-chloro-3-pyridyl
CF3
4-Cl
5.49 (2H, s), 6.85 (1H, dd), 7.35 (1H,
m/z = 350






d), 7.76 (1H, dd), 7.85 (1H, dd), 8.44
(M + H)






(1H, d), 8.62 (1H, s)



P218
2-chloro-5-thiazolyl
CF3
5-Cl
5.56 (2H, s), 7.68 (1H, s), 7.74 (1H,
m/z = 356






dd), 7.84 (1H, d), 8.58 (1H, d)
(M + H)


P219
2-chloro-5-thiazolyl
CF3
5-F
5.60 (2H, s), 7.69 (1H, s), 7.72 (1H,
m/z = 340






td), 7.86 (1H, m), 8.67 (1H, m)
(M + H)


P220
2-chloro-5-thiazolyl
CF3
4-Cl
5.58 (2H, s), 6.90 (1H, d), 7.67 (1H,
m/z = 356






s), 7.90 (1H, d), 8.61 (1H, s)
(M + H)


P221
6-chloro-3-pyridyl
CF3
3-Me
2.31 (3H, s), 5.50 (2H, s), 6.98 (1H,
m/z = 330






m), 7.34 (1H, d), 7.73 (1H, dd),
(M + H)






7.77 (2H, m), 8.42 (1H, d)



P222
6-chloro-3-pyridyl
CF3
4-Me
2.40 (3H, S), 5.49 (2H, s), 6.70 (1H,
m/z = 330






dd), 7.32 (1H, d), 7.70 (1H, d), 7.86
(M + H)






(1H, dd), 8.37 (1H, s), 8.43 (1H, d)



P223
6-chloro-3-pyridyl
CF3
5-Me
2.29 (3H, s), 5.52 (2H, s), 7.32 (1H,
m/z = 330






d), 7.62 (1H, s), 7.65 (1H, dd), 7.88
(M + H)






(1H, dd), 8.46 (1H, d), 8.50 (1H, d)



P224
phenyl
CF3
H
5.58 (2H, s), 6.81 (1H, m), 7.37 (4H,
m/z = 281






m), 7.77 (2H, m), 8.50 (1H, d)
(M + H)


P225
4-chlorophenyl
CF3
H
5.52 (2H, s), 6.85 (1H, m), 7.30 (2H,
m/z = 315






d), 7.36 (2H, d), 7.75 (1H, td), 7.84
(M + H)






(1H, d), 8.47 (1H, d)



P226
3-pyridyl
CF3
H
5.57 (2H, s), 6.86 (1H, m), 7.26-7.35
m/z = 282






(2H, m), 7.78 (1H, td), 7.86 (1H, m),
(M + H)






8.63 (2H, m), 8.67 (1H, d)



P227
6-chloro-5-fluoro-
CF3
H
5.54 (2H, s), 6.89 (1H, td), 7.76 (1H,
m/z = 334



3-pyridyl


dd), 7.80 (1H, td), 7.85 (1H, d), 8.29
(M + H)






(1H, d), 8.57 (1H, d)



P228
6-trifluoromethyl-
CF3
H
5.62 (2H, s), 6.90 (1H, t), 7.69 (1H,
m/z = 350



3-pyridyl


d), 7.81 (1H, t), 7.88 (1H, d), 8.06
(M + H)






(1H, d), 8.56 (1H, d), 8.78 (1H, s)



P229
6-fluoro-3-pyridyl
CF3
H
5.56 (2H, s), 6.89 (1H, td), 6.94 (1H,
m/z = 300






d), 7.79 (1H, td), 7.87 (1H, d), 8.03
(M + H)






(1H, m), 8.31 (1H, s), 8.54 (1H, d)



P230
5,6-dichloro-3-
CF3
H
5.49 (2H, s), 6.89 (1H, t), 7.79-7.90
m/z = 350



pyridyl


(2H, m), 8.04 (1H, d), 8.37 (1H, d),
(M + H)






8.56 (1H, m)
















TABLE 2









embedded image

















Compound




IR (KBr, v,


No.
Ar
R1a
Y

1H-NMR (CDCl3, δ, ppm)

cm−1) or MS





P231
6-bromo-3-pyridyl
CF3
H
5.52 (2H, s), 6.88 (1H, t), 7.48 (1H, d),
m/z = 360






7.78 (2H, m), 7.84 (1H, d), 8.44 (1H,
(M + H)






d), 8.53 (1H, d)



P232
6-chloro-3-pyridyl
CF3
4-F
5.52 (2H, s), 6.71 (1H, m), 7.35 (1H,
m/z = 334






d), 7.86 (1H, dd), 7.94 (1H, m), 8.33
(M + H)






(1H, dd), 8.44 (1H, d)



P233
6-chloro-3-pyridyl
CF3
3-F
5.53 (2H, s), 6.74 (1H, m), 7.33 (1H,
m/z = 334






d), 7.87 (1H, dd), 8.07 (1H, m), 8.29
(M + H)






(1H, dd), 8.45 (1H, d)



P234
6-chloro-3-pyridyl
CHCl2
H
5.54 (2H, s), 6.02 (1H, s), 6.77 (1H, t),
m/z = 330






7.32 (1H, m), 7.69 (1H, m), 7.77 (1H,
(M + H)






d), 7.89 (1H, m), 8.42 (1H, m), 8.49







(1H, s)



P235
6-chloro-3-pyridyl
CCl3
H
5.59 (2H, s), 6.86 (1H, t), 7.32 (1H,
m/z = 364






d), 7.78 (1H, td), 7.91 (2H, m), 8.43
(M + H)






(1H, d), 8.50 (1H, d)



P236
6-chloro-3-pyridyl
CH2Cl
H
4.17 (2H, s), 5.46 (2H, s), 6.64 (1H,
m/z = 296






td), 7.31 (1H, d), 7.60 (1H, td), 7.64
(M + H)






(1H, dd), 7.80 (1H, dd), 8.32 (1H, d),







8.45 (1H, d)



P238
6-chloro-3-pyridyl
CHF2
H
5.52 (2H, s), 5.90 (1H, t), 6.79 (1H,
m/z = 298






td), 7.33 (1H, d), 7.71 (1H, m), 7.77
(M + H)






(1H, dd), 7.85 (1H, dd), 8.45 (1H, d),







8.50 (1H, d)



P239
6-chloro-3-pyridyl
CF2Cl
H
5.56 (2H, s), 6.92 (1H, t), 7.33 (1H, d),
m/z = 332






7.82 (1H, m), 7.91 (1H, dd), 8.02 (1H,
(M + H)






d), 8.45 (1H, d), 8.48 (1H, d)



P240
6-chloro-3-pyridyl
CHClBr
H
5.53 (1H, d), 5.58 (1H, d), 6.06 (1H,
m/z = 374






s), 6.76 (1H, td), 7.32 (1H, d), 7.69
(M + H)






(1H, m), 7.70 (1H, m), 7.90 (1H, dd),







8.40 (1H, d), 8.50 (1H, d)



P241
6-chloro-3-pyridyl
CHBr2
H
5.56 (2H, s), 5.99 (1H, s), 6.78 (1H,
m/z = 418






td), 7.33 (1H, d), 7.69 (1H, td), 7.76
(M + H)






(1H, dd), 7.93 (1H, dd), 8.39 (1H, d),







8.50 (1H, d)



P242
6-chloro-3-pyridyl
CF2CF3
H
5.56 (2H, s), 6.90 (1H, td), 7.32 (1H,
m/z = 366






d), 7.79 (2H, m), 7.84 (1H, d), 8.43
(M + H)






(1H, d), 8.56 (1H, d)



P243
2-chloro-5-
CF3
H
5.54 (2H, s), 6.98 (1H, m), 7.87 (1H,
m/z = 317



pyrimidinyl


m), 8.18 (1H, m), 8.48 (1H, m), 8.83
(M + H)






(2H, m)



P244
6-chloro-3-pyridyl
CH2Br
H
4.17 (2H, s), 5.46 (2H, s), 6.63 (1H,







td), 7.31 (1H, d), 7.60 (1H, td), 7.65







(1H, dd), 7.80 (1H, dd), 8.32 (1H, d),







8.47 (1H, d)









(2) a nitrogen-containing heterocyclic derivative or a salt thereof having a 2-imino group represented by Formula (I) in (1), wherein Ar in Formula (I) is a 6-chloro-3-pyridyl group, a 6-chloro-5-fluoro-3-pyridyl group, a 6-fluoro-3-pyridyl group, a 6-bromo-3-pyridyl group, a 2-chloro-5-pyrimidinyl group, a 2-chloro-5-thiazolyl group, or a 5-chloro-2-pyradinyl group,


(3) a nitrogen-containing heterocyclic derivative or a salt thereof having a 2-imino group indicated in either (1) or (2) in the above, wherein A in the formula (I) is equivalent to formula (A-1) in (1), Y being a hydrogen atom, a halogen atom, or a cyano group,


(4) a nitrogen-containing heterocyclic derivative or a salt thereof having a 2-imino group indicated in any of (1) to (3) in the above, wherein R in the formula (I) is a (c) group of the following formula:




embedded image


(5) a nitrogen-containing heterocyclic derivative or a salt thereof having a 2-imino group indicated in any of (1) to (3) in the above, wherein R in the formula (I) is an (a) group of the following formula:




embedded image


(6) a nitrogen-containing heterocyclic derivative having a 2-imino group or a salt thereof according to any one of (1) to (3), wherein R in the Formula (I) is a group of Formula (d):




embedded image


in which R4 is a C1 to C18 alkyl group which may be substituted, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a substituted or unsubstituted (C6 to C10) aryl group, a substituted or unsubstituted (C6 to C10) aryl (C1 to C6) alkyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkenyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkynyl group, a substituted or unsubstituted phenoxy (C1 to C6) alkyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkenyl group, a substituted or unsubstituted phenoxy (C2 to C6) alkynyl group, a substituted or unsubstituted 5- to 10-membered heterocycle, a substituted or unsubstituted 5- to 10-membered heterocycle (C1 to C6) alkyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkenyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkynyl group, a (C1 to C4) alkoxy (C1 to C5) alkyl group, a (C1 to C4) alkoxy (C2 to C5) alkenyl group, a (C1 to C4) alkoxy (C2 to C5) alkynyl group, a (C1 to C4) alkylthio (C1 to C5) alkyl group, a (C1 to C4) alkylthio (C2 to C5) alkenyl group, a (C1 to C4) alkylthio (C2 to C5) alkynyl group, and R5 is a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, or a C2 to C6 alkynyl group which may be substituted with a halogen atom,


(7) a nitrogen-containing heterocyclic derivative or a salt thereof having a 2-imino group indicated in (1) in the above, the 2-imino group being N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroethanthioamide,


(8) a pest control agent including a nitrogen-containing heterocyclic derivative having a 2-imino group, which is described in any one of (1) to (7) or salts thereof,


(9) a method for controlling pests, using a nitrogen-containing heterocyclic derivative having a 2-imino group, which is described in any one of (1) to (7) or salts thereof, or a pest control agent described in (8),


(10) a method for controlling pests, including: treating seeds, roots, tubers, bulbs and rhizomes of plants, soil, a nutrient solution in nutrient solution culture, a solid medium in nutrient solution culture or a simple body that grows plants with a nitrogen-containing heterocyclic derivative having a 2-imino group, which is described in any one of (1) to (7) or salts thereof, or a pest control agent described in (8) to penetrate and migrate the compound into the plants,


(11) a method described in (9) or (10), in which the pest is an agricultural and horticultural pest,


(12) a method described in (9), in which the pest is an animal parasitic pest,


(13) a method described in (9) to (12), in which the pest is a drug-resistant pest,


(14) a method for preparing a compound represented by Formula (I-3) [in the formula, Ar, A, Y and R3 have the same meaning as those defined as Formula (I) in (1)],




embedded image


in which a reaction of converting an oxygen atom in the compound represented by Formula (II-3a) [in the formula, Ar, A, Y and R3 have the same meaning as those defined as Formula (I) in (1)] or




embedded image


Formula (II-3c) [in the formula, A, Y and R3 have the same meaning as those defined as Formula (I) in (1)]




embedded image


into a sulfur atom is performed, and


(15) a method for preparing a compound represented by Formula (I-4) (in which Ar, A, Y, R4 and R5 are defined as in Formula (I) of (1)):




embedded image


wherein a compound represented by Formula (II-4a):




embedded image


(in which Ar, A, Y and R5 are defined as in Formula (I) of (1)) is reacted with a compound represented by R4—NH2 (in which R4 is defined as in Formula (I) of (1)).


Advantageous Effects of Invention

It is possible to effectively perform pest control against cabbage moths, Spodoptera litura, aphids, planthoppers, leafhoppers, thrips and other numerous pests by using the nitrogen-containing heterocyclic derivative having a 2-imino group of the present invention.







DESCRIPTION OF EMBODIMENTS

In a nitrogen-containing heterocyclic derivative having a 2-imino group denoted in the formula (I) provided in the present invention, examples of a substituent that may be substituted with “a phenyl group which may be substituted” and “a 5- to 6-membered heterocycle which may be substituted”, which are represented by Ar, include a halogen atom, a C1 to C4 alkyl group which may be substituted with a halogen atom, a C1 to C4 alkyloxy group which may be substituted with a halogen atom, a hydroxyl group, a cyano group, a nitro group and the like, preferably a halogen atom, a trifluoromethyl group and a cyano group, and particularly preferably a halogen atom.


Specific examples of the “a phenyl group which may be substituted” represented by Ar of a nitrogen-containing heterocyclic derivative compound having a 2-imino group represented by Formula (I) include a phenyl group and a 3-cyano phenyl group.


“A 5- to 6-membered heterocycle which may be substituted”, represented by Ar of a nitrogen-containing heterocyclic derivative compound having a 2-imino group represented by Formula (I) represents an aromatic 5- to 6-membered heterocycle including one or two of a heteroatom such as an oxygen atom, a sulfur atom or a nitrogen atom, specific examples thereof include a pyridine ring, a pyrazine ring, a pyrimidine ring, a pyridazine ring, a thiazole ring, an oxazole ring and the like, and preferable aspects thereof include a 6-chloro-3-pyridyl group, a 6-chloro-5-fluoro-3-pyridyl group, a 6-bromo-3-pyridyl group, a 6-fluoro-3-pyridyl group, a 6-trifluoromethyl-3-pyridyl group, a 6-chloro-3-pyridazinyl group, a 5-chloro-2-pyrazinyl group, a 2-chloro-5-pyrimidinyl group, a 2-chloro-5-thiazolyl group, a 2-chloro-4-pyridyl group, and more preferably a 6-chloro-3-pyridyl group, a 6-fluoro-3-pyridyl group, a 6-chloro-5-fluoro-3-pyridyl group, a 6-bromo-3-pyridyl group and a 2-chloro-5-pyrimidinyl group.


Specific examples of “a 4- to 10-membered heterocycloalkyl group” represented by Ar of a nitrogen-containing hetero ring derivative having a 2-imino group represented by Formula (I) include a 2-tetrahydrofuranyl group, a 3-tetrahydrofuranyl group and the like and preferably a 3-tetrahydrofuranyl group.


“A heterocycle having a 5- to 10-membered unsaturated bond including one or more nitrogen atoms”, which A of a nitrogen-containing heterocyclic derivative having a 2-imino group, which is represented by Formula (I), represents, means




embedded image


in Formula (I), but represents any one ring represented by the following Formulas A-1 to A-40. In each formula, the end of a double bond is the substitution position of a nitrogen atom.




embedded image


embedded image


embedded image


embedded image


The ring is preferably the ring of Formulas A-1, A-13, A-14, A-15, A-16, A-23, A-25, A-38 and A-39 and more preferably the ring of Formula A-1.


“A C1 to C6 alkyl group which may be substituted with a halogen atom”, which Y of the nitrogen-containing heterocyclic derivative having a 2-imino group, which is represented by Formula (I), represents, is a C1 to C6 alkyl group, which is chained, branched, cyclic or combination thereof, and the upper limit of the number of halogen atoms which may be substituted is the number of hydrogen atoms which the alkyl group has. When a branched or cyclic alkyl group is included, it is obvious that the number of carbons is 3 or more.


Specific examples of “a C1 to C6 alkyloxy group which may be substituted with a halogen atom” which Y represents include a methoxy group, an ethoxy group, a trifluoromethyloxy group and a difluoromethyloxy group.


A preferred aspect of Y is preferably a hydrogen atom or a halogen atom and more preferably a hydrogen atom.


In Formula (I), when R represents a Formula (a) group, “a substituted C1 to C6 alkyl group” which R1 represents is an alkyl group having 1 to 6 carbon atoms, which is chained, branched, cyclic or combination thereof, and the upper limit of the number of substituted substituents is the number of hydrogen atoms which the alkyl group has. Examples of the substituent include a halogen atom, a hydroxyl group, a cyano group, a nitro group, a phenyl group (this phenyl group may be substituted with a C1 to C4 alkyl group which may be substituted with a halogen, a C1 to C4 alkyloxy group which may be substituted with a halogen, a hydroxyl group, or a halogen atom), a phenoxy group (this phenoxy group may be substituted with a C1 to C4 alkyl group which may be substituted with a halogen, a C1 to C4 alkyloxy group which may be substituted with a halogen, a hydroxyl group, or a halogen atom), a benzyloxy group (the phenyl group in this benzyloxy group may be substituted with a C1 to C4 alkyl group which may be substituted with a halogen, a C1 to C4 alkyloxy group which may be substituted with a halogen, a hydroxyl group, or a halogen atom), and the like. Specific examples of the substituent include a trifluoromethyl group, a trichloromethyl group, a difluorochloromethyl group, a difluoromethyl group, a dichloromethyl group, a dibromomethyl group, a chloromethyl group, a difluoroethyl group, a dichloroethyl group, a 2,2,2-trifluoroethyl group, a pentafluoroethyl group, a difluorocyclopropyl group, a 2-cyanoethyl group, and a 2-nitroethyl group, and the like. Preferably, the C1-C6 alkyl group is a 2,2,2-trifluoroethyl group, a trifluoromethyl group, a difluorochloromethyl group, a difluoromethyl group, and a pentafluoroethyl group, and more preferably, the substituent is a trifluoromethyl group, a difluorochloromethyl group, a difluoromethyl group, and a pentafluoroethyl group, and particularly, a trifluoromethyl group.


In Formula (I), “a C1 to C6 alkyl group which may be substituted with a halogen atom”, which R3 when R represents a Formula (c) group, R5 when R represents a Formula (d) group, R7 when R represents a Formula (e) group, Ry when R represents a Formula (y), and Rz when R represents a Formula (z) each represent, is an alkyl group having 1 to 6 carbon atoms, which is chained, branched, cyclic or combination thereof, and the upper limit of the number of substituted halogen atoms is the number of hydrogen atoms which the alkyl group has. When a branched or cyclic alkyl group is included, it is obvious that the number of carbons is 3 or more. Specific examples of the C1-C6 alkyl group include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, a t-butyl group, a cyclopropyl group, a cyclopentyl group, a cyclohexyl group, a trifluoromethyl group, a trichloromethyl group, a difluorochloromethyl group, a difluoromethyl group, a dichloromethyl group, a dibromomethyl group, a chloromethyl group, a difluoroethyl group, a dichloroethyl group, a 2,2,2-trifluoroethyl group, a pentafluoroethyl group, a difluorocyclopropyl group, a trifluoroisopropyl group, and a hexafluoroisopropyl group, and the like.


R3 is, preferably, an ethyl group, an isopropyl group, a cyclopropyl group, a trifluoromethyl group, a difluorochloromethyl group, a difluoromethyl group, and a pentafluoroethyl group, more preferably, a trifluoromethyl group, a difluorochloromethyl group, a difluoromethyl group, and a pentafluoroethyl group, and particularly preferably, a trifluoromethyl group. R5 is, preferably, a trifluoromethyl group, a trichloromethyl group, a dichloromethyl group, a difluoromethyl group, a difluorochloromethyl group, a chloromethyl group, and a pentafluoroethyl group, more preferably, a trifluoromethyl group, a difluoromethyl group, a difluorochloromethyl group, a pentafluoroethyl group, and particularly preferably, a trifluoromethyl group. R7 is, preferably, a trifluoromethyl group, a trichloromethyl group, a dichloromethyl group, a difluoromethyl group, a difluorochloromethyl group, a chloromethyl group, and a pentafluoroethyl group, more preferably, a trifluoromethyl group, a difluoromethyl group, a difluorochloromethyl group, and a pentafluoroethyl group, and particularly preferably, a trifluoromethyl group.


Ry is preferably a methyl group, ethyl group, propyl group or isopropyl group. Rz is preferably a methyl group or trifluoromethyl group.


In Formula (I), when R represents a Formula (b) group, “a C1 to C6 alkyl group which is substituted with a halogen atom” which R2 represents is an alkyl group having 1 to 6 carbon atoms, which is chained, branched, cyclic or combination thereof, and the upper limit of the number of substituted halogen atoms is the number of hydrogen atoms which the alkyl group has. When a branched or cyclic alkyl group is included, it is obvious that the number of carbons is 3 or more. Specific examples of the C1-C6 alkyl group includes a trifluoromethyl group, a trichloromethyl group, a difluorochloromethyl group, a difluoromethyl group, a dichloromethyl group, a dibromomethyl group, a chloromethyl group, a difluoroethyl group, a dichloroethyl group, a 2,2,2-trifluoroethyl group, a 1-(trifluoromethyl)ethyl group, a 1-trifluoromethyl-2,2,2-trifluoroethyl group, a pentafluoroethyl group, and a difluorocyclopropyl group, and the like, and preferably, the alkyl group is a 2,2,2-trifluoroethyl group, a 1-(trifluoromethyl)ethyl group, a 1-trifluoromethyl-2,2,2-trifluoroethyl group, a pentafluoroethyl group, and a difluorocyclopropyl group, and the like, and preferably, the alkyl group is a 2,2,2-trifluoroethyl group, a 1-(trifluoromethyl)ethyl group, and a 1-trifluoromethyl-2,2,2-trifluoroethyl group.


In Formula (I), “a C1 to C18 alkyl group which may be substituted”, which R4 when R represents a Formula (d) group and R6 when R represents a Formula (e) group represent, is an alkyl group having 1 to 18 carbon atoms, which is chained, branched, cyclic or combination thereof, and the upper limit of the number of substituents which may be substituted is the number of hydrogen atoms which the alkyl group has. When a branched or cyclic alkyl group is included, it is obvious that the number of carbons is 3 or more. Examples of the substituent which may be substituted with C1-C18 alkyl group include a halogen atom, a hydroxyl group, a cyano group, and a nitro group. Specific examples of C1-C18 alkyl group include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an s-butyl group, a t-butyl group, a 3-methyl-2-butyl group, a 3-pentyl group, a 4-heptyl group, a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, an n-octyl group, an n-tridecyl group, an n-hexadecyl group, an n-octadecyl group, a trifluoromethyl group, a trichloromethyl group, a difluorochloromethyl group, a difluoromethyl group, a dichloromethyl group, a dibromomethyl group, a chloromethyl group, a difluoroethyl group, a dichloroethyl group, a 2,2,2-trifluoroethyl group, a pentafluoroethyl group, a difluorocyclopropyl group, a 2-hydroxyethyl group, a 2-hydroxy-n-propyl group, a 3-hydroxy-n-propyl group, a 2,3-dihydroxy-n-propyl group, a cyanomethyl group, a 2-cyanoethyl group, and a 2-nitroethyl group, and the like.


R4 is, preferably, a methyl group, an ethyl group, a 2,2,2-trifluoroethyl group, a 2,2-difluoroethyl group, an n-propyl group, an isopropyl group, a cyclopropyl group, a t-butyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, and a 2-hydroxyethyl group, and more preferably, a methyl group, an ethyl group, an isopropyl group, an n-butyl group, a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, and a cyclohexyl group. R6 is, preferably, a methyl group, an ethyl group, an isopropyl group, a cyclopropyl group, a t-butyl group, and a cyanomethyl group, and more preferably, a methyl group, an ethyl group, a cyclopropyl group, and a t-butyl group.


In Formula (I), “a C1 to C6 alkyl group which may be substituted with a halogen atom”, which R4a when R represents a Formula (f) group, R4b when R represents a Formula (g) group, R4c when R represents a Formula (h) group, R6a when R represents a Formula (o) group, R6b when R represents a Formula (p) group, R6c when R represents a Formula (q) group, R4d when R represents a Formula (i), (j), (k) or (1) group, R4e and R4f when R represents Formulas (m) and (n) groups, R6d when R represents a Formula (r), (s), (t) or (u) group, R6e and R6f when R represents a Formula (v) group, R6g and R6h when R represents a Formula (w) group, and R6i, R6j and R6k when R represents a Formula (x) group represent, is an alkyl group having 1 to 6 carbon atoms, which is chained, branched, cyclic or combination thereof, and the upper limit of the number of substituted halogen atoms is the number of hydrogen atoms which the alkyl group has. When a branched or cyclic alkyl group is included, it is obvious that the number of carbons is 3 or more. Specific examples of the C1-C6 alkyl group include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, a t-butyl group, a cyclopropyl group, a cyclopentyl group, a cyclohexyl group, a trifluoromethyl group, a trichloromethyl group, a difluorochloromethyl group, a difluoromethyl group, a dichloromethyl group, a dibromomethyl group, a chloromethyl group, a difluoroethyl group, a 2-chloroethyl group, a dichloroethyl group, a 2,2,2-trifluoroethyl group, a pentafluoroethyl group, and a difluorocyclopropyl group, and the like. R6a is, preferably, a methyl group, an ethyl group, an isopropyl group, and a cyclopropyl group. R6b is, preferably, a methyl group.


“A C2 to C6 alkenyl group which may be substituted with a halogen atom”, which R1, R2, R3, R4, R4a, R4b, R4c, R5, R6, R6a, R6b, R6c, R7, R4d, R4e, R4f, R6d, R6e, R6f, R6g, R6h, R6i, R6j, R6k, Ry and Rz represent, is an alkenyl group having 2 to 6 carbon atoms, which is chained, branched, cyclic or combination thereof, and the upper limit of the number of substituted halogen atoms is the number of hydrogen atoms which the alkenyl group has. When a branched or cyclic alkenyl group is included, it is obvious that the number of carbons is 3 or more. Specifically, the C2-C6 alkenyl group is an ethenyl group, a 1-propenyl group, a 2-propenyl group, a 2-fluoro-1-propenyl group, a 2-methyl-1-propenyl group, and the like. R6 is, preferably, a 2-propenyl group, and R6a is, preferably, an ethenyl group.


“A C2 to C6 alkynyl group which may be substituted with a halogen atom”, which R1, R2, R3, R4, R4a, R4b, R4c, R5, R6, R6a, R6b, R6c, R7, R4d, R4e, R4f, R6d, R6e, R6f, R6g, R6h, R6i, R6j, R6k, Ry and Rz represent, is an alkynyl group having 2 to 6 carbon atoms, which is chained, branched or combination thereof, and the upper limit of the number of substituted halogen atoms is the number of hydrogen atoms which the alkynyl group has. When a branched or cyclic alkynyl group is included, it is obvious that the number of carbons is 3 or more. Specific examples thereof include a 1-propynyl group, a 2-propynyl group, a 1-butynyl group, a 2-butynyl group, a 1-pentynyl group, a 2-pentynyl group, a 3-pentynyl group and the like, and preferred examples thereof include a 1-propynyl group, a 2-propynyl group and a 2-butynyl group.


The (C6 to C10) aryl of “a substituted or unsubstituted (C6 to C10) aryl group, a substituted or unsubstituted (C6 to C10) aryl (C1 to C6) alkyl group, a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkenyl group and a substituted or unsubstituted (C6 to C10) aryl (C2 to C6) alkynyl group”, which R2, R3, R4, R4a, R4b, R4c, R5, R6, R6a, R6b, R6c, R7, Ry and Rz represent, specifically represents a phenyl group and a naphthyl group, and the (C1 to C6) alkyl group, the (C2 to C6) alkenyl group and the (C2 to C6) alkynyl group may have a straight chain, branch or ring. Examples of the substituent which may be substituted with an aryl group include a halogen atom, a C1 to C4 alkyl group which may be substituted with halogen, a C1 to C4 alkyloxy group which may be substituted with halogen, a C3 to C6 cyclic alkyl group, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group and the like. Specific examples of the (C6-C10) aryl include a phenyl group, a benzyl group, a 2-phenylethyl group, a 2-phenylethenyl group, a 2-phenylethynyl group, a 4-methylphenyl group, a 2-cyanophenyl group, a 3-chlorophenyl group, a 4-methoxyphenyl group, and a 3-cyanophenyl group, a 1,1-diphenylmethyl group, a naphthylethyl group, a naphthylpropyl group, and the like, and preferably, a benzyl group, a 2-phenylethyl group, a naphthylethyl group, and a naphthylpropynyl group.


The (C1 to C6) alkyl group, (C2 to C6) alkenyl group and (C2 to C6) alkynyl group of “a substituted or unsubstituted phenoxy group (C1 to C6) alkyl group, a substituted or unsubstituted phenoxy group (C2 to C6) alkenyl group and a substituted or unsubstituted phenoxy group (C2 to C6) alkynyl group”, which R3, R4, R4a, R4b, R4c, R5, R6, R6a, R6b, R6c, R7, Ry and Rz represent, may have a straight chain, branch or ring. Examples of the substituent which may be substituted with a phenoxy group include a halogen atom, a C1 to C4 alkyl group which may be substituted with halogen, a C1 to C4 alkyloxy group which may be substituted with halogen, a C3 to C6 cyclic alkyl group, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group and the like. Specific examples of the (C1 to C6) alkyl group, a (C2 to C6) alkenyl group, and the (C2 to C6) alkynyl group include a phenoxy group, a phenoxymethyl group, a 2-phenoxyethyl group, a 2-phenoxyethenyl group, a 2-phenoxyethynyl group, a 4-chlorophenoxy group, and a 2-methylphenoxy group, and the like, and preferably, a 2-phenoxyethyl group.


The 5- to 10-membered heterocycle of “a substituted or unsubstituted 5- to 10-membered heterocycle, a substituted or unsubstituted 5- to 10-membered heterocycle (C1 to C6) alkyl group, a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkenyl group and a substituted or unsubstituted 5- to 10-membered heterocycle (C2 to C6) alkynyl group”, which R2, R3, R4, R4a, R4b, R4c, R5, R6, R6a, R6b, R6c, R7, Ry and Rz represent, represents a ring including one to four heteroatoms such as an oxygen atom, a sulfur atom or a nitrogen atom and the like as an atom constituting the ring, and examples thereof include a furanyl group, a thienyl group, a pyridyl group, a pyrrolidinyl group, a piperidinyl group, a piperazinyl group, a pyrimidinyl group, a morpholinyl group, a thiazolyl group, an imidazolyl group, a triazolyl group, a tetrahydrofuranyl group, a quinolinyl group and the like. Examples of the substituent which may be substituted with a heterocycle include a halogen atom, a C1 to C4 alkyl group which may be substituted with halogen, a C1 to C4 alkyloxy group which may be substituted with halogen, a C3 to C6 cyclic alkyl group, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group and the like. The (C1 to C6) alkyl group, (C2 to C6) alkenyl group and (C2 to C6) alkenyl group may have a straight chain, branch or ring. Specifically, the 5- to 10-membered heterocycle is a 2-pyridyl group, a 3-pyridyl group, a 4-pyridyl group, a 2-pyridylmethyl group, a 3-pyridylmethyl group, a 4-pyridylmethyl group, a 2-(4-pyridyl)ethenyl group, a 2-(4-pyridyl)ethynyl group, a 2-furanylmethyl group, a 2-thienylmethyl group, a 2-tetrahydrofuranylmethyl group, and the like, and R4 is, preferably, a 2-pyridylmethyl group, a 3-pyridylmethyl group, a 4-pyridylmethyl group, a 2-furanylmethyl group, a 2-thienylmethyl group, and a 2-tetrahydrofuranylmethyl group.


The (C1 to C4) alkoxy of “a (C1 to C4) alkoxy (C1 to C5) alkyl group, a (C1 to C4) alkoxy (C2 to C5) alkenyl group and a (C1 to C4) alkoxy (C2 to C5) alkynyl group”, which R3, R4, R4a, R4b, R4c, R5, R6, R6a, R6b, R6c, R7, R6e, R6f and Rz represent, represents a (C1 to C4) alkyloxy, alkenyloxy and alkynyloxy having a straight chain, branch or ring. Specific examples of the (C1 to C4) alkoxy includes a methoxymethyl group, a 2-methoxyethyl group, an ethoxymethyl group, a 2-ethoxyethyl group, a 3-methoxy-2-propenyl group, and a 3-methoxy-2-propynyl group, and the like, and R4 is, preferably, a 2-methoxyethyl group.


The (C1 to C4) alkylthio of “a (C1 to C4) alkylthio (C1 to C5) alkyl group, a (C1 to C4) alkylthio (C2 to C5) alkenyl group and a (C1 to C4) alkylthio (C2 to C5) alkynyl group”, which R3, R4, R4a, R4b, R4c, R5, R6, R6a, R6b, R6c, R7, R6e, R6f and Rz represent, represents a (C1 to C4) alkylthio, alkenylthio and alkynylthio having a straight chain, branch or ring. The (C1 to C4) alkylthio includes a methylthiomethyl group, a 2-methylthioethyl group, an ethylthiomethyl group, a 2-ethylthioethyl group, a 3-methylthio-2-propenyl group, and a 3-methylthio-2-propynyl group, and the like, and R4 is, preferably, a 2-methylthioethyl group.


The (C6 to C10) aryl group of “a substituted or unsubstituted (C6 to C10) aryl group”, which R4d, R4e, R4f, R6d, R6e, R6f, R6g, R6h, R6i, R6j and R6k represent, specifically represents a phenyl group and a naphthyl group, and the (C1 to C6) alkyl group, (C2 to C6) alkenyl group and (C2 to C6) alkynyl group may have a straight chain, branch or ring. Examples of the substituent which may be substituted with an aryl group include a halogen atom, a C1 to C4 alkyl group which may be substituted with halogen, a C1 to C4 alkyloxy group which may be substituted with halogen, a C3 to C6 cyclic alkyl group, a methylsulfonyl group, a methoxy group, a nitro group, a cyano group and the like. Specific examples of the (C6-C10) aryl include a phenyl group, a 2-methylphenyl group, a 3-methoxyphenyl group, a 4-nitrophenyl group, and a 4-cyanophenyl group.


The 5- to 10-membered heterocycle of “a substituted or unsubstituted 5- to 10-membered heterocycle”, which R4d, R4e, R4f, R6d, R6e, R6f, R6g and R6h represent, represents a ring including one to four heteroatoms such as an oxygen atom, a sulfur atom or a nitrogen atom and the like as an atom constituting the ring, and examples thereof include a furanyl group, a thienyl group, a pyridyl group, a pyrrolidinyl group, a piperidinyl group, a piperazinyl group, a pyrimidinyl group, a morpholinyl group, a thiazolyl group, an imidazolyl group, a triazolyl group, a tetrahydrofuranyl group, a quinolinyl group and the like. The substituent which may be substituted with a heterocycle includes a halogen atom, a C1 to C4 alkyl group which may be substituted with a halogen, a C1 to C4 alkyloxy group which may be substituted with a halogen, a C3 to C6 cyclic alkyl group, a methylsulphonyl group, a methoxy group, a nitro group, and a cyano group, and the like. Specific examples of the 5- to 10-membered heterocycle include a 2-pyridyl group, a 3-pyridyl group, a 4-pyridyl group, a 2-furanyl group, a 2-thienyl group, and a 2-tetrahydrofuranyl group, and the like.


As a preferred aspect of a compound represented by Formula (I),


R represents the following Formula (a) group




embedded image


Ar represents a 6-chloro-3-pyridyl group, a 2-chloro-5-thiazolyl group, a 6-chloro-5-fluoro-3-pyridyl group, a 6-fluoro-3-pyridyl group, a 6-bromo-3-pyridyl group, a 2-chloro-5-pyrimidinyl group, a 6-trifluoromethyl-3-pyridyl group and a 2-chloro-5-pyrimidinyl group,


A represents a ring represented by A-1, A-13, A-14, A-15, A-16, A-23 and A-38,


Y represents a hydrogen atom and a 3-cyano group, and


R1 represents a trifluoromethyl group, a difluoromethyl group, a chlorodifluoromethyl group, a pentafluoroethyl group, a trifluoroethyl group, an ethenyl group and a 2-propynyl group.


As another preferred aspect of a compound represented by Formula (I),


R represents the following Formula (c) group




embedded image


Ar represents a 6-chloro-3-pyridyl group, a 2-chloro-5-thiazolyl group, a 6-chloro-5-fluoro-3-pyridyl group, a 6-fluoro-3-pyridyl group, a 6-bromo-3-pyridyl group, a 2-chloro-5-pyrimidyl group and a 6-trifluoromethyl-3-pyridyl group,


A represents a ring represented by A-1,


Y represents a hydrogen atom, and


R3 represents a trifluoromethyl group, a difluoromethyl group, a chlorodifluoromethyl group and a pentafluoroethyl group.


As still another preferred aspect of a compound represented by Formula (I),


R represents the following Formula (d) group




embedded image


Ar represents a 6-chloro-3-pyridyl group, a 6-chloro-5-fluoro-3-pyridyl group, a 6-fluoro-3-pyridyl group, a 6-bromo-3-pyridyl group and a 2-chloro-5-pyrimidyl group,


A represents a ring represented by A-1,


Y represents a hydrogen atom,


R4 represents a hydrogen atom, a methyl group, an ethyl group, an n-propyl group, an isopropyl group, a cyclopropyl group, a cyclobutyl group, a cyclohexyl group, and a cyclopentyl group, and


R5 represents a trifluoromethyl group, a difluoromethyl group, a chlorodifluoromethyl group and a pentafluoroethyl group.


As still another preferred aspect of a compound represented by Formula (I),


R represents the following Formula (e) group




embedded image


Ar represents a 6-chloro-3-pyridyl group, a 6-chloro-5-fluoro-3-pyridyl group, a 6-fluoro-3-pyridyl group, a 6-bromo-3-pyridyl group and a 2-chloro-5-pyrimidyl group,


A represents a ring represented by A-1,


Y represents a hydrogen atom,


R6 represents a hydrogen atom, a methyl group, an ethyl group, a 2-propenyl group, a methylcarbonyl group, a ethylcarbonyl group, a cyclopropylcarbonyl group, an ethenylcarbonyl group, 2-propylcarbonyl group, benzoyl group, 3-pyridylcarbonyl group, methyloxycarbonyl group, and a phenyloxycarbonyl group, and


R7 represents a trifluoromethyl group, a difluoromethyl group, a chlorodifluoromethyl group and a pentafluoroethyl group.


The nitrogen-containing heterocyclic derivative having a 2-imino group may be a hydrochloride salt, nitrate salt, sulfate salt, phosphate salt, acetate salt or other acid addition salt.


Specific examples of the compound represented by Formula (I) include compounds shown in the following Table A (Tables 3 to 21) and Table B (Tables 22 to 37).









TABLE 3







Table A













Compound







No.
Ar
A
Y
R
















Table 1
1-5~1-710
6-Chloro-3-pyridyl
A-1
H
represents a







combination of







substituents







corresponding to







each row of Nos. (1







and 6) below of Table B


Table 2
2-1~2-710
2-Chloro-5-thiazolyl
A-1
H
represents a







combination of







substituents







corresponding to







each row of Table B


Table 3
3-2~3-710
6-Fluoro-3-pyridyl
A-1
H
represents a







combination of







substituents







corresponding to







each row of Nos. (1







and 3) below of Table B


Table 4
4-2~4-710
6-Bromo-3-pyridyl
A-1
H
represents a







combination of







substituents







corresponding to







each row of Nos. (1







and 3) below of Table B


Table 5
5-2~5-710
6-Chloro-5-fluoro-
A-1
H
represents a




3-pyridyl


combination of







substituents







corresponding to







1 each row of Nos. (1







and 3) below of Table B


Table 6
6-2~6-710
2-Chloro-5-pyrimidinyl
A-1
H
represents a







combination of







substituents







corresponding to







each row of Nos. (1







and 3) below of Table B


Table 7
7-1~7-710
5-Chloropyrazin-
A-1
H
represents a




2-yl


combination of







substituents







corresponding to







each row of Table B


Table 8
8-1~8-710
6-Chloropyridazin-
A-1
H
represents a




3-yl


combination of







substituents







corresponding to







each row of Table B


Table 9
9-1~9-
2-Chloro-5-oxazolyl
A-1
H
represents a



710



combination of







substituents







corresponding to







each row of Table B


Table
10-1~10-
6-trifluoromethyl-
A-1
H
represents a


10
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
11-1~11-
3-tetrahydrofuranyl
A-1
H
represents a


11
710



combination of







substituents







corresponding to







each row of Table B


Table
12-1~12-
2-Chloro-4-pyridyl
A-1
H
represents a


12
710



combination of







substituents







corresponding to







each row of Table B


Table
13-1~13-
3-Cyanophenyl
A-1
H
represents a


13
710



combination of







substituents







corresponding to







each row of Table B


Table
14-1~14-
6-Chloro-3-pyridyl
A-1
3-F
represents a


14
710



combination of







substituents







corresponding to







each row of Table B


Table
15-1~15-
2-Chloro-5-thiazolyl
A-1
3-F
represents a


15
710



combination of







substituents







corresponding to







each row of Table B


Table
16-1~16-
6-Fluoro-3-pyridyI
A-1
3-F
represents a


16
710



combination of







substituents







corresponding to







each row of Table B


Table
17-1~17-
6-Bromo-3-pyridyl
A-1
3-F
represents a


17
710



combination of







substituents







corresponding to







each row of Table B


Table
18-1~18-
6-Chloro-5-fluoro-
A-1
3-F
represents a


18
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
19-1~19-
2-Chloro-5-pyrimidinyl
A-1
3-F
represents a


19
710



combination of







substituents







corresponding to







each row of Table B


Table
20-1~20-
5-Chloropyrazin-
A-1
3-F
represents a


20
710
2-yl


combination of







substituents







corresponding to







each row of Table B


Table
21-1~21-
6-Chloropyridazin-
A-1
3-F
represents a


21
710
3-yl


combination of







substituents







corresponding to







each row of Table B


Table
22-1~22-
2-Chloro-5-oxazolyl
A-1
3-F
represents a


22
710



combination of







substituents







corresponding to







each row of Table B


Table
23-1~23-
6-trifluoromethyl-
A-1
3-F
represents a


23
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
24-1~24-
3-tetrahydrofuranyl
A-1
3-F
represents a


24
710



combination of







substituents







corresponding to







each row of Table B


Table
25-1~25-
6-Chloro-3-pyridyl
A-1
4-F
represents a


25
710



combination of







substituents







corresponding to







each row of Table B


Table
26-1~26-
2-Chloro-5-thiazolyl
A-1
4-F
represents a


26
710



combination of







substituents







corresponding to







each row of Table B


Table
27-1~27-
6-Fluoro-3-pyridyl
A-1
4-F
represents a


27
710



combination of







substituents







corresponding to







each row of Table B


Table
28-1~28-
6-Bromo-3-pyridyl
A-1
4-F
represents a


28
710



combination of







substituents







corresponding to







each row of Table B


Table
29-1~29-
6-Chloro-5-fluoro-
A-1
4-F
represents a


29
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
30-1~30-
2-Chloro-5-pyrimidinyl
A-1
4-F
represents a


30
710



combination of







substituents







corresponding to







each row of Table B


Table
31-1~31-
5-Chloropyrazin-
A-1
4-F
represents a


31
710
2-yl


combination of







substituents







corresponding to







each row of Table B


Table
32-1~32-
6-Chloropyridazin-
A-1
4-F
represents a


32
710
3-yl


combination of







substituents







corresponding to







each row of Table B
















TABLE 4







Table A













Compound







No.
Ar
A
Y
R
















Table
33-1~33-
2-Chloro-5-oxazolyl
A-1
4-F
represents a


33
710



combination of







substituents







corresponding to







each row of Table B


Table
34-1~34-
6-trifluoromethyl-
A-1
4-F
represents a


34
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
35-1~35-
3-tetrahydrofuranyl
A-1
4-F
represents a


35
710



combination of







substituents







corresponding to







each row of Table B


Table
36-1~36-
6-Chloro-3-pyridyl
A-1
5-F
represents a


36
710



combination of







substituents







corresponding to







each row of Table B


Table
37-1~37-
2-Chloro-5-thiazolyl
A-1
5-F
represents a


37
710



combination of







substituents







corresponding to







each row of Table B


Table
38-1~38-
6-Fluoro-3-pyridyl
A-1
5-F
represents a


38
710



combination of







substituents







corresponding to







each row of Table B


Table
39-1~39-
6-Bromo-3-pyridyl
A-1
5-F
represents a


39
710



combination of







substituents







corresponding to







each row of Table B


Table
40-1~40-
6-Chloro-5-fluoro-
A-1
5-F
represents a


40
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
41-1~41-
2-Chloro-5-pyrimidinyl
A-1
5-F
represents a


41
710



combination of







substituents







corresponding to







each row of Table B


Table
42-1~42-
5-Chloropyrazin-
A-1
5-F
represents a


42
710
2-yl


combination of







substituents







corresponding to







each row of Table B


Table
43-1~43-
6-Chloropyridazin-
A-1
5-F
represents a


43
710
3-yl


combination of







substituents







corresponding to







each row of Table B


Table
44-1~44-
2-Chloro-5-oxazolyl
A-1
5-F
represents a


44
710



combination of







substituents







corresponding to







each row of Table B


Table
45-1~45-
6-trifluoromethyl-
A-1
5-F
represents a


45
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
46-1~46-
3-tetrahydrofuranyl
A-1
5-F
represents a


46
710



combination of







substituents







corresponding to







each row of Table B


Table
47-1~47-
6-Chloro-3-pyridyl
A-1
6-F
represents a


47
710



combination of







substituents







corresponding to







each row of Table B


Table
48-1~48-
2-Chloro-5-thiazolyl
A-1
6-F
represents a


48
710



combination of







substituents







corresponding to







each row of Table B


Table
49-1~49-
6-Fluoro-3-pyridyl
A-1
6-F
represents a


49
710



combination of







substituents







corresponding to







each row of Table B


Table
50-1~50-
6-Bromo-3-pyridyl
A-1
6-F
represents a


50
710



combination of







substituents







corresponding to







each row of Table B


Table
51-1~51-
6-Chloro-5-fluoro-
A-1
6-F
represents a


51
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
52-1~52-
2-Chloro-5-pyrimidinyl
A-1
6-F
represents a


52
710



combination of







substituents







corresponding to







each row of Table B


Table
53-1~53-
5-Chloropyrazin-
A-1
6-F
represents a


53
710
2-yl


combination of







substituents







corresponding to







each row of Table B


Table
54-1~54-
6-Chloropyridazin-
A-1
6-F
represents a


54
710
3-yl


combination of







substituents







corresponding to







each row of Table B


Table
55-1~55-
2-Chloro-5-oxazolyl
A-1
6-F
represents a


55
710



combination of







substituents







corresponding to







each row of Table B


Table
56-1~56-
6-trifluoromethyl-
A-1
6-F
represents a


56
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
57-1~57-
3-tetrahydrofuranyl
A-1
6-F
represents a


57
710



combination of







substituents







corresponding to







each row of Table B


Table
58-1~58-
6-Chloro-3-pyridyl
A-1
3-
represents a


58
710


Cl
combination of







substituents







corresponding to







each row of Table B


Table
59-1~59-
2-Chloro-5-thiazolyl
A-1
3-
represents a


59
710


Cl
combination of







substituents







corresponding to







each row of Table B


Table
60-1~60-
6-Fluoro-3-pyridyl
A-1
3-
represents a


60
710


Cl
combination of







substituents







corresponding to







each row of Table B


Table
61-1~61-
6-Bromo-3-pyridyl
A-1
3-
represents a


61
710


Cl
combination of







substituents







corresponding to







each row of Table B


Table
62-1~62-
6-Chloro-5-fluoro-
A-1
3-
represents a


62
710
3-pyridyl

Cl
combination of







substituents







corresponding to







each row of Table B


Table
63-1~63-
2-Chloro-5-pyrimidinyl
A-1
3-
represents a


63
642


Cl
combination of







substituents







corresponding to







each row of Table B


Table
64-1~64-
5-Chloropyrazin-
A-1
3-
represents a


64
710
2-yl

Cl
combination of







substituents







corresponding to







each row of Table B
















TABLE 5







Table A













Compound







No.
Ar
A
Y
R
















Table
65-
6-
A-1
3-
represents a


65
1~65-
Chloropyridazin-

Cl
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
66-
2-Chloro-5-
A-1
3-
represents a


66
1~66-
oxazolyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
67-
6-
A-1
3-
represents a


67
1~67-
trifluoromethyl-

Cl
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
68-
3-
A-1
3-
represents a


68
1~68-
tetrahydro-

Cl
combination of



710
furanyl


substituents







corresponding to







each row of







Table B


Table
69-
6-Chloro-3-
A-1
4-
represents a


69
1~69-
pyridyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
70-
2-Chloro-5-
A-1
4-
represents a


70
1~70-
thiazolyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
71-
6-Fluoro-3-
A-1
4-
represents a


71
1~71-
pyridyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
72-
6-Bromo-3-
A-1
4-
represents a


72
1~72-
pyridyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
73-
6-Chloro-5-
A-1
4-
represents a


73
1~73-
fluoro-3-

Cl
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
74-
2-Chloro-5-
A-1
4-
represents a


74
1~74-
pyrimidinyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
75-
5-
A-1
4-
represents a


75
1~75-
Chloropyrazin-

Cl
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
76-
6-
A-1
4-
represents a


76
1~76-
Chloropyridazin-

Cl
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
77-
2-Chloro-5-
A-1
4-
represents a


77
1~77-
oxazolyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
78-
6-
A-1
4-
represents a


78
1~78-
trifluoromethyl-

Cl
combination of



710
3-pyridyI


substituents







corresponding to







each row of







Table B


Table
79-
3-
A-1
4-
represents a


79
1~79-
tetrahydro-

Cl
combination of



710
furanyl


substituents







corresponding to







each row of







Table B


Table
80-
6-Chloro-3-
A-1
5-
represents a


80
1~80-
pyridyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
81-
2-Chloro-5-
A-1
5-
represents a


81
1~81-
thiazolyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
82-
6-Fluoro-3-
A-1
5-
represents a


82
1~82-
pyridyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
83-
6-Bromo-3-
A-1
5-
represents a


83
1~83-
pyridyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
84-
6-Chloro-5-
A-1
5-
represents a


84
1~84-
fluoro-3-

Cl
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
85-
2-Chloro-5-
A-1
5-
represents a


85
1~85-
pyrimidinyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
86-
5-
A-1
5-
represents a


86
1~86-
Chloropyrazin-

Cl
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
87-
6-
A-1
5-
represents a


87
1~87-
Chloropyridazin-

Cl
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
88-
2-Chloro-5-
A-1
5-
represents a


88
1~88-
oxazolyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
89-
6-
A-1
5-
represents a


89
1~89-
trifluoromethyl-

Cl
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
90-
3-
A-1
5-
represents a


90
1~90-
tetrahydro-

Cl
combination of



710
furanyl


substituents







corresponding to







each row of







Table B


Table
91-
6-Chloro-3-
A-1
6-
represents a


91
1~91-
pyridyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
92-
2-Chloro-
A-1
6-
represents a


92
1~92-
5-thiazolyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
93-
6-Fluoro-3-
A-1
6-Cl
represents a


93
1~93-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
94-
6-Bromo-3-
A-1
6-
represents a


94
1~94-
pyridyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
95-
6-Chloro-5-
A-1
6-
represents a


95
1~95-
fluoro-3-

Cl
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
96-
2-Chloro-5-
A-1
6-
represents a


96
1~96-
pyrimidinyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B
















TABLE 6







Table A













Compound







No.
Ar
A
Y
R
















Table
97-
5-
A-1
6-
represents a


97
1~97-
Chloropyrazin-

Cl
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
98-
6-
A-1
6-
represents a


98
1~98-
Chloropyridazin-

Cl
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
99-
2-Chloro-5-
A-1
6-
represents a


99
1~99-
oxazolyl

Cl
combination of



710



substituents







corresponding to







each row of







Table B


Table
100-
6-
A-1
6-
represents a


100
1~100-
trifluoromethyl-

Cl
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
101-
3-
A-1
6-
represents a


101
1~101-
tetrahydro-

Cl
combination of



710
furanyl


substituents







corresponding to







each row of







Table B


Table
102-
6-Chloro-3-
A-1
3-
represents a


102
1~102-
pyridyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
103-
2-Chloro-5-
A-1
3-
represents a


103
1~103-
thiazolyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
104-
6-Fluoro-3-
A-1
3-
represents a


104
1~104-
pyridyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
105-
6-Bromo-3-
A-1
3-
represents a


105
1~105-
pyridyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
106-
6-Chloro-5-
A-1
3-
represents a


106
1~106-
fluoro-3-

CN
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
107-
2-Chloro-5-
A-1
3-
represents a


107
1~107-
pyrimidinyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
108-
5-
A-1
3-
represents a


108
1~108-
Chloropyrazin-

CN
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
109-
6-
A-1
3-
represents a


109
1~109-
Chloropyridazin-

CN
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
110-
2-Chloro-5-
A-1
3-
represents a


110
1~110-
oxazolyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
111-
6-
A-1
3-
represents a


111
1~111-
trifluoromethyl-

CN
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
112-
3-
A-1
3-
represents a


112
1~112-
tetrahydro-

CN
combination of



710
furanyl


substituents







corresponding to







each row of







Table B


Table
113-
6-Chloro-3-
A-1
4-
represents a


113
1~113-
pyridyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
114-
2-Chloro-5-
A-1
4-
represents a


114
1~114-
thiazolyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
115-
6-Fluoro-3-
A-1
4-
represents a


115
1~115-
pyridyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
116-
6-Bromo-3-
A-1
4-
represents a


116
1~116-
pyridyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
117-
6-Chloro-5-
A-1
4-
represents a


117
1~117-
Fluoro-3-

CN
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
118-
2-Chloro-5-
A-1
4-
represents a


118
1~118-
pyrimidinyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
119-
5-
A-1
4-
represents a


119
1~119-
Chloropyrazin-

CN
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
120-
6-
A-1
4-
represents a


120
1~120-
Chloropyridazin-

CN
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
121-
2-Chloro-5-
A-1
4-
represents a


121
1~121-
oxazolyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
122-
6-
A-1
4-
represents a


122
1~122-
trifluoromethyl-

CN
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
123-
3-
A-1
4-
represents a


123
1~123-
tetrahydro-

CN
combination of



710
furanyl


substituents







corresponding to







each row of







Table B


Table
124-
6-Chloro-3-
A-1
5-
represents a


124
1~124-
pyridyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
125-
2-Chloro-5-
A-1
5-
represents a


125
1~155-
thiazolyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
126-
6-Fluoro-3-
A-1
5-
represents a


126
1~126-
pyridyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
127-
6-Bromo-3-
A-1
5-
represents a


127
1~127-
pyridyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
128-
6-Chloro-5-
A-1
5-
represents a


128
1~128-
fluoro-3-

CN
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B
















TABLE 7







Table A













Compound







No.
Ar
A
Y
R
















Table
129-
2-Chloro-5-
A-1
5-
represents a


129
1~129-
pyrimidinyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
130-
5-Chloro-
A-1
5-
represents a


130
1~130-
pyrazin-2-yl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
131-
6-Chloro-
A-1
5-
represents a


131
1~131-
pyridazin-3-yl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
132-
2-Chloro-5-
A-1
5-
represents a


132
1~132-
oxazolyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
133-
6-trifluoromethyl-
A-1
5-
represents a


133
1~133-
3-pyridyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
134-
3-tetrahydro-
A-1
5-
represents a


134
1~134-
furanyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
135-
6-Chloro-
A-1
6-
represents a


135
1~135-
3-pyridyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
136-
2-Chloro-5-
A-1
6-
represents a


136
1~136-
thiazolyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
137-
6-Fluoro-3-
A-1
6-
represents a


137
1~137-
pyridyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
138-
6-Bromo-3-
A-1
6-
represents a


138
1~138-
pyridyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
139-
6-Chloro-5-
A-1
6-
represents a


139
1~139-
fluoro-3-

CN
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
140-
2-Chloro-5-
A-1
6-
represents a


140
1~140-
pyrimidinyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
141-
5-
A-1
6-
represents a


141
1~141-
Chloropyrazin-

CN
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
142-
6-
A-1
6-
represents a


142
1~142-
Chloropyridazin-

CN
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
143-
2-Chloro-5-
A-1
6-
represents a


143
1~143-
oxazolyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
144-
6-
A-1
6-
represents a


144
1~144-
trifluoromethyl-

CN
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
145-
3-tetrahydro-
A-1
6-
represents a


145
1~145-
furanyl

CN
combination of



710



substituents







corresponding to







each row of







Table B


Table
146-
6-Chloro-3-
A-1
3-
represents a


146
1~146-
pyridyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
147-
2-Chloro-5-
A-1
3-
represents a


147
1~147-
thiazolyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
148-
6-Fluoro-3-
A-1
3-
represents a


148
1~148-
pyridyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
149-
6-Bromo-3-
A-1
3-
represents a


149
1~149-
pyridyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
150-
6-Chloro-5-
A-1
3-
represents a


150
1~150-
Fluoro-3-

OH
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
151-
2-Chloro-5-
A-1
3-
represents a


151
1~151-
pyrimidinyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
152-
5-
A-1
3-
represents a


152
1~152-
Chloropyrazin-

OH
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
153-
6-
A-1
3-
represents a


153
1~153-
Chloropyridazin-

OH
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
154-
2-Chloro-5-
A-1
3-
represents a


154
1~154-
oxazolyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
155-
6-
A-1
3-
represents a


155
1~155-
trifluoromethyl-

OH
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
156-
3-tetrahydro-
A-1
3-
represents a


156
1~156-
furanyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
157-
6-Chloro-3-
A-1
4-
represents a


157
1~157-
pyridyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
158-
2-Chloro-5-
A-1
4-
represents a


158
1~158-
thiazolyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
159-
6-Fluoro-3-
A-1
4-
represents a


159
1~159-
pyridyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
160-
6-Bromo-3-
A-1
4-
represents a


160
1~160-
pyridyl

OH
combination of



710



substituents







corresponding to







each row of







Table B
















TABLE 8







Table A













Compound







No.
Ar
A
Y
R
















Table
161-
6-Chloro-5-
A-1
4-
represents a


161
1~161-
fluoro-3-

OH
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
162-
2-Chloro-5-
A-1
4-
represents a


162
1~162-
pyrimidinyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
163-
5-Chloro-
A-1
4-
represents a


163
1~163-
pyrazin-2-yl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
164-
6-Chloro-
A-1
4-
represents a


164
1~164-
pyridazin-3-yl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
165-
2-Chloro-5-
A-1
4-
represents a


165
1~165-
oxazolyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
166-
6-
A-1
4-
represents a


166
1~166-
trifluoromethyl-

OH
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
167-
3-tetrahydro-
A-1
4-
represents a


167
1~167-
furanyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
168-
6-Chloro-3-
A-1
5-
represents a


168
1~168-
pyridyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
169-
2-Chloro-5-
A-1
5-
represents a


169
1~169-
thiazolyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
170-
6-Fluoro-3-
A-1
5-
represents a


170
1~170-
pyridyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
171-
6-Bromo-3-
A-1
5-
represents a


171
1~171-
pyridyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
172-
6-Chloro-5-
A-1
5-
represents a


172
1~172-
fluoro-3-

OH
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
173-
2-Chloro-5-
A-1
5-
represents a


173
1~173-
pyrimidinyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
174-
5-
A-1
5-
represents a


174
1~174-
Chloropyrazin-

OH
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
175-
6-
A-1
5-
represents a


175
1~175-
Chloropyridazin-

OH
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
176-
2-Chloro-5-
A-1
5-
represents a


176
1~176-
oxazolyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
177-
6-
A-1
5-
represents a


177
1~77-
ftriluoromethyl-

OH
combination of



710
3-pyridyI


substituents







corresponding to







each row of







Table B


Table
178-
3-tetrahydro-
A-1
5-
represents a


178
1~178-
furanyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
179-
6-Chloro-3-
A-1
6-
represents a


179
1~179-
pyridyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
180-
2-Chloro-5-
A-1
6-
represents a


180
1~180-
thiazolyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
181-
6-Fluoro-3-
A-1
6-
represents a


181
1~181-
pyridyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
182-
6-Bromo-3-
A-1
6-
represents a


182
1~182-
pyridyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
183-
6-Chloro-5-
A-1
6-
represents a


183
1~183-
fluoro-3-

OH
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
184-
2-Chloro-5-
A-1
6-
represents a


184
1~184-
pyrimidinyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
185-
5-
A-1
6-
represents a


185
1~185-
Chloropyrazin-

OH
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
186-
6-
A-1
6-
represents a


186
1~186-
Chloropyridazin-

OH
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
187-
2-Chloro-5-
A-1
6-
represents a


187
1~187-
oxazolyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
188-
6-
A-1
6-
represents a


188
1~188-
trifluoromethyl-

OH
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
189-
3-tetrahydro-
A-1
6-
represents a


189
1~189-
furanyl

OH
combination of



710



substituents







corresponding to







each row of







Table B


Table
190-
6-Chloro-3-
A-13
H
represents a


190
1~190-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
191-
2-Chloro-5-
A-13
H
represents a


191
1~191-
thiazolyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
192-
6-Fluoro-3-
A-13
H
represents a


192
1~192-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B
















TABLE 9







Table A













Compound







No.
Ar
A
Y
R





Table
193-1~193-
6-Bromo-3-pyridyl
A-
H
represents a


193
710

13

combination of







substituents







corresponding to







each row of Table B


Table
194-1~194-
6-Chloro-5-fluoro-
A-
H
represents a


194
710
3-pyridyl
13

combination of







substituents







corresponding to







each row of Table B


Table
195-1~195-
2-Chloro-5-
A-
H
represents a


195
710
pyrimidinyl
13

combination of







substituents







corresponding to







each row of Table B


Table
196-1~196-
5-Chloropyrazin-
A-
H
represents a


196
710
2-yl
13

combination of







substituents







corresponding to







each row of Table B


Table
197-1~197-
6-Chloropyridazin-
A-
H
represents a


197
710
3-yl
13

combination of







substituents







corresponding to







each row of Table B


Table
198-1~198-
2-Chloro-5-oxazolyl
A-
H
represents a


198
710

13

combination of







substituents







corresponding to







each row of Table B


Table
199-1~199-
6-trifluoromethyl-
A-
H
represents a


199
710
3-pyridyl
13

combination of







substituents







corresponding to







each row of Table B


Table
200-1~200-
3-tetrahydrofuranyl
A-
H
represents a


200
710

13

combination of







substituents







corresponding to







each row of Table B


Table
201-1~201-
6-Chloro-3-pyridyl
A-
H
represents a


201
710

14

combination of







substituents







corresponding to







each row of Table B


Table
202-1~202-
2-Chloro-5-thiazolyl
A-
H
represents a


202
710

14

combination of







substituents







corresponding to







each row of Table B


Table
203-1~203-
6-Fluoro-3-pyridyl
A-
H
represents a


203
710

14

combination of







substituents







corresponding to







each row of Table B


Table
204-1~204-
6-Bromo-3-pyridyl
A-
H
represents a


204
710

14

combination of







substituents







corresponding to







each row of Table B


Table
205-1~205-
6-Chloro-5-fluoro-
A-
H
represents a


205
710
3-pyridyl
14

combination of







substituents







corresponding to







each row of Table B


Table
206-1~206-
2-Chloro-5-
A-
H
represents a


206
710
pyrimidinyl
14

combination of







substituents







corresponding to







each row of Table B


Table
207-1~207-
5-Chloropyrazin-
A-
H
represents a


207
710
2-yl
14

combination of







substituents







corresponding to







each row of Table B


Table
208-1~208-
6-Chloropyridazin-
A-
H
represents a


208
710
3-yl
14

combination of







substituents







corresponding to







each row of Table B


Table
209-1~209-
2-Chloro-5-oxazolyl
A-
H
represents a


209
710

14

combination of







substituents







corresponding to







each row of Table B


Table
210-1~210-
6-trifluoromethyl-
A-
H
represents a


210
710
3-pyridyl
14

combination of







substituents







corresponding to







each row of Table B


Table
211-1~211-
3-tetrahydrofuranyl
A-
H
represents a


211
710

14

combination of







substituents







corresponding to







each row of Table B


Table
212-1~212-
6-Chloro-3-pyridyl
A-
H
represents a


212
710

15

combination of







substituents







corresponding to







each row of Table B


Table
213-1~213-
2-Chloro-5-thiazolyl
A-
H
represents a


213
710

15

combination of







substituents







corresponding to







each row of Table B


Table
214-1~214-
6-Fluoro-3-pyridyl
A-
H
represents a


214
710

15

combination of







substituents







corresponding to







each row of Table B


Table
215-1~215-
6-Bromo-3-pyridyl
A-
H
represents a


215
710

15

combination of







substituents







corresponding to







each row of Table B


Table
216-1~216-
6-Chloro-5-fluoro-
A-
H
represents a


216
710
3-pyridyl
15

combination of







substituents







corresponding to







each row of Table B


Table
217-1~217-
2-Chloro-5-
A-
H
represents a


217
710
pyrimidinyl
15

combination of







substituents







corresponding to







each row of Table B


Table
218-1~218-
5-Chloropyrazin-
A-
H
represents a


218
710
2-yl
15

combination of







substituents







corresponding to







each row of Table B


Table
219-1~219-
6-Chloropyridazin-
A-
H
represents a


219
710
3-yl
15

combination of







substituents







corresponding to







each row of Table B


Table
220-1~220-
2-Chloro-5-oxazolyl
A-
H
represents a


220
710

15

combination of







substituents







corresponding to







each row of Table B


Table
221-1~221-
6-trifluoromethyl-
A-
H
represents a


221
710
3-pyridyl
15

combination of







substituents







corresponding to







each row of Table B


Table
222-1~222-
3-tetrahydrofuranyl
A-
H
represents a


222
710

15

combination of







substituents







corresponding to







each row of Table B


Table
223-1~223-
6-Chloro-3-pyridyl
A-
H
represents a


223
710

16

combination of







substituents







corresponding to







each row of Table B


Table
224-1~224-
2-Chloro-5-thiazolyl
A-
H
represents a


224
710

16

combination of







substituents







corresponding to







each row of Table B
















TABLE 10







Table A













Compound







No.
Ar
A
Y
R





Table
225-1~225-
6-Fluoro-3-pyridyl
A-
H
represents a


225
710

16

combination of







substituents







corresponding to







each row of







Table B


Table
226-1~226-
6-Bromo-3-pyridyl
A-
H
represents a


226
710

16

combination of







substituents







corresponding to







each row of







Table B


Table
227-1~227-
6-Chloro-5-fluoro-
A-
H
represents a


227
710
3-pyridyl
16

combination of







substituents







corresponding to







each row of







Table B


Table
228-1~228-
2-Chloro-5-
A-
H
represents a


228
710
pyrimidinyl
16

combination of







substituents







corresponding to







each row of







Table B


Table
229-1~229-
5-Chloropyrazin-
A-
H
represents a


229
710
2-yl
16

combination of







substituents







corresponding to







each row of







Table B


Table
230-1~230-
6-Chloropyridazin-
A-
H
represents a


230
710
3-yl
16

combination of







substituents







corresponding to







each row of







Table B


Table
231-1~231-
2-Chloro-5-oxazolyl
A-
H
represents a


231
710

16

combination of







substituents







corresponding to







each row of







Table B


Table
232-1~232-
6-trifluoromethyl-
A-
H
represents a


232
710
3-pyridyl
16

combination of







substituents







corresponding to







each row of







Table B


Table
233-1~233-
3-tetrahydrofuranyl
A-
H
represents a


233
710

16

combination of







substituents







corresponding to







each row of







Table B


Table
234-1~234-
6-Chloro-3-pyridyl
A-2
H
represents a


234
710



combination of







substituents







corresponding to







each row of







Table B


Table
235-1~235-
6-Chloro-3-pyridyl
A-3
H
represents a


235
710



combination of







substituents







corresponding to







each row of







Table B


Table
236-1~236-
6-Chloro-3-pyridyl
A-4
H
represents a


236
710



combination of







substituents







corresponding to







each row of







Table B


Table
237-1~237-
6-Chloro-3-pyridyl
A-5
H
represents a


237
710



combination of







substituents







corresponding to







each row of







Table B


Table
238-1~238-
6-Chloro-3-pyridyl
A-6
H
represents a


238
710



combination of







substituents







corresponding to







each row of







Table B


Table
239-1~239-
6-Chloro-3-pyridyl
A-7
H
represents a


239
710



combination of







substituents







corresponding to







each row of







Table B


Table
240-1~240-
6-Chloro-3-pyridyl
A-8
H
represents a


240
710



combination of







substituents







corresponding to







each row of







Table B


Table
241-1~241-
6-Chloro-3-pyridyl
A-9
H
represents a


241
710



combination of







substituents







corresponding to







each row of







Table B


Table
242-1~242-
6-Chloro-3-pyridyl
A-
H
represents a


242
710

10

combination of







substituents







corresponding to







each row of







Table B


Table
243-1~243-
6-Chloro-3-pyridyl
A-
H
represents a


243
710

11

combination of







substituents







corresponding to







each row of







Table B


Table
244-1~244-
6-Chloro-3-pyridyl
A-
H
represents a


244
710

12

combination of







substituents







corresponding to







each row of







Table B


Table
245-1~245-
6-Chloro-3-pyridyl
A-
H
represents a


245
710

17

combination of







substituents







corresponding to







each row of







Table B


Table
246-1~246-
6-Chloro-3-pyridyl
A-
H
represents a


246
710

18

combination of







substituents







corresponding to







each row of







Table B


Table
247-1~247-
6-Chloro-3-pyridyl
A-
H
represents a


247
710

19

combination of







substituents







corresponding to







each row of







Table B


Table
248-1~248-
6-Chloro-3-pyridyl
A-
H
represents a


248
710

20

combination of







substituents







corresponding to







each row of







Table B


Table
249-1~249-
6-Chloro-3-pyridyl
A-
H
represents a


249
710

21

combination of







substituents







corresponding to







each row of







Table B


Table
250-1~250-
6-Chloro-3-pyridyl
A-
H
represents a


250
710

22

combination of







substituents







corresponding to







each row of







Table B


Table
251-1~251-
6-Chloro-3-pyridyl
A-
H
represents a


251
710

23

combination of







substituents







corresponding to







each row of







Table B


Table
252-1~252-
6-Chloro-3-pyridyl
A-
H
represents a


252
710

24

combination of







substituents







corresponding to







each row of







Table B


Table
253-1~253-
6-Chloro-3-pyridyl
A-
H
represents a


253
710

25

combination of







substituents







corresponding to







each row of







Table B


Table
254-1~254-
6-Chloro-3-pyridyl
A-
H
represents a


254
710

26

combination of







substituents







corresponding to







each row of







Table B


Table
255-1~255-
6-Chloro-3-pyridyl
A-
H
represents a


255
710

27

combination of







substituents







corresponding to







each row of







Table B


Table
256-1~256-
6-Chloro-3-pyridyl
A-
H
represents a


256
710

28

combination of







substituents







corresponding to







each row of







Table B
















TABLE 11







Table A













Compound







No.
Ar
A
Y
R





Table
257-1~257-
6-Chloro-3-pyridyl
A-29
H
represents a


257
710



combination of







substituents







corresponding to







each row of







Table B


Table
258-1~258-
6-Chloro-3-pyridyl
A-30
H
represents a


258
710



combination of







substituents







corresponding to







each row of







Table B


Table
259-1~259-
6-Chloro-3-pyridyl
A-31
H
represents a


259
710



combination of







substituents







corresponding to







each row of







Table B


Table
260-1~260-
6-Chloro-3-pyridyl
A-32
H
represents a


260
710



combination of







substituents







corresponding to







each row of







Table B


Table
261-1~261-
6-Chloro-3-pyridyl
A-33
H
represents a


261
710



combination of







substituents







corresponding to







each row of







Table B


Table
262-1~262-
6-Chloro-3-pyridyl
A-34
H
represents a


262
710



combination of







substituents







corresponding to







each row of







Table B


Table
263-1~263-
6-Chloro-3-pyridyl
A-35
H
represents a


263
710



combination of







substituents







corresponding to







each row of







Table B


Table
264-1~264-
6-Chloro-3-pyridyl
A-36
H
represents a


264
710



combination of







substituents







corresponding to







each row of







Table B


Table
265-1~265-
6-Chloro-3-pyridyl
A-37
H
represents a


265
710



combination of







substituents







corresponding to







each row of







Table B


Table
266-1~266-
6-Chloro-3-pyridyl
A-38
H
represents a


266
710



combination of







substituents







corresponding to







each row of







Table B


Table
267-1~267-
6-Chloro-3-pyridyl
A-39
H
represents a


267
710



combination of







substituents







corresponding to







each row of







Table B


Table
268-1~268-
6-Chloro-3-pyridyl
A-40
H
represents a


268
710



combination of







substituents







corresponding to







each row of







Table B


Table
269-1~269-
6-Chloro-3-pyridyl
A-2
H
represents a


269
710



combination of







substituents







corresponding to







each row of







Table B


Table
270-1~270-
6-Chloro-3-pyridyl
A-3
H
represents a


270
710



combination of







substituents







corresponding to







each row of







Table B


Table
271-1~271-
6-Chloro-3-pyridyl
A-4
H
represents a


271
710



combination of







substituents







corresponding to







each row of







Table B


Table
272-1~272-
6-Chloro-3-pyridyl
A-5
H
represents a


272
710



combination of







substituents







corresponding to







each row of







Table B


Table
273-1~273-
6-Chloro-3-pyridyl
A-6
H
represents a


273
710



combination of







substituents







corresponding to







each row of







Table B


Table
274-1~274-
6-Chloro-3-pyridyl
A-7
H
represents a


274
710



combination of







substituents







corresponding to







each row of







Table B


Table
275-1~275-
6-Chloro-3-pyridyl
A-8
H
represents a


275
710



combination of







substituents







corresponding to







each row of







Table B


Table
276-1~276-
6-Chloro-3-pyridyl
A-9
H
represents a


276
710



combination of







substituents







corresponding to







each row of







Table B


Table
277-1~277-
6-Chloro-3-pyridyl
A-10
H
represents a


277
710



combination of







substituents







corresponding to







each row of







Table B


Table
278-1~278-
6-Chloro-3-pyridyl
A-11
H
represents a


278
710



combination of







substituents







corresponding to







each row of







Table B


Table
279-1~279-
6-Chloro-3-pyridyl
A-12
H
represents a


279
710



combination of







substituents







corresponding to







each row of







Table B


Table
280-1~280-
6-Chloro-3-pyridyl
A-17
H
represents a


280
710



combination of







substituents







corresponding to







each row of







Table B


Table
281-1~281-
6-Chloro-3-pyridyl
A-18
H
represents a


281
710



combination of







substituents







corresponding to







each row of







Table B


Table
282-1~282-
6-Chloro-3-pyridyl
A-19
H
represents a


282
710



combination of







substituents







corresponding to







each row of







Table B


Table
283-1~283-
6-Chloro-3-pyridyl
A-20
H
represents a


283
710



combination of







substituents







corresponding to







each row of







Table B


Table
284-1~284-
6-Chloro-3-pyridyl
A-21
H
represents a


284
710



combination of







substituents







corresponding to







each row of







Table B


Table
285-1~285-
6-Chloro-3-pyridyl
A-22
H
represents a


285
710



combination of







substituents







corresponding to







each row of







Table B


Table
286-1~286-
6-Chloro-3-pyridyl
A-23
H
represents a


286
710



combination of







substituents







corresponding to







each row of







Table B


Table
287-1~287-
6-Chloro-3-pyridyl
A-24
H
represents a


287
710



combination of







substituents







corresponding to







each row of







Table B


Table
288-1~288-
6-Chloro-3-pyridyl
A-25
H
represents a


288
710



combination of







substituents







corresponding to







each row of







Table B
















TABLE 12







Table A













Compound







No.
Ar
A
Y
R





Table
289-1~289-
6-Chloro-3-pyridyl
A-26
H
represents a


289
710



combination of







substituents







corresponding to







each row of







Table B


Table
290-1~290-
6-Chloro-3-pyridyl
A-27
H
represents a


290
710



combination of







substituents







corresponding to







each row of







Table B


Table
291-1~291-
6-Chloro-3-pyridyl
A-28
H
represents a


291
710



combination of







substituents







corresponding to







each row of







Table B


Table
292-1~292-
6-Chloro-3-pyridyl
A-29
H
represents a


292
710



combination of







substituents







corresponding to







each row of







Table B


Table
293-1~293-
6-Chloro-3-pyridyl
A-30
H
represents a


293
710



combination of







substituents







corresponding to







each row of







Table B


Table
294-1~294-
6-Chloro-3-pyridyl
A-31
H
represents a


294
710



combination of







substituents







corresponding to







each row of







Table B


Table
295-1~295-
6-Chloro-3-pyridyl
A-32
H
represents a


295
710



combination of







substituents







corresponding to







each row of







Table B


Table
296-1~296-
6-Chloro-3-pyridyl
A-33
H
represents a


296
710



combination of







substituents







corresponding to







each row of







Table B


Table
297-1~297-
6-Chloro-3-pyridyl
A-34
H
represents a


297
710



combination of







substituents







corresponding to







each row of







Table B


Table
298-1~298-
6-Chloro-3-pyridyl
A-35
H
represents a


298
710



combination of







substituents







corresponding to







each row of







Table B


Table
299-1~299-
6-Chloro-3-pyridyl
A-36
H
represents a


299
710



combination of







substituents







corresponding to







each row of







Table B


Table
300-1~300-
6-Chloro-3-pyridyl
A-37
H
represents a


300
710



combination of







substituents







corresponding to







each row of







Table B


Table
301-1~301-
6-Chloro-3-pyridyl
A-38
H
represents a


301
710



combination of







substituents







corresponding to







each row of







Table B


Table
302-1~302-
6-Chloro-3-pyridyl
A-39
H
represents a


302
710



combination of







substituents







corresponding to







each row of







Table B


Table
303-1~303-
6-Chloro-3-pyridyl
A-40
H
represents a


303
710



combination of







substituents







corresponding to







each row of







Table B


Table
304-1~304-
6-Chloro-3-pyridyl
A-2
H
represents a


304
710



combination of







substituents







corresponding to







each row of







Table B


Table
305-1~305-
6-Chloro-3-pyridyl
A-3
H
represents a


305
710



combination of







substituents







corresponding to







each row of







Table B


Table
306-1~306-
6-Chloro-3-pyridyl
A-4
H
represents a


306
710



combination of







substituents







corresponding to







each row of







Table B


Table
307-1~307-
6-Chloro-3-pyridyl
A-5
H
represents a


307
710



combination of







substituents







corresponding to







each row of







Table B


Table
308-1~308-
6-Chloro-3-pyridyl
A-6
H
represents a


308
710



combination of







substituents







corresponding to







each row of







Table B


Table
309-1~309-
6-Chloro-3-pyridyl
A-7
H
represents a


309
710



combination of







substituents







corresponding to







each row of







Table B


Table
310-1~310-
6-Chloro-3-pyridyl
A-8
H
represents a


310
710



combination of







substituents







corresponding to







each row of







Table B


Table
311-1~311-
6-Chloro-3-pyridyl
A-9
H
represents a


311
710



combination of







substituents







corresponding to







each row of







Table B


Table
312-1~312-
6-Chloro-3-pyridyl
A-10
H
represents a


312
710



combination of







substituents







corresponding to







each row of







Table B


Table
313-1~313-
6-Chloro-3-pyridyl
A-11
H
represents a


313
710



combination of







substituents







corresponding to







each row of







Table B


Table
314-1~314-
6-Chloro-3-pyridyl
A-12
H
represents a


314
710



combination of







substituents







corresponding to







each row of







Table B


Table
315-1~315-
6-Chloro-3-pyridyl
A-17
H
represents a


315
710



combination of







substituents







corresponding to







each row of







Table B


Table
316-1~316-
6-Chloro-3-pyridyl
A-18
H
represents a


316
710



combination of







substituents







corresponding to







each row of







Table B


Table
317-1~317-
6-Chloro-3-pyridyl
A-19
H
represents a


317
710



combination of







substituents







corresponding to







each row of







Table B


Table
318-1~318-
6-Chloro-3-pyridyl
A-20
H
represents a


318
710



combination of







substituents







corresponding to







each row of







Table B


Table
319-1~319-
6-Chloro-3-pyridyl
A-21
H
represents a


319
710



combination of







substituents







corresponding to







each row of







Table B


Table
320-1~320-
6-Chloro-3-pyridyl
A-22
H
represents a


320
710



combination of







substituents







corresponding to







each row of







Table B
















TABLE 13







Table A













Compound No
Ar
A
Y
R





Table
321-1~321-
6-Chloro-3-
A-23
H
represents a


321
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
322-1~322-
6-Chloro-3-
A-24
H
represents a


322
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
323-1~323-
6-Chloro-3-
A-25
H
represents a


323
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
324-1~324-
6-Chloro-3-
A-26
H
represents a


324
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
325-1~325-
6-Chloro-3-
A-27
H
represents a


325
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
326-1~326-
6-Chloro-3-
A-28
H
represents a


326
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
327-1~327-
6-Chloro-3-
A-29
H
represents a


327
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
328-1~328-
6-Chloro-3-
A-30
H
represents a


328
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
329-1~329-
6-Chloro-3-
A-31
H
represents a


329
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
330-1~330-
6-Chloro-3-
A-32
H
represents a


330
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
331-1~331-
6-Chloro-3-
A-33
H
represents a


331
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
332-1~332-
6-Chloro-3-
A-34
H
represents a


332
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
333-1~333-
6-Chloro-3-
A-35
H
represents a


333
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
334-1~334-
6-Chloro-3-
A-36
H
represents a


334
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
335-1~335-
6-Chloro-3-
A-37
H
represents a


335
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
336-1~336-
6-Chloro-3-
A-38
H
represents a


336
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
337-1~337-
6-Chloro-3-
A-39
H
represents a


337
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
338-1~338-
6-Chloro-3-
A-40
H
represents a


338
710
pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
339-1~339-
2-Chloro-5-
A-2
H
represents a


339
710
thiazolyl


combination of







substituents







corresponding to







each row of Table B


Table
340-1~340-
3-Trifluoro-
A-3
H
represents a


340
710
methylphenyl


combination of







substituents







corresponding to







each row of Table B


Table
341-1~341-
2-
A-4
H
represents a


341
710
Methylphenyl


combination of







substituents







corresponding to







each row of Table B


Table
342-1~342-
3-
A-5
H
represents a


342
710
Methylphenyl


combination of







substituents







corresponding to







each row of Table B


Table
343-1~343-
4-
A-6
H
represents a


343
710
Methylphenyl


combination of







substituents







corresponding to







each row of Table B


Table
344-1~344-
4-Trifluoro-
A-7
H
represents a


344
710
methylphenyl


combination of







substituents







corresponding to







each row of Table B


Table
345-1~345-
2-Trifluoro-
A-8
H
represents a


345
710
methylphenyl


combination of







substituents







corresponding to







each row of Table B


Table
346-1~346-
2-
A-9
H
represents a


346
710
Methoxyphenyl


combination of







substituents







corresponding to







each row of Table B


Table
347-1~347-
3-
A-10
H
represents a


347
710
Methoxyphenyl


combination of







substituents







corresponding to







each row of Table B


Table
348-1~348-
4-l
A-11
H
represents a


348
710
Methoxypheny


combination of







substituents







corresponding to







each row of Table B


Table
349-1~349-
2-Cyanophenyl
A-12
H
represents a


349
710



combination of







substituents







corresponding to







each row of Table B


Table
350-1~350-
3-Cyanophenyl
A-17
H
represents a


350
710



combination of







substituents







corresponding to







each row of Table B


Table
351-1~351-
4-Cyanophenyl
A-18
H
represents a


351
710



combination of







substituents







corresponding to







each row of Table B


Table
352-1~352-
2-Nitrophenyl
A-19
H
represents a


352
710



combination of







substituents







corresponding to







each row of Table B
















TABLE 14







Table A













Compound







No
Ar
A
Y
R
















Table
353-
3-Nitrophenyl
A-20
H
represents a


353
1~353-



combination of



710



substituents







corresponding to







each row of







Table B


Table
354-
4-Nitrophenyl
A-21
H
represents a


354
1~354-



combination of



710



substituents







corresponding to







each row of







Table B


Table
355-
3-Hydroxy-2-
A-22
H
represents a


355
1~355-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
356-
4-hydroxy-2-
A-23
H
represents a


356
1~356-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
357-
5-hydroxy-2-
A-24
H
represents a


357
1~357-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
358-
6-hydroxy-2-
A-25
H
represents a


358
1~358-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
359-
2-Hydroxy-3-
A-26
H
represents a


359
1~359-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
360-
5-Hydroxy-3-
A-27
H
represents a


360
1~360-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
361-
6-Hydroxy-3-
A-28
H
represents a


361
1~361-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
362-
4-Hydroxy-3-
A-29
H
represents a


362
1~362-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
363-
2-Hydroxy-4-
A-30
H
represents a


363
1~363-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
364-
3-Hydroxy-4-
A-31
H
represents a


364
1~364-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
365-
3-Chloro-2-
A-32
H
represents a


365
1~365-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
366-
4-Chloro-2-
A-33
H
represents a


366
1~366-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
367-
5-Chloro-2-
A-34
H
represents a


367
1~367-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
368-
6-Chloro-2-
A-35
H
represents a


368
1~368-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
369-
2-Chloro-3-
A-36
H
represents a


369
1~369-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
370-
5-Chloro-3-
A-37
H
represents a


370
1~370-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
371-
6-Chloro-3-
A-38
H
represents a


371
1~371-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
372-
4-Chloro-3-
A-39
H
represents a


372
1~372-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
373-
2-Chloro-4-
A-40
H
represents a


373
1~373-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
374-
3-Chloro-4-
A-2
H
represents a


374
1~374-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
375-
3-bromo-2-
A-3
H
represents a


375
1~375-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
376-
4-bromo-2-
A-4
H
represents a


376
1~376-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
377-
5-bromo-2-
A-5
H
represents a


377
1~377-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
378-
6-bromo-2-
A-6
H
represents a


378
1~378-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
379-
2-bromo-3-
A-7
H
represents a


379
1~379-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
380-
5-bromo-3-
A-8
H
represents a


380
1~380-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
381-
6-bromo-3-
A-9
H
represents a


381
1~381-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
382-
4-bromo-3-
A-10
H
represents a


382
1~382-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
383-
2-bromo-4-
A-11
H
represents a


383
1~383-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
384-
3-bromo-4-
A-12
H
represents a


384
1~384-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B
















TABLE 15







Table A













Compound







No
Ar
A
Y
R
















Table
385-
3-Fluoro-2-
A-17
H
represents a


385
1~385-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
386-
4-Fluoro-2-
A-18
H
represents a


386
1~386-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
387-
5-Fluoro-2-
A-19
H
represents a


387
1~387-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
388-
6-Fluoro-2-
A-20
H
represents a


388
1~388-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
389-
2-Fluoro-3-
A-21
H
represents a


389
1~389-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
390-
5-Fluoro-3-
A-22
H
represents a


390
1~390-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
391-
6-Fluoro-3-
A-23
H
represents a


391
1~391-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
392-
4-Fluoro-3-
A-24
H
represents a


392
1~392-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
393-
2-Fluoro-4-
A-25
H
represents a


393
1~393-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
394-
3-Fluoro-4-
A-26
H
represents a


394
1~394-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
395-
6-Fluoro-3-
A-27
H
represents a


395
1~395-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
396-
3-iodo-2-
A-28
H
represents a


396
1~396-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
397-
4-iodo-2-
A-29
H
represents a


397
1~397-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
398-
5-iodo-2-
A-30
H
represents a


398
1~398-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
399-
6-iodo-2~
A-31
H
represents a


399
1~399-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
400-
2-iodo-3-
A-32
H
represents a


400
1~400-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
401-
5-iodo-3-
A-33
H
represents a


401
1~401-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
402-
6-iodo-3-
A-34
H
represents a


402
1~402-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
403-
4-iodo~3-
A-35
H
represents a


403
1~403-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
404-
2-iodo-4-
A-36
H
represents a


404
1~404-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
405-
3-iodo-4-
A-37
H
represents a


405
1~405-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
406-
6-iodo-3-
A-38
H
represents a


406
1~406-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
407-
6-iodo-3-
A-39
H
represents a


407
1~407-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
408-
2-tetrahydro-
A-40
H
represents a


408
1~408-
furanyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
409-
3-tetrahydro-
A-2
H
represents a


409
1~409-
furanyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
410-
5-Chloro-2-
A-3
H
represents a


410
1~410-
thiazolyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
411-
6-Fluoro-3-
A-4
H
represents a


411
1~411-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
412-
6-Bromo-3-
A-5
H
represents a


412
1~412-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
413-
6-Chloro-5-
A-6
H
represents a


413
1~413-
Fluoro-3-


combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
414-
3,5-Dimethyl-
A-7
H
represents a


414
1~414-
phenyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
415-
2,3-Dimethyl-
A-8
H
represents a


415
1~415-
phenyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
416-
2,4-Dimethyo-
A-9
H
represents a


416
1~416-
phenyl


combination of



710



substituents







corresponding to







each row of







Table B
















TABLE 16







Table A













Compound







No
Ar
A
Y
R
















Table
417-
Phenyl
A-10
H
represents a


417
1~417-



combination of



710



substituents







corresponding to







each row of







Table B


Table
418-
cyclopentyl
A-11
H
represents a


418
1~418-



combination of



710



substituents







corresponding to







each row of







Table B


Table
419-
cyclohexyl
A-12
H
represents a


419
1~419-



combination of



710



substituents







corresponding to







each row of







Table B


Table
420-
3-
A-17
H
represents a


420
1~420-
methyl-


combination of



710
cyclohexyl


substituents







corresponding to







each row of







Table B


Table
421-
cyclobutyl
A-18
H
represents a


421
1~421-



combination of



710



substituents







corresponding to







each row of







Table B


Table
422-
2-oxetanyl
A-19
H
represents a


422
1~422-



combination of



710



substituents







corresponding to







each row of







Table B


Table
423-
3-oxetanyl
A-20
H
represents a


423
1~423-



combination of



710



substituents







corresponding to







each row of







Table B


Table
424-
2-thietanyl
A-21
H
represents a


424
1~424-



combination of



710



substituents







corresponding to







each row of







Table B


Table
425-
3-thietanyl
A-22
H
represents a


425
1~425-



combination of



710



substituents







corresponding to







each row of







Table B


Table
426-
2-azetidinyl
A-23
H
represents a


426
1~426-



combination of



710



substituents







corresponding to







each row of







Table B


Table
427-
3-azetidinyl
A-24
H
represents a


427
1~427-



combination of



710



substituents







corresponding to







each row of







Table B


Table
428-
6-iodo-3-
A-25
H
represents a


428
1~428-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
429-
6-iodo-
A-26
H
represents a


429
1~429-
3-pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
430-
2-
A-27
H
represents a


430
1~430-
tetrahydro-


combination of



710
furanyl


substituents







corresponding to







each row of







Table B


Table
431-
2-Chloro-3-
A-28
H
represents a


431
1~431-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
432-
5-Chloro-3-
A-29
H
represents a


432
1~432-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
433-
6-Chloro-3-
A-30
H
represents a


433
1~433-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
434-
4-Chloro-3-
A-31
H
represents a


434
1~434-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
435-
2-Chloro-4-
A-32
H
represents a


435
1~435-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
436-
3-Chloro-4-
A-33
H
represents a


436
1~436-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
437-
3-bromo-2-
A-34
H
represents a


437
1~437-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
438-
4-bromo-2-
A-35
H
represents a


438
1~438-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
439-
2-FIuoro-4-
A-36
H
represents a


439
1~439-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
440-
3-Fluoro-4-
A-37
H
represents a


440
1~440-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
441-
6-Fluoro-3-
A-38
H
represents a


441
1~441-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
442-
3-iodo-
A-39
H
represents a


442
1~442-
2-pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
443-
6-Fluoro-3-
A-40
H
represents a


443
1~443-
pyridyl


combination of



710



substituents







corresponding to







each row of







Table B


Table
444-
2-Chloro-5-
A-38
H
represents a


444
1~444-
thiazolyl


combination of



710



substituents







corresponding to







each row of







Table B
















TABLE 17







Table A













Compound







No.
Ar
A
Y
R
















Table
445-
6-Chloro-3-
A-1
3-
represents a


445
1~445-
pyridyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
446-
2-Chloro-5-
A-1
3-
represents a


446
1~446-
thiazolyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
447-
6-Fluoro-3-
A-1
3-
represents a


447
1~447-
pyridyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
448-
6-Bromo-3-
A-1
3-
represents a


448
1~448-
pyridyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
449-
6-Chloro-5-
A-1
3-
represents a


449
1~449-
fluoro-3-

CH3
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
450-
2-Chloro-5-
A-1
3-
represents a


450
1~450-
pyrimidinyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
451-
5-
A-1
3-
represents a


451
1~451-
Chloropyrazin-

CH3
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
452-
6-
A-1
3-
represents a


452
1~452-
Chloropyridazin-

CH3
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
453-
2-Chloro-5-
A-1
3-
represents a


453
1~453-
oxazolyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
454-
6-
A-1
3-
represents a


454
1~454-
trifluoromethyl-

CH3
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
455-
3-
A-1
3-
represents a


455
1~455-
tetrahydrofu-

CH3
combination of



710
ranyl


substituents







corresponding to







each row of







Table B


Table
456-
6-Chloro-3-
A-1
4-
represents a


456
1~456-
pyridyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
457-
2-Chloro-5-
A-1
4-
represents a


457
1~457-
thiazolyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
458-
6-Fluoro-3-
A-1
4-
represents a


458
1~458-
pyridyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
459-
6-Bromo-3-
A-1
4-
represents a


459
1~459-
pyridyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
460-
6-Chloro-5-
A-1
4-
represents a


460
1~460-
Fluoro-3-

CH3
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
461-
2-Chloro-5-
A-1
4-
represents a


461
1~461-
pyrimidinyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
462-
5-
A-1
4-
represents a


462
1~462-
Chloropyrazin-

CH3
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
463-
6-
A-1
4-
represents a


463
1~463-
Chloropyridazin-

CH3
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
464-
2-Chloro-5-
A-1
4-
represents a


464
1~464-
oxazolyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
465-
6-
A-1
4-
represents a


465
1~465-
trifluoromethyl-

CH3
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
466-
3-
A-1
4-
represents a


466
1~466-
tetrahydrofu-

CH3
combination of



710
ranyl


substituents







corresponding to







each row of







Table B


Table
467-
6-Chloro-3-
A-1
5-
represents a


467
1~467-
pyridyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
468-
2-Chloro-5-
A-1
5-
represents a


468
1~468-
thiazolyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
469-
6-Fluoro-3-
A-1
5-
represents a


469
1~469-
pyridyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
470-
6-Bromo-3-
A-1
5-
represents a


470
1~470-
pyridyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
471-
6-Chloro-5-
A-1
5-
represents a


471
1~471-
fluoro-3-

CH3
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
472-
2-Chloro-5-
A-1
5-
represents a


472
1~472-
pyrimidinyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
473-
5-
A-1
5-
represents a


473
1~473-
Chloropyrazin-

CH3
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
474-
6-
A-1
5-
represents a


474
1~474-
Chloropyridazin-

CH3
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
475-
2-Chloro-5-
A-1
5-
represents a


475
1~475-
oxazolyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
476-
6-
A-1
5-
represents a


476
1~476-
trifluoromethyl-

CH3
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B
















TABLE 18







Table A













Compound







No.
Ar
A
Y
R
















Table
477-
3-
A-1
5-
represents a


477
1~477-
tetrahydrofu-

CH3
combination of



710
ranyl


substituents







corresponding to







each row of







Table B


Table
478-
6-Chloro-3-
A-1
6-
represents a


478
1~478-
pyridyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
479-
2-Chloro-5-
A-1
6-
represents a


479
1~479-
thiazolyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
480-
6-Fluoro-3-
A-1
6-
represents a


480
1~480-
pyridyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
481-
6-Bromo-3-
A-1
6-
represents a


481
1~481-
pyridyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
482-
6-Chloro-5-
A-1
6-
represents a


482
1~482-
fluoro-3-

CH3
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
483-
2-Chloro-5-
A-1
6-
represents a


483
1~483-
pyrimidinyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
484-
5-
A-1
6-
represents a


484
1~484-
Chloropyrazin-

CH3
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
485-
6-
A-1
6-
represents a


485
1~485-
Chloropyridazin-

CH3
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
486-
2-Chloro-5-
A-1
6-
represents a


486
1~486-
oxazolyl

CH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
487-
6-
A-1
6-
represents a


487
1~487-
trifluoromethyl-

CH3
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
488-
3-
A-1
6-
represents a


488
1~488-
tetrahydrofu-

CH3
combination of



710
ranyl


substituents







corresponding to







each row of







Table B


Table
489-
6-Chloro-3-
A-1
3-
represents a


489
1~489-
pyridyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
490-
2-Chloro-5-
A-1
3-
represents a


490
1~490-
thiazolyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
491-
6-Fluoro-3-
A-1
3-
represents a


491
1~491-
pyridyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
492-
6-Bromo-
A-1
3-
represents a


492
1~492-
3-pyridyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
493-
6-Chloro-5-
A-1
3-
represents a


493
1~493-
Fluoro-3-

NO2
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
494-
2-Chloro-5-
A-1
3-
represents a


494
1~494-
pyrimidinyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
495-
5-
A-1
3-
represents a


495
1~495-
Chloropyrazin-

NO2
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
496-
6-
A-1
3-
represents a


496
1~496-
Chloropyridazin-

NO2
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
497-
2-Chloro-5-
A-1
3-
represents a


497
1~497-
oxazolyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
498-
6-
A-1
3-
represents a


498
1~498-
trifluoromethyl-

NO2
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
499-
3-
A-1
3-
represents a


499
1~499-
tetrahydrofu-

NO2
combination of



710
ranyl


substituents







corresponding to







each row of







Table B


Table
500-
6-Chloro-3-
A-1
4-
represents a


500
1~500-
pyridyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
501-
2-Chloro-5-
A-1
4-
represents a


501
1~501-
thiazolyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
502-
6-Fluoro-3-
A-1
4-
represents a


502
1~502-
pyridyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
503-
6-Bromo-3-
A-1
4-
represents a


503
1~503-
pyridyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
504-
6-Chloro-5-
A-1
4-
represents a


504
1~504-
fluoro-3-

NO2
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
505-
2-Chloro-5-
A-1
4-
represents a


505
1~505-
pyrimidinyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
506-
5-
A-1
4-
represents a


506
1~506-
Chloropyrazin-

NO2
combination of



710
2-yl


substituents







corresponding to







each row of







Table B


Table
507-
6-
A-1
4-
represents a


507
1~507-
Chloropyridazin-

NO2
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
508-
2-Chloro-5-
A-1
4-
represents a


508
1~508-
oxazolyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B
















TABLE 19







Table A













Compound







No.
Ar
A
Y
R
















Table
509~
6-tri-
A-1
4-
represents a


509
1~509-
fluoromethyl-

NO2
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
510-
3-
A-1
4-
represents a


510
1~510-
tetrahydro-

NO2
combination of



710
furanyl


substituents







corresponding to







each row of







Table B


Table
511-
6-Chloro-3-
A-1
5-
represents a


511
1~511-
pyridyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
512-
2-Chloro-5-
A-1
5-
represents a


512
1~512-
thiazolyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
513-
6-Fluoro-3-
A-1
5-
represents a


513
1~513-
pyridyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
514-
6-Bromo-3-
A-1
5-
represents a


514
1~514-
pyridyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
515-
6-Chloro-5-
A-1
5-
represents a


515
1~515-
fluoro-3-

NO2
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
516-
2-Chloro-5-
A-1
5-
represents a


516
1~516-
pyrimidinyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
517-
5-Chloro-
A-1
5-
represents a


517
1~517-
pyrazin-2-yl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
518-
6-Chloro-
A-1
5-
represents a


518
1~518-
pyridazin-

NO2
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
519-
2-Chloro-5-
A-1
5-
represents a


519
1~519-
oxazolyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
520-
6-tri-
A-1
5-
represents a


520
1~520-
fluoromethyl-

NO2
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
521-
3-tetrahydro-
A-1
5-
represents a


521
1~521-
furanyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
522-
6-Chloro-3-
A-1
6-
represents a


522
1~522-
pyridyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
523-
2-Chloro-5-
A-1
6-
represents a


523
1~523-
thiazolyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
524-
6-Fluoro-3-
A-1
6-
represents a


524
1~524-
pyridyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
525-
6-Bromo-3-
A-1
6-
represents a


525
1~525-
pyridyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
526-
6-Chloro-5-
A-1
6-
represents a


526
1~526-
Fluoro-3-

NO2
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
527-
2-Chloro-5-
A-1
6-
represents a


527
1~527-
pyrimidinyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
528-
5-Chloro-
A-1
6-
represents a


528
1~528-
pyrazin-2-yl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
529-
6-Chloro-
A-1
6-
represents a


529
1~529-
pyridazin-

NO2
combination of



710
3-yl


substituents







corresponding to







each row of







Table B


Table
530-
2-Chloro-5-
A-1
6-
represents a


530
1~530-
oxazolyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
531-
6-tri-
A-1
6-
represents a


531
1~531-
fluoromethyl-

NO2
combination of



710
3-pyridyl


substituents







corresponding to







each row of







Table B


Table
532-
3-tetra-
A-1
6-
represents a


532
1~532-
hydrofuranyl

NO2
combination of



710



substituents







corresponding to







each row of







Table B


Table
533-
6-Chloro-3-
A-1
3-
represents a


533
1~533-
pyridyl

OCH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
534-
2-Chloro-5-
A-1
3-
represents a


534
1~534-
thiazolyl

OCH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
535-
6-Fluoro-3-
A-1
3-
represents a


535
1~535-
pyridyl

OCH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
536-
6-Bromo-3-
A-1
3-
represents a


536
1~536-
pyridyl

OCH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
537-
6-Chloro-5-
A-1
3-
represents a


537
1~537-
fluoro-3-

OCH3
combination of



710
pyridyl


substituents







corresponding to







each row of







Table B


Table
538-
2-Chloro-5-
A-1
3-
represents a


538
1~538-
pyrimidinyl

OCH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
539-
5-Chloro-
A-1
3-
represents a


539
1~539-
pyrazin-2-yl

OCH3
combination of



710



substituents







corresponding to







each row of







Table B


Table
540-
6-Chloro-
A-1
3-
represents a


540
1~540-
pyridazin-3-yl

OCH3
combination of



710



substituents







corresponding to







each row of







Table B
















TABLE 20







Table A













Compound







No.
Ar
A
Y
R
















Table
541-1~541-
2-Chloro-5-oxazolyl
A-1
3-OCH3
represents a


541
710



combination of







substituents







corresponding to







each row of Table B


Table
542-1~542-
6-trifluoromethyl-
A-1
3-OCH3
represents a


542
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
543-1~543-
3-tetrahydrofuranyl
A-1
3-OCH3
represents a


543
710



combination of







substituents







corresponding to







each row of Table B


Table
544-1~544-
6-Chloro-3-pyridyl
A-1
4-OCH3
represents a


544
710



combination of







substituents







corresponding to







each row of Table B


Table
545-1~545-
2-Chloro-5-thiazolyl
A-1
4-OCH3
represents a


545
710



combination of







substituents







corresponding to







each row of Table B


Table
546-1~546-
6-Fluoro-3-pyridyl
A-1
4-OCH3
represents a


546
710



combination of







substituents







corresponding to







each row of Table B


Table
547-1~547-
6-Bromo-3-pyridyl
A-1
4-OCH3
represents a


547
710



combination of







substituents







corresponding to







each row of Table B


Table
548-1~548-
6-Chloro-5-Fluoro-
A-1
4-OCH3
represents a


548
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
549-1~549-
2-Chloro-5-pyrimidinyl
A-1
4-OCH3
represents a


549
710



combination of







substituents







corresponding to







each row of Table B


Table
550-1~550-
5-Chloropyrazin-
A-1
4-OCH3
represents a


550
710
2-yl


combination of







substituents







corresponding to







each row of Table B


Table
551-1~551-
6-Chloropyridazin-
A-1
4-OCH3
represents a


551
710
3-yl


combination of







substituents







corresponding to







each row of Table B


Table
552-1~552-
2-Chloro-5-oxazolyl
A-1
4-OCH3
represents a


552
710



combination of







substituents







corresponding to







each row of Table B


Table
553-1~553-
6-trifluoromethyl-
A-1
4-OCH3
represents a


553
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
554-1~554-
3-tetrahydrofuranyl
A-1
4-OCH3
represents a


554
710



combination of







substituents







corresponding to







each row of Table B


Table
555-1~555-
6-Chloro-3-pyridyl
A-1
5-OCH3
represents a


555
710



combination of







substituents







corresponding to







each row of Table B


Table
556-1~556-
2-Chloro-5-thiazolyl
A-1
5-OCH3
represents a


556
710



combination of







substituents







corresponding to







each row of Table B


Table
557-1~557-
6-Fluoro-3-pyridyl
A-1
5-OCH3
represents a


557
710



combination of







substituents







corresponding to







each row of Table B


Table
558-1~558-
6-Bromo-3-pyridyl
A-1
5-OCH3
represents a


558
710



combination of







substituents







corresponding to







each row of Table B


Table
559-1~559-
6-Chloro-5-fluoro-
A-1
5-OCH3
represents a


559
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
560-1~560-
2-Chloro-5-pyrimidinyl
A-1
5-OCH3
represents a


560
710



combination of







substituents







corresponding to







each row of Table B


Table
561-1~561-
5-Chloropyrazin-
A-1
5-OCH3
represents a


561
710
2-yl


combination of







substituents







corresponding to







each row of Table B


Table
562-1~562-
6-Chloropyridazin-
A-1
5-OCH3
represents a


562
710
3-yl


combination of







substituents







corresponding to







each row of Table B


Table
563-1~563-
2-Chloro-5-oxazolyl
A-1
5-OCH3
represents a


563
710



combination of







substituents







corresponding to







each row of Table B


Table
564-1~564-
6-trifluoromethyl-
A-1
5-OCH3
represents a


564
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
565-1~565-
3-tetrahydrofuranyl
A-1
5-OCH3
represents a


565
710



combination of







substituents







corresponding to







each row of Table B


Table
566-1~566-
6-Chloro-3-pyridyl
A-1
6-OCH3
represents a


566
710



combination of







substituents







corresponding to







each row of Table B


Table
567-1~567-
2-Chloro-5-thiazolyl
A-1
6-OCH3
represents a


567
710



combination of







substituents







corresponding to







each row of Table B


Table
568-1~568-
6-Fluoro-3-pyridyl
A-1
6-OCH3
represents a


568
710



combination of







substituents







corresponding to







each row of Table B


Table
569-1~569-
6-Bromo-3-pyridyl
A-1
6-OCH3
represents a


569
710



combination of







substituents







corresponding to







each row of Table B


Table
570-1~570-
6-Chloro-5-Fluoro-
A-1
6-OCH3
represents a


570
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
571-1~571-
2-Chloro-5-pyrimidinyl
A-1
6-OCH3
represents a


571
710



combination of







substituents







corresponding to







each row of Table B


Table
572-1~572-
5-Chloropyrazin-
A-1
6-OCH3
represents a


572
710
2-yl


combination of







substituents







corresponding to







each row of Table B
















TABLE 21







Table A













Compound No.
Ar
A
Y
R
















Table
573-1~573-
6-Chloropyridazin-
A-1
6-OCH3
represents a


573
710
3-yl


combination of







substituents







corresponding to







each row of Table B


Table
574-1~574-
2-Chloro-5-oxazolyl
A-1
6-OCH3
represents a


574
710



combination of







substituents







corresponding to







each row of Table B


Table
575-1~575-
6-trifluoromethyl-
A-1
6-OCH3
represents a


575
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
576-1~576-
3-tetrahydrofuranyl
A-1
6-OCH3
represents a


576
710



combination of







substituents







corresponding to







each row of Table B


Table
577-1~577-
2,6-dichloro-
A-1
H
represents a


577
710
3-pyridyl


combination of







substituents







corresponding to







each row of Table B


Table
578-1~578-
3-pyridyl
A-1
H
represents a


578
710



combination of







substituents







corresponding to







each row of Table B


Table
579-1~579-
4-pyridyl
A-1
H
represents a


579
710



combination of







substituents







corresponding to







each row of Table B


Table
580-1~580-
6-chloro-3-pyridyl-
A-1
H
represents a


580
710
N-oxide


combination of







substituents







corresponding to







each row of Table B
















TABLE B





[Table 22]


R




















embedded image


    R1





 1

H


 2

CF3


 3

CHF2


 4

CF2Cl


 5

CF2CF3


 6

CH2Cl


 7

CHCl2


 8

CCl3


 9

CHClBr


10

2,2-difluorocyclopropyl


11

2,3,3-trifluoroacryl


12

CH2CHF2


13

CH2CF3


14

CH═CH2


15

CH2C≡CH


16

CH2CH2≡CH








embedded image


    R2





17

CH2CF3


18

CH(Me)CF3


19

CH(CF3)2








embedded image


    R3





20

CF3


21

CHF2


22

CF2Cl


23

CF2CF3


24

CH2Cl


25

CHCl2


26

CCl3


27

CHClBr


28

CHBr2


29

2,3,3-trifluoroacryl


30

CH2CHF2


31

CH2CF3


32

CH═CH2


33

CH2C≡CH


34

CH2CF3


35

CH2CH2Ph


36

Me


37

Et


38

n-Pr


39

i-Pr


40

cyclopropyl
















TABLE B







[Table 23]


R







embedded image















R4
R5





41
H
CF3


42
Me
CF3


43
Et
CF3


44
n-Pr
CF3


45
i-Pr
CF3


46
t-Bu
CF3


47
n-Bu
CF3


48
n-Pentyl
CF3


49
n-Hexyl
CF3


50
cyclopropyl
CF3


51
cyclobutyl
CF3


52
cyclopentyl
CF3


53
cyclohexyl
CF3


54
CH═CH2
CF3


55
CH2CH═CH2
CF3


56
CH2C≡CH
CF3


57
CH2CH2CΞCH
CF3


58
CH2CHF2
CF3


59
CH2CCF3
CF3


60
CH2CH2Cl
CF3


61
CH2CHCl2
CF3


62
2-fluoro-2-chloroethyl
CF3


63
CH2CCl3
CF3


64
CH2CN
CF3


65
CH2CH2CN
CF3


66
CH2CH(CN)CH2CN
CF3


67
CH2CH2OH
CF3


68
CH2CH2CH2OH
CF3


69
CH2CH(OH)CH2OH
CF3


70
CH2CH2NO2
CF3


71
Phenyl
CF3


72
CH2-Phenyl
CF3


73
CH(Me)-Phenyl
CF3


74
C(Me2)-Phenyl
CF3


75
C(cyclopropyl)-Phenyl
CF3


76
CH2CH2-Phenyl
CF3


77
CH2-(2-Methylphenyl)
CF3


78
CH2-(3-Methylphenyl)
CF3


79
CH2-(4-Methylphenyl)
CF3


80
CH2-(2-Methoxylphenyl)
CF3


81
CH2-(3-Methoxylphenyl)
CF3


82
CH2-(4-Methoxylphenyl)
CF3


83
CH2-(2-fluorolphenyl)
CF3


84
CH2-(3-fluorolphenyl)
CF3


85
CH2-(4-fluorolphenyl)
CF3


86
CH2-(2-Chlorophenyl)
CF3


87
CH2-(3-Chlorophenyl)
CF3


88
CH2-(4-Chlorophenyl)
CF3


89
CH2-(2-Bromophenyl)
CF3


90
CH2-(3-Bromophenyl)
CF3


91
CH2-(4-Bromophenyl)
CF3


92
CH2-(2-iodophenyl)
CF3


93
CH2-(3-iodophenyl)
CF3
















TABLE B







[TABLE 24]


R




embedded image

















R4
R5














94
CH2-(4-iodo-
CF3




phenyl)




95
CH2-(1-
CF3




naphthalenyl)




96
CH2-(2-
CF3




naphthalenyl)




97
naphthalen-1-
CF3




ylmethyl




98
naphthalen-2-
CF3




ylmethyl




99
quinolin-2-yl
CF3




methyl




100
quinolin-7-yl-
CF3




methyl




101
isoquinolin-7-
CF3




ylmethyl)




102
isoquinolin-6-
CF3




ylmethyl




103
quinolin-6-yl-
CF3




methyl




104
quinolin-3-yl-
CF3




methyl




105
isoquinolin-3-
CF3




ylmethyl




106
isoquinolin-1-
CF3




ylmethyl




107
isoquinolin-4-
CF3




ylmethyl




108
quinolin-4-yl-
CF3




methyl




109
quinolin-5-yl
CF3




methyl




110
isoquinolin-5-
CF3




ylmethyl




111
isoquinolin-8-
CF3




ylmethyl




112
quinolin-8-yl-
CF3




methyl




113
CH2O-Phenyl
CF3



114
CH2CH2O-Phenyl
CF3



115
2-pyridyl
CF3



116
3-pyridyl
CF3



117
4-pyridyl
CF3



118
CH2-(2-pyridyl)
CF3



119
CH2-(3-pyridyl)
CF3



120
CH2-(4-Chloro-
CF3




3-pyridyl)




121
CH2-(4-pyridyl)
CF3



122
CH2-(2-thienyl)
CF3



123
CH2-(3-thienyl)
CF3



124
CH2-(2-furanyl)
CF3



125
CH2-(3-furanyl)
CF3



126
CH2-(2-tetra-
CF3




hydrofuranyl)




127
CH2-(3-tetra-
CF3




hydrofuranyl)




128
(1H-imidazol-
CF3




2-yl)methyl




129
(1H-imidazol-
CF3




1-yl)methyl




130
(1H-imidazol-
CF3




4-yl)methyl




131
CH2-(2-
CF3




thiazolyl)




132
CH2-(3-
CF3




thiazolyl)




133
CH2-(2-pyrrol-
CF3




yl)




134
CH2-(3-pyrrol-
CF3




yl)




135
CH2-(5-methyl-
CF3




pyrazol-1-yl)




136
CH2-(1-
CF3




pyrazolyl)




137
CH2-(2-
CF3




pyrazolyl)




138
CH2-(3-
CF3




pyrazolyl)




139
CH2-(4-
CF3




pyrazolyl)




140
CH2-(5-
CF3




pyrazolyl)




141
CH2-(2-oxazol-
CF3




yl)




142
CH2-(3-oxazol-
CF3




yl)




143
CH2-(3-
CF3




isoxazolyl)




144
CH2-(4-
CF3




isoxazolyl)




145
CH2-(5-
CF3




isoxazolyl)




146
CH2CH2OCH3
CF3



147
CH2CH2OCH2CH3
CF3
















TABLE B







[Table 25]


R




embedded image

















R4
R5














148
CH2CH2CH2OCH3
CF3



149
CH2CH2CH2OCH2CH3
CF3



150
CH2CH2SCH3
CF3



151
CH2CH2SCH2CH3
CF3



152
CH2CH2CH2SCH3
CF3



153
CH2CH2CH2SCH2CH3
CF3



154
Me
CHF2



155
Et
CHF2



156
n-Pr
CHF2



157
i-Pr
CHF2



158
t-Bu
CHF2



159
n-Bu
CHF2



160
n-Pentyl
CHF2



161
n-Hexyl
CHF2



162
cyclopropyl
CHF2



163
cyclobutyl
CHF2



164
cyclopentyl
CHF2



165
cyclohexyl
CHF2



166
CH═CH2
CHF2



167
CH2CH═CH2
CHF2



168
CH2≡CH
CHF2



169
CH2CH2C≡CH
CHF2



170
CH2CHF2
CHF2



171
CH2CCF3
CHF2



172
CH2CH2Cl
CHF2



173
CH2CHCl2
CHF2



174
2-fluoro-2-
CHF2




chloroethyl




175
CH2CCl3
CHF2



176
CH2CH2CN
CHF2



177
CH2CH2CH2CN
CHF2



178
CH2CH(CN)CH2CN
CHF2



179
CH2CH2OH
CHF2



180
CH2CH2CH2OH
CHF2



181
CH2CH(OH)CH2OH
CHF2



182
CH2CH2NO2
CHF2



183
Phenyl
CHF2



184
CH2-Phenyl
CHF2



185
CH(Me)-Phenyl
CHF2



186
C(Me2)-Phenyl
CHF2



187
C(cyclopropyl)-
CHF2




Phenyl




188
CH2CH2-Phenyl
CHF2



189
CH2-(2-Methyl-
CHF2




phenyl)




190
CH2-(3-Methyl-
CHF2




phenyl)




191
CH2-(4-Methyl-
CHF2




phenyl)




192
CH2-(2-Methoxyl-
CHF2




phenyl)




193
CH2-(3-Methyl-
CHF2




phenyl)




194
CH2-(4-Methyl-
CHF2




phenyl)




195
CH2-(2-
CHF2




fluorolphenyl)




196
CH2-(3-
CHF2




fluorolphenyl)




197
CH2-(4-fluorol-
CHF2




phenyl)




198
CH2-(2-Chloro-
CHF2




phenvl)




199
CH2-(3-Chloro-
CHF2




phenyl)




200
CH2-(4-Chloro-
CHF2




phenyl)




201
CH2-(2-Bromo-
CHF2




phenyl)

















TABLE B







[Table 26]


R




embedded image

















R4
R5














202
CH2-(3-Bromo-
CHF2




phenyl)




203
CH2-(4-Bromo-
CHF2




phenyl)




204
CH2-(2-iodo-
CHF2




phenyl)




205
CH2-(3-iodo-
CHF2




phenyl)




206
CH2-(4-iodo-
CHF2




phenyl)




207
CH2-(1-naph-
CHF2




thalenyl)




208
CH2-(2-naph-
CHF2




thalenyl)




209
naphthalen-1-
CHF2




ylmethyl




210
naphthalen-2-
CHF2




ylmethyl




211
quinolin-2-yl
CHF2




methyl




212
quinolin-7-yl
CHF2




methyl




213
isoquinolin-7-
CHF2




ylmethyl




214
isoquinolin-6-
CHF2




ylmethyl




215
quinolin-6-yl-
CHF2




methyl




216
quinolin-3-yl-
CHF2




methyl




217
isoquinolin-3-
CHF2




ylmethyl




218
isoquinolin-1-
CHF2




ylmethyl




219
isoquinolin-4-
CHF2




ylmethyl




220
quinolin-4-yl-
CHF2




methyl




221
quinolin-5-yl-
CHF2




methyl




222
isoquinolin-5-
CHF2




ylmethyl




223
isoquinolin-8-
CHF2




ylmethyl




224
quinolin-8-yl-
CHF2




methyl




225
CH2O-Phenyl
CHF2



226
CH2CH2O-Phenyl
CHF2



227
2-pyridyl
CHF2



228
3-pyridyl
CHF2



229
4-pyridyl
CHF2



230
CH2-(2-pyridyl)
CHF2



231
CH2-(3-pyridyl)
CHF2



232
CH2-(4-chloro-
CHF2




3-pyridyl)




233
CH2-(4-pyridyl)
CHF2



234
CH2-(2-thienyl)
CHF2



235
CH2-(3-thienyl)
CHF2



236
CH2-(2-furanyl)
CHF2



237
CH2-(3-furanyl)
CHF2



238
CH2-(2-tetra-
CHF2




hydrofuranyl)




239
CH2-(3-tetra-
CHF2




hydrofuranyl)




240
(1H-imidazol-
CHF2




2-yl)methyl




241
(1H-imidazol-
CHF2




1-yl)methyl




242
(1H-imidazol-
CHF2




4-yl)methyl




243
CH2-(2-
CHF2




thiazolyl)




244
CH2-(3-
CHF2




thiazolyl)




245
CH2-(2-pyrrol-
CHF2




yl)




246
CH2-(3-pyrrol-
CHF2




yl)




247
CH2-(5-methyl-
CHF2




pyrazol-1-yl)




248
CH2-(1-
CHF2




pyrazolyl)




249
CH2-(2-
CHF2




pyrazolyl)




250
CH2-(3-
CHF2




pyrazolyl)




251
CH2-(4-
CHF2




pyrazolyl)




252
CH2-(5-
CHF2




pyrazolyl)




253
CH2-(2-oxazol-
CHF2




yl)




254
CH2-(3-oxazol-
CHF2




yl




255
CH2-(3-
CHF2




isoxazolyl)

















TABLE B







[Table 27]


R




embedded image

















R4
R5














256
CH2-(4-
CHF2




isoxazolyl)




257
CH2-(5-
CHF2




isoxazolyl)




258
CH2CH2OCH3
CHF2



259
CH2CH2OCH2CH3
CHF2



260
CH2CH2CH2OCH3
CHF2



261
CH2CH2CH2OCH2CH3
CHF2



262
CH2CH2SCH3
CHF2



263
CH2CH2SCH2CH3
CHF2



264
CH2CH2CH2SCH3
CHF2



265
CH2CH2CH2SCH2CH3
CHF2



266
Me
CF2Cl



267
Et
CF2Cl



268
n-Pr
CF2Cl



269
i-Pr
CF2Cl



270
t-Bu
CF2Cl



271
n-Bu
CF2Cl



272
n-Pentyl
CF2Cl



273
n-Hexyl
CF2Cl



274
cyclopropyl
CF2Cl



275
cyclobutyl
CF2Cl



276
cyclopentyl
CF2Cl



277
cyclohexyl
CF2Cl



278
CH═CH2
CF2Cl



279
CH2CH═CH2
CF2Cl



280
CH2C≡CH
CF2Cl



281
CH2CH2C≡CH
CF2Cl



282
CH2CHF2
CF2Cl



283
CH2CCF3
CF2Cl



284
CH2CH2Cl
CF2Cl



285
CH2CHCl2
CF2Cl



286
2-fluoro-2-
CF2Cl




chloroethyl




287
CH2CCl3
CF2Cl



288
CH2CH2CN
CF2Cl



289
CH2CH2CH2CN
CF2Cl



290
CH2CH(CN)CH2CN
CF2Cl



291
CH2CH2OH
CF2Cl



292
CH2CH2CH2OH
CF2Cl



293
CH2CH(OH)CH2OH
CF2Cl



294
CH2CH2NO2
CF2Cl



295
Phenyl
CF2Cl



296
CH2-Phenyl
CF2Cl



297
CH(Me)-Phenyl
CF2Cl



298
C(Me2)-Phenyl
CF2Cl



299
C(cyclopropyl)-
CF2Cl




Phenyl




300
CH2CH2-Phenyl
CF2Cl



301
CH2-(2-Methyl-
CF2Cl




phenyl)




302
CH2-(3-Methyl-
CF2Cl




phenyl)




303
CH2-(4-Methyl-
CF2Cl




phenyl)




304
CH2-(2-Methox-
CF2Cl




ylphenyl)




305
CH2-(3-Methox-
CF2Cl




ylphenyl)




306
CH2-(4-Methox-
CF2Cl




ylphenyl)




307
CH2-(2-fluorol-
CF2Cl




phenyl)




308
CH2-(3-fluorol-
CF2Cl




phenyl)




309
CH2-(4-fluorol-
CF2Cl




phenyl)

















TABLE B







[Table 28]


R




embedded image

















R4
R5














310
CH2-(2-Chloro-
CF2Cl




phenyl)




311
CH2-(3-Chloro-
CF2Cl




phenyl)




312
CH2-(4-Chloro-
CF2Cl




phenyl)




313
CH2-(2-Bromo-
CF2Cl




phenyl)




314
CH2-(3-Bromo-
CF2Cl




phenyl)




315
CH2-(4-Bromo-
CF2Cl




phenyl)




316
CH2-(2-iodo-
CF2Cl




phenyl)




317
CH2-(3-iodo-
CF2Cl




phenyl)




318
CH2-(4-iodo-
CF2Cl




phenyl)




319
CH2-(1-naph-
CF2Cl




thalenyl)




320
CH2-(2-naph-
CF2Cl




thalenyl)




321
naphthalen-1-
CF2Cl




ylmethyl




322
naphthalen-2-
CF2Cl




ylmethyl




323
quinolin-2-yl-
CF2Cl




methyl




324
quinolin-7-yl-
CF2Cl




methyl




325
isoquinolin-7-
CF2Cl




ylmethyl




326
isoquinolin-6-
CF2Cl




ylmethyl




327
quinolin-6-yl-
CF2Cl




methyl




328
quinolin-3-yl-
CF2Cl




methyl




329
isoquinolin-3-
CF2Cl




ylmethyl




330
isoquinolin-1-
CF2Cl




ylmethyl




331
isoquinolin-4-
CF2Cl




ylmethyl




332
quinolin-4-yl-
CF2Cl




methyl




333
quinolin-5-yl-
CF2Cl




methyl




334
isoquinolin-5-
CF2Cl




ylmethyl




335
isoquinolin-8-
CF2Cl




ylmethyl




336
quinolin-8-yl-
CF2Cl




methyl




337
CH2O-Phenyl
CF2Cl



338
CH2CH2O-Phenyl
CF2Cl



339
2-pyridyl
CF2Cl



340
3-pyridyl
CF2Cl



341
4-pyridyl
CF2Cl



342
CH2-(2-pyridyl
CF2Cl



343
CH2-(3-pyridyl)
CF2Cl



344
CH2-(4-Chloro-
CF2Cl




3-pyridyl)




345
CH2-(4-pyridyl)
CF2Cl



346
CH2-(2-thienyl)
CF2Cl



347
CH2-(3-thienyl)
CF2Cl



348
CH2-(2-furanyl)
CF2Cl



349
CH2-(3-furanyl)
CF2Cl



350
CH2-(2-tetra-
CF2Cl




hydrofuranyl)




351
CH2-(3-tetra-
CF2Cl




hydrofuranyl)




352
(1H-imidazol-
CF2Cl




2-yl)methyl




353
(1H-imidazol-
CF2Cl




1-yl)methyl




354
(1H-imidazol-
CF2Cl




4-yl)methyl




355
CH2-(2-
CF2Cl




thiazolyl)




356
CH2-(3-
CF2Cl




thiazolyl)




357
CH2-(2-pyrrol-
CF2Cl




yl)




358
CH2-(3-pyrrol-
CF2Cl




yl)




359
CH2-(1-pyrazol-
CF2Cl




yl)




360
CH2-(2-pyrazol-
CF2Cl




yl)




361
CH2-(3-pyrazol-
CF2Cl




yl)




362
CH2-(4-pyrazol-
CF2Cl




yl)




363
CH2-(5-pyrazol-
CF2Cl




yl)
















TABLE B







[Table 29]


R




embedded image

















R4
R5














364
CH2-(5-
CF2Cl




pyrazolyl)




365
CH2-(2-
CF2Cl




oxazolyl)




366
CH2-(3-
CF2Cl




oxazolyl)




367
CH2-(3-
CF2Cl




isoxazolyl)




368
CH2-(4-
CF2Cl




isoxazolyl)




369
CH2-(5-
CF2Cl




isoxazolyl)




370
CH2CH2OCH3
CF2Cl



371
CH2CH2OCH2CH3
CF2Cl



372
CH2CH2CH2OCH3
CF2Cl



373
CH2CH2CH2OCH2CH3
CF2Cl



374
CH2CH2SCH3
CF2Cl



375
CH2CH2SCH2CH3
CF2Cl



376
CH2CH2CH2SCH3
CF2Cl



377
CH2CH2CH2SCH2CH3
CF2Cl



378
Me
CF2CF3



379
Et
CF2CF3



380
n-Pr
CF2CF3



381
i-Pr
CF2CF3



382
t-Bu
CF2CF3



383
n-Bu
CF2CF3



384
n-Pentyl
CF2CF3



385
n-Hexyl
CF2CF3



386
cyclopropyl
CF2CF3



387
cyclobutyl
CF2CF3



388
cyclopentyl
CF2CF3



389
cyclohexyl
CF2CF3



390
CH═CH2
CF2CF3



391
CH2CH═CH2
CF2CF3



392
CH2C≡CH
CF2CF3



393
CH2CH2C≡CH
CF2CF3



394
CH2CHF2
CF2CF3



395
CH2CCF3
CF2CF3



396
CH2CH2Cl
CF2CF3



397
CH2CHCl2
CF2CF3



398
2-fluoro-2-
CF2CF3




chloroethyl




399
CH2CCl3
CF2CF3



400
CH2CH2CN
CF2CF3



401
CH2CH2CH2CN
CF2CF3



402
CH2CH(CN)CH2CN
CF2CF3



403
CH2CH2OH
CF2CF3



404
CH2CH2CH2OH
CF2CF3



405
CH2CH(OH)CH2OH
CF2CF3



406
CH2CH2NO2
CF2CF3



407
Phenyl
CF2CF3



408
CH2-Phenyl
CF2CF3



409
CH(Me)-Phenyl
CF2CF3



410
C(Me2)-Phenyl
CF2CF3



411
C(cyclopropyl)-
CF2CF3




Phenyl




412
CH2CH2-Phenyl
CF2CF3



413
CH2-(2-Methyl-
CF2CF3




phenyl)




414
CH2-(3-Methyl-
CF2CF3




phenyl)




415
CH2-(4-Methyl-
CF2CF3




phenyl)




416
CH2-(2-Methoxyl-
CF2CF3




phenyl)




417
CH2-(3-Methoxyl-
CF2CF3




phenyl)

















TABLE 30







Table B









R





embedded image















R4
R5





418
CH2-(4-
CF2CF3



Methoxylphenyl)



419
CH2-(2-
CF2CF3



fluorolphenyl)



420
CH2-(3-
CF2CF3



fluorolphenyl)



421
CH2-(4-
CF2CF3



fluorolphenyl)



422
CH2-(2-
CF2CF3



Chlorophenyl)



423
CH2-(3-
CF2CF3



Chlorophenyl)



424
CH2-(4-
CF2CF3



Chlorophenyl)



425
CH2-(2-
CF2CF3



Bromophenyl)



426
CH2-(3-
CF2CF3



Bromophenyl)



427
CH2-(4-
CF2CF3



Bromophenyl)



428
CH2-(2-
CF2CF3



iodophenyl)



429
CH2-(3-
CF2CF3



iodophenyl)



430
CH2-(4-
CF2CF3



iodophenyl)



431
CH2-(1-
CF2CF3



naphthalenyl)



432
CH2-(2-
CF2CF3



naphthalenyl)



433
naphthalen-1-
CF2CF3



ylmethyl



434
naphthalen-2-
CF2CF3



ylmethyl



435
quinolin-2-
CF2CF3



ylmethyl



436
quinolin-7-
CF2CF3



ylmethyl



437
isoquinolin-7-
CF2CF3



ylmethyl



438
isoquinolin-6-
CF2CF3



ylmethyl



439
quinolin-6-
CF2CF3



ylmethyl



440
quinolin-3-
CF2CF3



ylmethyl



441
isoquinolin-3-
CF2CF3



ylmethyl



442
isoquinolin-1-
CF2CF3



ylmethyl



443
isoquinolin-4-
CF2CF3



ylmethyl



444
quinolin-4-
CF2CF3



ylmethyl



445
quinolin-5-
CF2CF3



ylmethyl



446
isoquinolin-5-
CF2CF3



ylmethyl



447
isoquinolin-8-
CF2CF3



ylmethyl



448
quinolin-8-
CF2CF3



ylmethyl



449
CH2O-Phenyl
CF2CF3


450
CH2CH2O-
CF2CF3



Phenyl



451
2-pyridyl
CF2CF3


452
3-pyridyl
CF2CF3


453
4-pyridyl
CF2CF3


454
CH2-(2-
CF2CF3



pyridyl)



455
CH2-(3-
CF2CF3



pyridyl)



456
CH2-(4-Chloro-
CF2CF3



3-pyridyl)



457
CH2-(4-
CF2CF3



pyridyl)



458
CH2-(2-
CF2CF3



thienyl)



459
CH2-(3-
CF2CF3



thienyl)



460
CH2-(2-
CF2CF3



furanyl)



461
CH2-(3-
CF2CF3



furanyl)



462
CH2-(2-tetra-
CF2CF3



hydrofuranyl)



463
CH2-(3-tetra-
CF2CF3



hydrofuranyl)



464
(1H-imidazol-
CF2CF3



2-yl)methyl



465
(1H-imidazol-
CF2CF3



1-yImethyl



466
(1H-imidazol-
CF2CF3



4-yl)methyl



467
CH2-(2-
CF2CF3



thiazolyl)



468
CH2-(3-
CF2CF3



thiazolyl)



469
CH2-(2-
CF2CF3



pyrrolyl)



470
CH2-(3-
CF2CF3



pyrrolyl)



471
CH2-(5-methyl-
CF2CF3



pyrazolyl-1-yl)
















TABLE 31





Table B

















R





embedded image















R4
R5





472
CH2-(1-pyrazolyl)
CF2CF3


473
CH2-(2-pyrazolyl)
CF2CF3


474
CH2-(3-pyrazolyl)
CF2CF3


475
CH2-(4-pyrazolyl)
CF2CF3


476
CH2-(5-pyrazolyl)
CF2CF3


477
CH2-(2-oxazolyl)
CF2CF3


478
CH2-(3-oxazolyl)
CF2CF3


479
CH2-(3-isooxazolyl)
CF2CF3


480
CH2-(4-isooxazolyl)
CF2CF3


481
CH2-(5-isooxazolyl)
CF2CF3


482
CH2CH2OCH3
CF2CF3


483
CH2CH2OCH2CH3
CF2CF3


484
CH2CH2CH2OCH3
CF2CF3


485
CH2CH2CH2OCH2CH3
CF2CF3


486
CH2CH2SCH3
CF2CF3


487
CH2CH2SCH2CH3
CF2CF3


488
CH2CH2CH2SCH3
CF2CF3


489
CH2CH2CH2SCH2CH3
CF2CF3


490
Me
CH2CF3


491
Et
CH2Cl


492
n-Pr
CHCl2


493
i-Pr
CCl3


494
t-Bu
CHClBr


495
n-Bu
CHBr2


496
n-Pentyl
CH═CH2


497
n-Hexyl
CH2CH═CH2


498
cyclopropyl
CH2C≡CH














embedded image















R6
R7





499
H
CF3


500
Me
CF3


501
Et
CF3


502
n-Pr
CF3


503
i-Pr
CF3


504
t-Bu
CF3


505
cyclopropyl
CF3


506
CH═CH2
CF3


507
CH2CH═CH2
CF3


508
CH2C≡CH
CF3


509
Ph
CF3


510
CH2Ph
CF3


511
COMe
CF3


512
COEt
CF3


513
CO-n-Pr
CF3


514
CO-i-Pr
CF3


515
CO-cyclopropyl
CF3


516
COCH═CH2
CF3


517
COCH2CH═CH2
CF3


518
COCH2C≡CH
CF3


519
COPh
CF3


520
CO-(2-pyridyl)
CF3
















TABLE 32







Table B









R





embedded image















R6
R7





521
CO-(3-pyridyl)
CF3


522
CO-(4-pyridyl)
CF3


523
COOMe
CF3


524
COOEt
CF3


525
COO-i-Pr
CF3


526
COO-t-Bu
CF3


527
COOPh
CF3


528
SO2Me
CF3


529
SO2Et
CF3


530
SO2Ph
CF3


531
SO2-(4-methylphenyl)
CF3


532
NHMe
CF3


533
NHEt
CF3


534
NH-n-Pr
CF3


535
NHCH2CH2Cl
CF3


536
NHCH2Ph
CF3


537
N(Me)2
CF3


538
Me
CHF2


539
Et
CHF2


540
n-Pr
CHF2


541
i-Pr
CHF2


542
t-Bu
CHF2


543
cyclopropyl
CHF2


544
CH═CH2
CHF2


545
CH2CH═CH2
CHF2


546
CH2C≡CH
CHF2


547
Ph
CHF2


548
CH2Ph
CHF2


549
COMe
CHF2


550
COEt
CHF2


551
CO-n-Pr
CHF2


552
CO-i-Pr
CHF2


553
CO-cyclopropyl
CHF2


554
COCH═CH2
CHF2


555
COCH2CH═CH2
CHF2


556
COCH2C≡CH
CHF2


557
COPh
CHF2


558
CO-(2-pyridyl)
CHF2


559
CO-(3-pyridyl)
CHF2


560
CO-(4-pyridyl)
CHF2


561
COOMe
CHF2


562
COOEt
CHF2


563
COO-i-Pr
CHF2


564
COO-t-Bu
CHF2


565
COOPh
CHF2


566
SO2Me
CHF2


567
SO2Et
CHF2


568
SO2Ph
CHF2


569
SO2-(4-methylphenyl)
CHF2


570
Me
CF2Cl


571
Et
CF2Cl


572
n-Pr
CF2Cl


573
i-Pr
CF2Cl


574
t-Bu
CF2Cl
















TABLE 33







Table B









R





embedded image















R6
R7





575
cyclopropyl
CF2Cl


576
CH═CH2
CF2Cl


577
CH2CH═CH2
CF2Cl


578
CH2C≡CH
CF2Cl


579
Ph
CF2Cl


580
CH2Ph
CF2Cl


581
COMe
CF2Cl


582
COEt
CF2Cl


583
CO-n-Pr
CF2Cl


584
CO-i-Pr
CF2Cl


585
CO-cyclopropyl
CF2Cl


586
COCH═CH2
CF2Cl


587
COCH2CH═CH2
CF2Cl


588
COCH2C≡CH
CF2Cl


589
COPh
CF2Cl


590
CO-(2-pyridyl)
CF2Cl


591
CO-(3-pyridyl)
CF2Cl


592
CO-(4-pyridyl)
CF2Cl


593
COOMe
CF2Cl


594
COOEt
CF2Cl


595
COO-i-Pr
CF2Cl


596
COO-t-Bu
CF2Cl


597
COOPh
CF2Cl


598
SO2Me
CF2Cl


599
SO2Et
CF2Cl


600
SO2Ph
CF2Cl


601
SO2-(4-methylphenyl)
CF2Cl


602
Me
CF2CF3


603
Et
CF2CF3


604
n-Pr
CF2CF3


605
i-Pr
CF2CF3


606
t-Bu
CF2CF3


607
cyclopropyl
CF2CF3


608
CH═CH2
CF2CF3


609
CH2CH═CH2
CF2CF3


610
CH2C≡CH
CF2CF3


611
Ph
CF2CF3


612
CH2Ph
CF2CF3


613
COMe
CF2CF3


614
COEt
CF2CF3


615
CO-n-Pr
CF2CF3


616
CO-i-Pr
CF2CF3


617
CO-cyclopropyl
CF2CF3


618
COCH═CH2
CF2CF3


619
COCH2CH═CH2
CF2CF3


620
COCH2C≡CH
CF2CF3


621
COPh
CF2CF3


622
CO-(2-pyridyl)
CF2CF3


623
CO-(3-pyridyl)
CF2CF3


624
CO-(4-pyridyl)
CF2CF3


625
COOMe
CF2CF3


626
COOEt
CF2CF3


627
COO-i-Pr
CF2CF3
















TABLE 34







Table B











R






embedded image


















R6
R7







628
COO-t-Bu
CF2CF3



629
COOPh
CF2CF3



630
SO2Me
CF2CF3



631
SO2Et
CF2CF3



632
SO2Ph
CF2CF3



633
SO2- (4-methylphenyl)
CF2CF3



634
Me
CH2CF3



635
Et
CH2Cl



636
n-Pr
CHCl2



637
i-Pr
CCl3



638
t-Bu
CHClBr



639
cyclopropyl
CHBr2



640
CH═CH2
CH═CH2



641
CH2CH═CH2
CH2CH═CH2



642
CH2C≡CH
CH2C≡CH

















TABLE 35





Table B



















R






embedded image










R1







643
C6F5



644
CH2OCH2C6H5










embedded image










R2







645
CH2C6H5



646
isopropyl



647
CH2CH2CH═CH2










embedded image










R3







648
C6F5



649
CH2OCH2C6H5

















TABLE 36







Table B











R






embedded image


















R4
R5















650
Ethyl
CH2CF3



651
n-Propyl
CH2CF3



652
iso-Propyl
CH2CF3



653
t-Butyl
CH2CF3



654
n-Butyl
CH2CF3



655
cyclopropyl
CH2CF3



656
cyclopentyl
CH2CF3



657
cyclohexyl
CH2CF3



658
n-hexa decyl
CF3



659
n-tridecyl
CF3



660
CH(CH3)CH2CH3
CF3



661
CH(CH3)CH2CH2CH3
CF3



662
CH(CH3)-isopropyl
CF3



663
1-phenylethyl
CF3



664
1,2,3,4-tetra-
CF3




hydronaphthalen-1-yl




665
1-(naphthalen-1-yl)ethyl
CF3



666
1-(naphthalen-1-yl)propyl
CF3



667
1-(furan-2-yl)ethyl
CF3



668
3.3-dimethylbutan-2-yl
CF3



669
1-(thiophen-2-yl)ethyl
CF3



670
CH2CH2F
CF3



671
n-Octyl
CF3



672
n-Octyl
CHF2



673
n-Octyl
CF2Cl



674
n-Octyl
CF2CF3



675
n-Octyl
CF2CF3



676
CH(C6H5)2
CF3



677
CH(C6H5)2
CHF2



678
CH(C6H5)2
CF2Cl



679
CH(C6H5)2
CF2CF3



680
CH(C6H5)2
CH2CF3



681
CH(CH2CH3)2
CF3



682
CH(CH2CH3)2
CHF2



683
CH(CH2CH3)2
CF2Cl



684
CH(CH2CH3)2
CF2CF3



685
CH(CH2CH3)2
CH2CF3



686
CH(CH2CH2CH3)2
CF3



687
CH(CH2CH2CH3)2
CHF2



688
CH(CH2CH2CH3)2
CF2Cl



689
CH(CH2CH2CH3)2
CF2CF3



690
CH(CH2CH2CH3)2
CF2CF3

















TABLE 37





Table B

















R





embedded image
















Y1
Y2
Ry





691
O
O
Methyl


692
O
O
Ethyl


693
O
O
Propyl


694
O
O
isopropyl


695
S
O
Methyl


696
S
O
Ethyl


697
S
O
Propyl


698
S
O
isopropyl


699
S
S
Methyl


700
S
S
Ethyl


701
S
S
Propyl


702
S
S
isopropyl














embedded image















n
Rz





703
1
CF3


704
1
CF2CF3


705
1
CH2CF3


706
1
Me


707
2
CF3


708
2
CF2CF3


709
2
CH2CF3


710
2
Me









Preferred examples of the compound represented by Formula (I) include compounds in the following Tables 38, 39, and 40.













TABLE 38





Com-






pound


No
Ar
A
Y
R







266-2
6-Chloro-3-pyridyl
A-
H
COCF3




38


444-2
2-chloro-5-thiazolyl
A-
H
COCF3




38


190-2
6-Chloro-3-pyridyl
A-
H
COCF3




13


201-2
6-Chloro-3-pyridyl
A-
H
COCF3




14


223-2
6-Chloro-3-pyridyl
A-
H
COCF3




16


146-2
6-Chloro-3-pyridyl
A-1
3-
COCF3





OH


224-2
2-chloro-5-thiazolyl
A-
H
COCF3




16


102-2
6-Chloro-3-pyridyl
A-1
3-
COCF3





CN


212-2
6-Chloro-3-pyridyl
A-
H
COCF3




15


1-20
6-Chloro-3-pyridyl
A-1
H
CSCF3


12-2
2-Chloro-4-pyridyl
A-1
H
COCF3


213-2
2-chloro-5-thiazolyl
A-
H
COCF3




15


1-17
6-Chloro-3-pyridyl
A-1
H
COOCH2CF3


1-18
6-Chloro-3-pyridyl
A-1
H
COOCH(Me)CF3


1-19
6-Chloro-3-pyridyl
A-1
H
COOCH(CF3)2


7-2
5-Chloropyrazin-
A-1
H
COCF3



2-yl


1-13
6-Chloro-3-pyridyl
A-1
H
COCH2CF3


168-2
6-Chloro-3-pyridyl
A-1
5-
COCF3





OH


1-21
6-Chloro-3-pyridyl
A-1
H
CSCHF2


3-20
6-Fluoro-3-pyridyl
A-1
H
CSCF3


4-20
6-Bromo-3-pyridyl
A-1
H
CSCF3


3-3
6-Fluoro-3-pyridyl
A-1
H
COCHF2


4-3
6-Bromo-3-pyridyl
A-1
H
COCHF2


5-5
6-Chloro-5-fluoro-
A-1
H
COCF2CF3



3-pyridyl


6-5
2-Chloro-5-pyrimidinyl
A-1
H
COCF2CF3


1-22
6-Chloro-3-pyridyl
A-1
H
CSCF2Cl


1-23
6-Chloro-3-pyridyl
A-1
H
CSCF2CF3


5-20
6-Chloro-5-fluoro-
A-1
H
CSCF3



3-pyridyl


5-3
6-Chloro-5-fluoro-
A-1
H
COCHF2



3-pyridyl


6-3
2-Chloro-5-pyrimidinyl
A-1
H
COCHF2


8-2
6-Chloropyridazin-
A-1
H
COCF3



3-yl


5-4
6-Chloro-5-fluoro-
A-1
H
COCF2Cl



3-pyridyl


4-4
6-Bromo-3-pyridyl
A-1
H
COCF2Cl


6-4
2-Chloro-5-pyrimidinyl
A-1
H
COCF2Cl


4-5
6-Bromo-3-pyridyl
A-1
H
COCF2CF3


2-20
2-chloro-5-thiazolyl
A-1
H
CSCF3


10-20
6-trifluoromethyl-
A-1
H
CSCF3



3-pyridyl


3-4
6-Fluoro-3-pyridyl
A-1
H
COCF2Cl


3-5
6-Fluoro-3-pyridyl
A-1
H
COCF2CF3


11-20
3-THF
A-1
H
CSCF3


1-14
6-Chloro-3-pyridyl
A-1
H
COCH═CH2


1-37
6-Chloro-3-pyridyl
A-1
H
CSEt


1-39
6-Chloro-3-pyridyl
A-1
H
CS-i-Pr


1-40
6-Chloro-3-pyridyl
A-1
H
CS-cyclopropyl


1-15
6-Chloro-3-pyridyl
A-1
H
COCH2CΞCH


1-35
6-Chloro-3-pyridyl
A-1
H
CSCH2CH2Ph


1-501
6-Chloro-3-pyridyl
A-1
H
C(═NOEt)CF3


1-499
6-Chloro-3-pyridyl
A-1
H
C(═NOH)CF3


1-510
6-Chloro-3-pyridyl
A-1
H
C(═NOCH2Ph)CF3


1-511
6-Chloro-3-pyridyl
A-1
H
C(═NOCOMe)CF3


1-519
6-Chloro-3-pyridyl
A-1
H
C(═NOCOPh)CF3


1-523
6-Chloro-3-pyridyl
A-1
H
C(═NOCOOMe)CF3




















TABLE 39





Compound






No
Ar
A
Y
R







1-528
6-Chloro-3-pyridyl
A-1
H
C(═NOSO2Me)CF3


1-531
6-Chloro-3-pyridyl
A-1
H
C(═NOSO2-(4-Methylphenyl))CF3


1-507
6-Chloro-3-pyridyl
A-1
H
C(═NOCH2CH═CH2)CF3


1-516
6-Chloro-3-pyridyl
A-1
H
C(═NOCOCH═CH2)CF3


1-518
6-Chloro-3-pyridyl
A-1
H
C(═NOCOCH2C≡CH)CF3


1-527
6-Chloro-3-pyridyl
A-1
H
C(═NOCOOPh)CF3


1-521
6-Chloro-3-pyridyl
A-1
H
C(═NOCO-3-pyr)CF3


1-43
6-Chloro-3-pyridyl
A-1
H
C(═NEt)CF3


1-536
6-Chloro-3-pyridyl
A-1
H
C(═NOCONHCH2Ph)CF3


1-42
6-Chloro-3-pyridyl
A-1
H
C(═NMe)CF3


1-500
6-Chloro-3-pyridyl
A-1
H
C(═NOMe)CF3


1-504
6-Chloro-3-pyridyl
A-1
H
C(═NOtBu)CF3


1-534
6-Chloro-3-pyridyl
A-1
H
C(═NOCONHnPr)CF3


1-535
6-Chloro-3-pyridyl
A-1
H
C(═NOCONHCH2CH2Cl)CF3


1-72
6-Chloro-3-pyridyl
A-1
H
C(═NCH2Ph)CF3


1-150
6-Chloro-3-pyridyl
A-1
H
C(═NCH2CH2SMe)CF3


1-67
6-Chloro-3-pyridyl
A-1
H
C(═NCH2CH2OH)


1-515
6-Chloro-3-pyridyl
A-1
H
C(═NOCO-cyclopropyl)CF3


1-56
6-Chloro-3-pyridyl
A-1
H
C(═NCH2CΞCH)CF3


1-512
6-Chloro-3-pyridyl
A-1
H
C(═NOCOCH2CH3)CF3


1-514
6-Chloro-3-pyridyl
A-1
H
C(═NOCOiPr)CF3


1-50
6-Chloro-3-pyridyl
A-1
H
C(═N-cyclopropyl)CF3


1-114
6-Chloro-3-pyridyl
A-1
H
C(═NCH2CH2OPh)CF3


1-44
6-Chloro-3-pyridyl
A-1
H
C(═N-n-Pr)CF3


1-118
6-Chloro-3-pyridyl
A-1
H
C(═NCH2-(2-pyridyl))CF3


1-119
6-Chloro-3-pyridyl
A-1
H
C(═NCH2-(3-pyridyl))CF3


1-47
6-Chloro-3-pyridyl
A-1
H
C(═N-n-Bu)CF3


1-55
6-Chloro-3-pyridyl
A-1
H
C(═N—CH2CH═CH2)CF3


1-122
6-Chloro-3-pyridyl
A-1
H
C(═NCH2-(2-thienyl))CF3


1-45
6-Chloro-3-pyridyl
A-1
H
C(═N-i-Pr)CF3


1-124
6-Chloro-3-pyridyl
A-1
H
C(═NCH2-(2-furanyl))CF3


1-126
6-Chloro-3-pyridyl
A-1
H
C(═NCH2-(2-tetrahydrofuranyl))CF3


1-64
6-Chloro-3-pyridyl
A-1
H
C(═NCH2CN)CF3


1-146
6-Chloro-3-pyridyl
A-1
H
C(═NCH2CH2OCH3)CF3


1-52
6-Chloro-3-pyridyl
A-1
H
C(═N-cyclopentyl)CF3


1-121
6-Chloro-3-pyridyl
A-1
H
C(═NCH2-(4-pyridyl))CF3


1-53
6~Chloro-3-pyridyl
A-1
H
C(═N-cyclohexyl)CF3


1-76
6-Chloro-3-pyridyl
A-1
H
C(═NCH2CH2Ph)CF3


267-2
6-Chloro-3-pyridyl
A-39
H
COCF3


253-2
6-Chloro-3-pyridyl
A-25
H
COCF3


251-2
6-Chloro-3-pyridyl
A-23
H
COCF3


13-2
3-Cyanophenyl
A-1
H
COCF3


1-1
6-Chloro-3-pyridyl
A-1
H
CHO


1-41
6-Chloro-3-pyridyl
A-1
H
C(═NH)CF3




















TABLE 40





Compound






No.
Ar
A
Y
R







1-647
6-Chloro-3-pyridyl
A-1
H
COOCH2CH2CH═CH2


1-670
6-Chloro-3-pyridyl
A-1
H
C(═NCH2CH2F)CF3


157-2
6-Chloro-3-pyridyl
A-1
4-OH
COCF3


1-10
6-Chloro-3-pyridyl
A-1
H
CO(2,2-difluonocyclopropyl)


580-2
6-chloro-3-pyridyl-
A-1
H
COCF3



N-oxid


1-671
6-Chloro-3-pyridyl
A-1
H
C(═N(CH2)7CH3)CF3


1-658
6-Chloro-3-pyridyl
A-1
H
C(═N(CH2)15CH3)CF3


1-659
6-Chloro-3-pyridyl
A-1
H
C(═N(CH2)11CH3)CF3


1-660
6-Chloro-3-pyridyl
A-1
H
C(═NCH(CH3)CH2CH3)CF3


1-681
6-Chloro-3-pyridyl
A-1
H
C(═NCH(CH2CH3)2)CF3


1-686
6-Chloro-3-pyridyl
A-1
H
C(═NCH(CH2CH2CH3)2)CF3


1-661
6-Chloro-3-pyridyl
A-1
H
C(═NCH(CH3)CH2CH2CH3)CF3


1-662
6-Chloro-3-pyridyl
A-1
H
C(═NCH(iso-propyl)CH3)CF3


1-663
6-Chloro-3-pyridyl
A-1
H
C(═N(1-phenylethyl))CF3


1-664
6-Chloro-3-pyridyl
A-1
H
C(═N(1,2,3,4-tetrahydronaphthalen-1-yl)CF3


1-665
6-Chloro-3-pyridyl
A-1
H
C(═N(1-(naphthalen-1-yl)ethyl))CF3


1-666
6-Chloro-3-pyridyl
A-1
H
C(═N(1-(naphthalen-1-yl)propyl))CF3


1-667
6-Chloro-3-pyridyl
A-1
H
C(═N(1-(furan-2-yl)ethyl))CF3


1-676
6-Chloro-3-pyridyl
A-1
H
C(═NCH(C6H5)2)CF3


1-668
6-Chloro-3-pyridyl
A-1
H
C(═N(3,3-dimethylbutan-2-yl))CF3


47-2
6-Chloro-3-pyridyl
A-1
6-F
COCF3


91-2
6-Chloro-3-pyridyl
A-1
6-Cl
COCF3


478-2
6-Chloro-3-pyridyl
A-1
6-CH3
COCF3


479-2
2-Chloro-5-thiazolyl
A-1
6-CH3
COCF3


1-51
6-Chloro-3-pyridyl
A-1
H
C(═N-cyclobutyl)CF3


566-2
6-Chloro-3-pyridyl
A-1
6-CH3O
COCF3


488-2
3-
A-1
6-CH3
COCF3



tetrahydrofuranyl


511-2
6-Chloro-3-pyridyl
A-1
5-NO2
COCF3


1-669
6-Chloro-3-pyridyl
A-1
H
C(═N(1-(thiophen-






2-yl)ethyl))CF3


179-2
6-Chloro-3-pyridyl
A-1
6-OH
COCF3 (also represents






a tautomer)


555-2
6-Chloro-3-pyridyl
A-1
5-OCH3
COCF3


577-2
2,6-dichrolo-3-pyridyl
A-1
H
COCF3


544-2
6-Chloro-3-pyridyl
A-1
4-OCH3
COCF3


168-2
6-Chloro-3-pyridyl
A-1
5-OH
COCF3


1-644
6-Chloro-3-pyridyl
A-1
H
COCH2OCH2C6H5


578-644
3-pyridyl
A-1
H
COCH2OCH2C6H5


1-703
6-Chloro-3-pyridyl
A-1
H
SOCF3


1-707
6-Chloro-3-pyridyl
A-1
H
SO2CF3


1-706
6-Chloro-3-pyridyl
A-1
H
SOCH3


1-692
6-Chloro-3-pyridyl
A-1
H
P(═O)(OEt)2


1-700
6-Chloro-3-pyridyl
A-1
H
P(═S)(SEt)2


1-701
6-Chloro-3-pyridyl
A-1
H
P(═S)(S-n-propyl)2


1-702
6-Chloro-3-pyridyl
A-1
H
P(═S)(S-isopropyl)2


1-646
6-Chloro-3-pyridyl
A-1
H
COO-iso-Pr


1-645
6-Chloro-3-pyridyl
A-1
H
COOCH2C6H5


1-643
6-Chloro-3-pyridyl
A-1
H
COC6F5


2-643
2-Chloro-5-thiazolyl
A-1
H
COC6F5









Examples of particularly preferable compounds include compounds 3-3, 4-3, 5-3, 6-3, 1-20, 1-21, 3-20, 4-20, 1-22, 1-23, 5-20, and 1-45.


Examples of insect species against which a pest control agent containing at least one of the compounds of the present invention, which is represented by Formula (I), shows pest control effects are as follows.


Examples of agricultural and horticultural pests include lepidopteran pests (for example, Spodoptera litura, cabbage armyworm, Mythimna separata, cabbageworm, cabbage moth, Spodoptera exigua, rice stem borer, grass leaf roller, Naranga aenescens, tortricid, codling moth, leafminer moth, tussock moth, Agrotis spp, Helicoverpa spp, Heliothis spp and the like), hemipteran pests (for example, aphids (Aphididae, Adelgidae, Phylloxeridae) such as Myzus persicae, Aphis gossypii, Aphis fabae, corn leaf aphid, pea aphid, Aulacorthum solani, Aphis craccivora, Macrosiphum euphorbiae, Macrosiphum avenae, Methopolophium dirhodum, Rhopalosiphum padi, greenbug, Brevicoryne brassicae, Lipaphis erysimi, Aphis spiraecola, Rosy apple aphid, apple blight, Toxoptera aurantii, Toxoptera citricidus and the like, leafhoppers such as Nephotettix cincticeps, Empoasca vitis and the like, planthoppers such as Laodelphax striatella, Nilaparvata lugens, Sogatella furcifera and the like, Pentatomorpha such as Eysarcoris ventralis, Nezara viridula, Plautia stali, Trigonotylus caelestialium and the like, whiteflies (Aleyrodidae) such as silverleaf whitefly, Bemisia tabaci, greenhouse whitefly and the like, scale insects (Diaspididae, Margarodidae, Ortheziidae, Aclerdiae, Dactylopiidae, Kerridae, Pseudococcidae, Coccidae, Eriococcidae, Asterolecaniidae, Beesonidae, Lecanodiaspididae, Cerococcidae and the like) such as Pseudococcus comstocki, Planococcus citri, Pseudaulacaspis pentagona, Aonidiella aurantii and the like, coleopteran pests (for example, Lissorhoptrus oryzophilus, Callosobruchus chinensis, Tenebrio molitor, Diabrotica virgifera virgifera, Diabrotica undecimpunctata howardi, Anomala cuprea, Anomala rufocuprea, Phyllotreta striolata, Aulacophora femoralis, Leptinotarsa decemlineata, Oulema oryzae, Bostrichidae, Cerambycidae and the like), Acarina (for example, Tetranychus urticae, Tetranychus kanzawai, Panonychus citri and the like), hymenopteran pests (for example, Tenthredinidae), orthopteran pests (for example, Acridioidea), dipteran pests (for example, housefly and Agromyzidae), thysanopteran pests (for example, Thrips palmi, Frankliniella occidentalis and the like), phytoparasitic nematode (for example, Meloidogyne, Pratylenchus, Aphelenchoides besseyi, Bursaphelenchus xylophilus and the like), and the like.


Examples of animal parasitic pests include Ixodidae (for example, Amblyomma americanum, Amblyomma maculatum, Boophilus microplus, Dermacentor andersoni, Dermacentor occidentalis, Dermacentor variabilis, Haemaphysalis campanulata, Haemaphysalis flava, Haemaphysalis longicornis, Haemaphysalis megaspinosa Saito, Ixodes nipponensis, Ixodes ovatus, Ixodes pacifcus, Ixodes persulcatus, Ixodes ricinus, Ixodes scapularis, Ornithodoros moubata pacifcus and Rhipicephalus sanguineus), Cheyletidae (for example, Cheyletiella blakei and Cheyletiella yasguri), Demodex (for example, Demodex canis and Demodex cati), Psoroptidae (for example, Psoroptes communis), Sarcoptidae (for example, Chorioptes bovis and Otodectes cynotis), Dermanyssidae (for example, Ornithonyssus sylviarum), Dermanyssus gallinae, Pterolichus (for example, Megninia cubitalis and Pterolichus obtusus), Trombiculidae (for example, Helenicula miyagawai and Leptotrombidium akamushi), Shiphonaptera (for example, Ctenocephalides felis, Pulex irritans, Xenopsylla cheopis and Xenopsylla), Mallophaga (for example, Trichodectes canis and Menopon gallinae), Anoplura (for example, Haematopinus suis, Linognathus setosus, Pediculus humanus humanus, Pediculus humanus, Pthirus pubis and Cimex lectularius), Musca domestica, Hypoderma bovis, Stomoxys calcitrans, Gasterophilus, Psychodidae (for example, Phlebotomus), Glossina morsitans, Tabanidae, Aedes spp. (for example, Aedes albopictus and Aedes aegypti), Culex spp. (for example, Culex pipiens pallens), Anophelini, Ceratopogonidae, Simuliidae, Reduviidae, Monomorium pharaonis, Nematoda (for example, Strongyloides, Ancylostomatoidea, Strongyloidea (for example, Haemonchus contortus and Nippostrongylus braziliensis), Trichostrongyloidea, Metastrongyloidea (for example, Metastrongylus elongatus, Angiostrongylus cantonensis and Aelurostrongylus abstrutus), Oxyuroidea, Haterakoidea (for example, Ascaridia galli), Ascaridoidea (for example, Anisakis simplex, Ascaris suum, Parascaris equorum, Toxocara canis and Toxocara cati), Spiruroidea (for example, Subuluroidea, Gnathostoma spinigerum, Physaloptea praeputialis, Ascarops strongylina, Draschia megastoma and Ascaria hamulosa, Dracunculus medinensis), Filarioidea (for example, Dirofilaria immitis, lymphatic filarial, Onchocerca volvulus and Loa loa), Dioctophymatoidea, Trichinella (for example, Trichuris vulpis and Trichinella spiralis)), Trematoda (for example, Schistosoma japonicum and Fasciola hepatica), Acanthocephala, Taenia (for example, Pseudophyllidea (for example, Spirometra erinaceieuropaei) and Cyclophyllidea (for example, Dipylidium caninum)), Protozoa, and the like.


Examples of hygiene pests, nuisance pests, stored grain pests, stored product pests and house pests include Culicidae spp. (for example, Aedes albopictus and Culex pipiens pallens), Periplaneta (for example, Periplaneta fuliginosa, Periplaneta japonica and Blattella germanica), Acaridae (for example, Tyrophagusputrescentiae), Diptera (for example, housefly, Sarcophagaperegrina, Psychodidae, Drosophila and Chironomus), Simuliidae, Ceratopogonidae, hymenopteran insects (for example, Formicidae such as Camponotus japonicus, Solenopsis spp. and the like and Hymenoptera such as Vespa mandarinia), Arthropod of Isopoda (for example, Porcellio scaber, Ligia exotica and Armadillidium vulgare), hemipteran insescts (for example, Cimex lectularius), Arthropod of Myriapoda (for example, centipedes, millipedes and Diplopoda), Arthropod of Araneae (for example, Heteropoda venatoria), coleopteran insects (for example, Anisodactylus signatus), Arthropod of Collembola (for example, Onychiurus folsomi), dermapteran insects (for example, Labidura riparia), orthopteran insects (for example, Stenopelmatidae), coleopteran insects (for example, Callosobruchus chinensis, Sitophilus zeamais, Tenebroides mauritanicus, Tribolium castaneum, Anthrenus museorum, Anobiidae, Scolytidae spp., Dermestidae and Chlorophorus diadema inhirsutus Matsushita), lepidopteran insects (for example, Pyralidae and Tineidae), Hemipeplidae, isopteran insects (for example, Coptotermes formosanus, Incisitermes minor (Hagen) and Odontotermes formosanus), Thysanura (for example, Ctenolepisma villosa) and the like.


Among them, preferred examples of insect species to which the pest control agent of the present invention is applied include lepidopteran pests, hemipteran pests, thysanopteran pests, dipteran pests, coleopteran pests, animal parasitic Shiphonaptera or Acari, Dirofilaria immitis, mosquitoes, Periplaneta and isopteran insects (for example, at least one insect species selected from the group consisting of cabbage moth, Spodoptera litura, Aphis gossypii, Myzus persicae, Laodelphax striatella, Nilaparvata lugens, Sogatella furcifera, Nephotettix cincticeps, Trigonotylus caelestialium, Plautia stali, Frankliniella occidentalis, Oulema oryzae, Lissorhoptrus oryzophilus, housefly, Haemaphysalis longicornis, Dirofilaria immitis, Culex pipiens pallens, Blattella germanica and Coptotermes formosanus), more preferred examples thereof include hemipteran pests, coleopteran insects and Ixodidae, and particularly preferred examples thereof include planthoppers, Nephotettix cincticeps and imidacloprid or fipronil-resistant planthoppers.


Accordingly, examples of a pest control agent provided by the present invention include an agricultural and horticultural insecticide, an agent for controlling endoparasites of an animal, an agent for controlling ectoparasites of an animal, an agent for controlling hygiene pests, an agent for controlling nuisance pests, an agent for controlling stored grain and stored product pests, an agent for controlling house pests and the like, but preferred examples thereof include an agricultural and horticultural insecticide, an agent for controlling endoparasites of an animal and an agent for controlling ectoparasites of an animal.


The pest control agent of the present invention may be prepared by using a carrier according to the use thereof in addition to the compound represented by Formula (I).


When the pest control agent of the present invention is an agricultural pest control agent, the agent is usually mixed with an appropriate solid carrier, liquid carrier, gaseous carrier, surfactant, dispersant and other adjuvants for preparation to be provided in any formulation form of emulsifiable concentrates, liquid formulations, suspensions, wettable powders, flowables, dust, granules, tablets, oils, aerosols, fumigants and the like.


Examples of the solid carrier include talc, bentonite, clay, kaolin, diatomaceous earth, vermiculite, white carbon, calcium carbonate and the like.


Examples of the liquid carrier include alcohols such as methanol, n-hexanol, ethylene glycol and the like, ketones such as acetone, methyl ethyl ketone, cyclohexane and the like, aliphatic hydrocarbons such as n-hexane, kerosene, lamp oil and the like, aromatic hydrocarbons such as toluene, xylene, methyl naphthalene and the like, ethers such as diethyl ether, dioxane, tetrahydrofuran and the like, esters such as ethyl acetate and the like, nitriles such as acetonitrile, isobutyl nitrile and the like, acid amides such as dimethylformamide, dimethylacetamide and the like, vegetable oils such as soybean oil, cotton seed oil and the like, dimethyl sulfoxide, water and the like.


Further, examples of the gaseous carrier include LPG, air, nitrogen, carbonic acid gas, dimethyl ether and the like.


As the surfactant or dispersant for emulsification, dispersion, spreading and the like, it is possible to use, for example, alkylsulfate esters, alkyl (aryl) sulfonates, polyoxyalkylene alkyl (aryl) ethers, polyhydric alcohol esters, lignin sulfonates or the like.


In addition, as the adjuvant for improving the properties of the preparation, it is possible to use, for example, carboxymethylcellulose, gum arabic, polyethylene glycol, calcium stearate or the like.


The aforementioned carriers, surfactants, dispersants and adjuvants may be used either alone or in combination, if necessary.


The content of active ingredients in the preparation is not particularly limited, but is usually in the range from 1 to 75% by weight for the emulsifiable concentrate, from 0.3 to 25% by weight for the dust, from 1 to 90% by weight for the wettable powder, and from 0.5 to 10% by weight for the granule.


The application thereof may be performed before and after the invasion of pest insects.


In particular, it is possible to control pests by applying an effective amount of the compounds represented by Formula (I), a preparation including the same and a mixed formulation of other pest control agents with the same to a subject selected from the group consisting of seeds, roots, tubers, bulbs and rhizomes of plants, germinated plants, seedlings, soil, a nutrient solution in nutrient solution culture and a solid medium in nutrient solution culture and penetrating and migrating the compound, the preparation or the mixed formulation into the plants.


When the subject to be applied is seeds, roots, tubers, bulbs or rhizomes of plants, appropriate examples of the application method are not particularly limited, but include a dipping method, a dust coating method, a smearing method, a spraying method, a pelleting method, a coating method and the like as long as the penetration and migration are not disturbed.


In the case of seeds, examples of the application method include a dipping method, a dust coating method, a smearing method, a spraying method, a pelleting method, a coating method and a fumigating method. The dipping method is a method in which seeds are dipped in a liquid chemical solution, and the dust coating method is classified into a dry dust coating method in which a granular chemical is adhered onto dry seeds, and a wet dust coating method in which a granular chemical is adhered onto seeds which have been slightly soaked in water. Further, the smearing method is a method in which a suspended chemical is applied on the surface of seeds within a mixer and the spraying method is a method in which a suspended chemical is sprayed onto the surface of seeds. In addition, the pelleting method is a method in which a chemical is mixed with a filler and treated when seeds are pelleted together with the filler to form pellets having certain size and shape, the coating method is a method in which a chemical-containing film is coated onto seeds, and the fumigating method is a method in which seeds are sterilized with a chemical which has been gasified within a hermetically sealed container.


When the method is applied to germinated plants and seedlings, these plants may be protected by the treatment of the whole or a part thereof by dipping by applying the method after germination, after budding from soil or before transplantation.


Further, when the method is applied to seeds, roots, tubers, bulbs, rhizomes or the like, examples of the method also include a method in which seeds, roots, tubers, bulbs, rhizomes or the like are planted or dipped in the chemical for a time enough to penetrate and migrate the chemical into the plants. In this case, the time and temperature for dipping is appropriately determined by those skilled in the art depending on the subject to be applied, kind and amount of drug and the like. Moreover, time for penetration and migration is not particularly limited, but is, for example, 1 hour or longer. In addition, the temperature for penetration and migration is, for example, from 5° C. to 45° C.


Examples of the method for applying the chemical to soil include a method in which granules of the compounds of the present invention, a preparation including the same and a mixed formulation of other pest control agents with the same are applied into soil or on soil. Preferred soil application methods include spraying, stripe application, groove application, and planting hole application. Here, the spraying treatment includes a surface treatment over the entire area to be treated and a subsequent mechanical introduction into soil.


In addition, application by drenching of soil with a solution prepared by emulsifying or dissolving the nitrogen-containing heterocyclic derivatives having a 2-imino group of the present invention, a preparation including the same and a mixed formulation of other pest control agents with the same in water is also an advantageous soil application method.


When the method is applied to a nutrient solution in nutrient solution culture systems such as solid medium cultivation, such as hydroponic culture, sand culture, NFT (nutrient film technique), rock wool culture and the like for the production of vegetables and flowering plants, it is obvious that the compounds of the present invention, a preparation including the same and a mixed formulation of other pest control agents with the same may be applied directly to artificial culture soil including vermiculite and a solid medium including an artificial mat for growing seedling.


Further, in the application process, an effective amount of the compound of Formula (I) or salts thereof is preferably an amount enough for the compound of Formula (1) to be penetrated and migrated into the plant in the subsequent penetration and migration process.


The effective amount may be appropriately determined by considering the properties of the compound, the kind and amount of subject to be applied, the length of the subsequent penetration and migration process, the temperature and the like, but for example, in the case of a seed, the compound of Formula (I) or salts thereof is applied in an amount of preferably from 1 g to 10 kg and more preferably from 10 g to 1 kg, per 10 kg of the seed. Further, the amount of the compound of Formula (I) or salts thereof applied to soil is preferably from 0.1 g to 10 kg and more preferably from 1 g to 1 kg, per 10 acres of cultivated land. The amount of the compound of Formula (I) or salts thereof treated to leaves and stems of a plant is preferably from 0.1 g to 10 kg and more preferably from 1 g to 1 kg, per 10 acres of cultivated land.


When the pest control agent of the present invention is a control agent for animal parasitic pests, the agent is provided in the form of liquid formulations, emulsifiable concentrates, liquid drops, sprays, foam preparations, tablets, granules, fine subtilaes, dust, capsules, chewable formulations, injections, suppositories, creams, shampoos, rinses, resin agents, fumigants, poison baits and the like, and is particularly preferably provided in the form of liquid formulations and liquid drops.


The liquid formulation may also be blended with a typical adjuvant for preparation, such as an emulsifier, a dispersant, a spreading agent, a wetting agent, a suspending agent, a preservative, a propellant and the like, and may also be blended with a typical film former. As the surfactant for emulsification, dispersion, spreading and the like, it is possible to use, for example, soaps, polyoxyalkylene alkyl (aryl) ethers, polyoxyethylene alkyl aryl ethers, polyoxyethylene fatty acid ester, higher alcohols, alkyl aryl sulfonates and the like. Examples of dispersants include casein, gelatin, polysaccharides, lignin derivatives, saccharides, synthetic water soluble polymers and the like. Examples of spreading and wetting agents include glycerin, polyethylene glycol and the like. Examples of suspending agents include casein, gelatin, hydroxypropylcellulose, gum arabic and the like, and examples of stabilizers include phenolic antioxidants (BHT, BHA and the like), amine antioxidants (diphenylamine and the like), organic sulfur antioxidants and the like. Examples of preservatives include methyl p-oxybenzoate, ethyl p-oxybenzoate, propyl p-oxybenzoate, butyl p-oxybenzoate and the like. The aforementioned carriers, surfactants, dispersants and adjuvants may be used either alone or in combination, if necessary. In addition, perfumes, synergists and the like may also be contained. It is appropriate that the content of the active ingredients in the pest control agent of the present invention is usually from 1 to 75% by weight for the liquid formulation.


Examples of carriers used for the preparation of creams include non-volatile hydrocarbons (liquid paraffin and the like), lanolin hydrogenated fats and oils, higher fatty acids, fatty acid esters, animal and vegetable oils, silicone oils, water and the like. Further, emulsifiers, humectants, antioxidants, perfumes, borax and ultraviolet absorbers may also be used either alone or in combination, if necessary. Examples of emulsifiers include fatty acid sorbitan, polyoxyethylene alkyl ether, and fatty acid polyoxyethylene and the like. It is appropriate that the content of the active ingredients in the pest control agent of the present invention is usually from 0.5 to 70% by weight for the cream.


The capsules, pills or tablets may be used such that the active ingredients in the composition of the present invention are divided into suitable small portions, the small portion is mixed with a diluting solution or a carrier such as starch, lactose, talc, or the like, a disintegrator and/or a binder, such as magnesium stearate is added thereto, and the mixture is tabletted, if necessary.


Injections need to be prepared as an aseptic solution. For injections, the solution may contain, for example, a salt or glucose enough to isotonicate the solution with blood. Examples of available carriers for the preparation of injections include esters such as fatty acid derivatives of glyceride, benzyl benzoate, isopropyl myristate and propylene glycol, and the like, and organic solvents such as N-methylpyrrolidone and glycerol formal. It is appropriate that the content of the active ingredients in the pest control agent of the present invention is usually from 0.01 to 10% by weight for the injection.


Examples of carriers for the preparation of resin agents include vinyl chloride polymers, polyurethane and the like. Plasticizers such as phthalic acid esters, adipic acid esters, stearic acid and the like may be added to these bases, if necessary. After the active ingredients are kneaded into the base, the kneaded product may be molded by injection molding, extrusion molding, press molding and the like. Further, the molded product may also be properly subjected to processes such as molding, cutting or the like to form an ear tag for animals or insecticidal collar for animals.


Examples of carriers for toxic baits include bait substances and attraction substances (farina such as wheat flour, corn flour and the like, starch such as corn starch, potato starch and the like, saccharides such as granulated sugar, malt sugar, honey and the like, food flavors such as glycerin, onion flavor, milk flavor and the like, animal powders such as pupal powder, fish powder and the like, various pheromones and the like). It is appropriate that the content of the active ingredients in the pest control agent of the present invention is usually from 0.0001 to 90% by weight for the toxic bait.


It is possible to control pests by administering the pest control agent of the present invention into an applied animal either orally or by injection, or wholly or partly administering the agent into the body surface of the applied animal. In addition, it is also possible to control pests by covering places, in which the invasion, parasitism and movement of pests are expected, with the pest control agent of the present invention.


The pest control agent of the present invention may be used as it is, but may be diluted with water, liquid carriers, commercially available shampoos, rinses, baits, breed cage bottoms and the like and applied in some cases.


Further, the pest control agent according to the present invention may be mixed with other insecticides, fungicides, miticides, herbicides, plant growth regulators, fertilizers and the like and the mixture may be used. Examples of a chemical that may be mixed and used include those described in The Pesticide Manual (13th edition and published by the British Crop Protection Council) or the SHIBUYA INDEX (15th edition, 2010 and published by SHIBUYA INDEX RESEARCH GROUP). As insecticides, miticides or nematicides, more specific examples thereof include an organic phosphoric ester compound such as acephate, dichlorvos, EPN, fenitrothion, fenamifos, prothiofos, profenofos, pyraclofos, chlorpyrifos-methyl, diazinon, fosthiazate, imicyafos, trichlorfon, tetrachlorvinphos, bromofenofos and cythioate, a carbamate-based compound such as methomyl, thiodicarb, aldicarb, oxamyl, propoxur, carbaryl, fenobucarb, ethiofencarb, fenothiocarb, pirimicarb, carbofuran and benfuracarb, a nereistoxin derivative such as cartap and thiocyclam, an organochlorine compound such as dicofol and tetradifon, a pyrethroid-based compound such as allethrin, d•d-T allethrin, dl•d-T80 allethrin, pyrethrins, phenothrin, flumethrin, cyfluthrin, d•d-T80 prarethrin, phthalthrin, transfluthrin, resmethrin, cyphenothrin, pyrethrum extract, synepirin222, synepirin 500, permethrin, tefluthrin, cypermethrin, deltamethrin, cyhalothrin, fenvalerate, fluvalinate, ethofenprox and silafluofen, a benzoyl urea-based compound such as diflubenzuron, teflubenzuron, flufenoxuron, chlorfluazuron and lufenuron, a juvenile hormone-like compound such as methoprene and a molting hormone-like compound such as chromafenozide. In addition, examples of other compounds include buprofezin, hexythiazox, amitraz, chlordimeform, pyridaben, fenpyroxymate, pyrimidifen, tebufenpyrad, tolfenpyrad, fluacrypyrim, acequinocyl, cyflumetofen, flubendiamide, ethiprole, fipronil, etoxazole, imidacloprid, clothianidin, thiamethoxam, acetamiprid, nitenpyram, thiacloprid, dinotefuran, pymetrozine, bifenazate, spirodiclofen, spiromesifen, flonicamid, chlorfenapyr, pyriproxyfen, indoxacarb, pyridalyl, spinosad, avermectin, milbemycin, cyenopyrafen, spinetoram, pyrifluquinazon, chlorantraniliprole, cyantraniliprole, spirotetramat, lepimectin, metaflumizone, pyrafluprole, pyriprole, hydramethylnon, triazamate, sulfoxaflor, flupyradifurone, flometoquin, pyflubumide, pyrafluprole, ivermectin, selamectin, moxidectin, doramectin, eprinomectin, milbemycin oxime, deet, metoxadiazone, cyromazine, triflumuron, star anise oil, triclabendazole, flubendazole, fenbendazole, antimony sodium gluconate, levamisole hydrochloride, bithionol, dichlorophen, phenothiazine, piperazine-carbon disulfide, piperazine phosphate, piperazine adipate, piperazine citrate, melarsomine dihydrochloride, metyridine, santonin, pyrantel pamoate, pyrantel, praziquantel, febantel, emodepside, emamectin benzoate, cycloxaprid, 1-((6-chloropyridin-3-yl)methyl)-4-oxo-3-phenyl-4H-pyr ido[1,2-a]pyrimidin-1-ium-2-olate, an organic metal-based compound, a dinitro-based compound, an organic sulfur compound, a urea-based compound, a triazine-based compound, and a hydrazine-based compound.


The pest control agent of the present invention may be used in admixture or in combination with a microbial pesticide such as a BT agent, an entomopathogenic viral agent and the like.


Examples of the fungicide used in admixture or in combination include, for example, a strobilurin-based compound such as azoxystrobin, kresoxym-methyl, trifloxystrobin, metominostrobin, and orysastrobin, an anilinopyrimidine-based compound such as mepanipyrim, pyrimethanil and cyprodinil, an azole-based compound such as triadimefon, bitertanol, triflumizole, etaconazole, metoconazole, propiconazole, penconazole, flusilazole, myclobutanil, cyproconazole, tebuconazole, hexaconazole, prochloraz and simeconazole, a quinoxaline-based compound such as quinomethionate, a dithiocarbamate-based compound such as maneb, zineb, mancozeb, polycarbamate and propineb, a phenyl carbamate-based compound such as diethofencarb, an organochlorine compound such as chlorothalonil and quintozene, a benzimidazole-based compound such as benomyl, thiophanate-methyl and carbendazole, a phenyl amide-based compound such as metalaxyl, oxadixyl, ofurase, benalaxyl, furalaxyl and cyprofuram, a sulfenic acid-based compound such as dichlofluanid, a copper-based compound such as copper (II) hydroxide and copper oxyquinoline (oxine-copper), an isoxazole-based compound such as hydroxyisoxazole, an organic phosphorus-based compound such as fosetyl-aluminium and tolclofos-methyl, an N-halogenothioalkyl-based compound such as captan, captafol and folpet, a dicarboximide-based compound such as procymidone, iprodione and vinchlozolin, a carboxanilide-based compound such as flutolanil, mepronil, furamepyr, thifluzamide, boscalid, and penthiopyrad, a morpholine-based compound such as fenpropimorph and dimethomorph, an organic tin-based compound such as fentin hydroxide and fentin acetate, a cyanopyrrole-based compound such as fludioxonil and fenpiclonil, and other examples include tricyclazole, pyroquilon, carpropamid, diclocymet, fenoxanil, fthalide, fluazinam, cymoxanil, triforine, pyrifenox, fenarimol, fenpropidin, pencycuron, ferimzone, cyazofamid, iprovalicarb, benthiavalicarb-isopropyl, iminoctadin-albesilate, cyflufenamid, kasugamycin, validamycin, streptomycin, oxolinic-acid, tebufloquin, probenazole, tiadinil, and isotianil.


Examples of the herbicide used in admixture or in combination include lipid synthesis inhibitors, acetolactic acid synthesis inhibitors, photosynthesis inhibitors, protoporphyrinogen IX oxidation inhibitors, bleaching herbicides, amino acid synthesis inhibitors, dihydropteroate synthase inhibitors, cell division inhibitors, very long chain fatty acid synthesis inhibitors, cellulose biosynthesis inhibitors, uncouplers, auxin-like herbicides, auxin transport inhibitors and the like. Specific examples include alloxydim, alloxydim-sodium, butroxydim, clethodim, clodinafop, clodinafop-propargyl, cycloxydim, cyhalofop, cyhalofop-butyl, diclofop, diclofop-methyl, fenoxaprop, fenoxaprop-ethyl, fenoxaprop-P, fenoxaprop-P-ethyl, fluazifop, fluazifop-butyl, fluazifop-P, fluazifop-P-butyl, haloxyfop, haloxyfop-methyl, haloxyfop-P, haloxyfop-P-methyl ester, metamifop, pinoxaden, profoxydim, propaquizafop, quizalofop, quizalofop-ethyl, quizalofop-tefuryl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, sethoxydim, tepraloxydim, tralkoxydim, benfuresate, butylate, cycloate, dalapon, dimepiperate, ethyl dipropylthiocarbamate (EPTC), esprocarb, ethofumesate, flupropanate, molinate, orbencarb, pebulate, prosulfocarb, trichloroacetic acid (TCA), thiobencarb, tiocarbazil, triallate, vernolate, sulfonylureas (amidosulfuron, azimsulfuron, bensulfuron, bensulfuron-methyl, chlorimuron, chlorimuron-ethyl, chlorsulfuron, cinosulfuron, cyclosulfamuron, ethametsulfuron, ethametsulfuron-methyl, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, flupyrsulfuron-methyl-sodium, foramsulfuron, halosulfuron, halosulfuron-methyl, imazosulfuron, iodosulfuron, iodosulfuron-methylsodium, mesosulfuron, metazosulfuron, metsulfuron, metsulfuron-methyl, nicosulfuron, orthosulfamuron, oxasulfuron, primisulfuron, primisulfuron-methyl, propyrisulfuron, prosulfuron, pyrazosulfuron, pyrazosulfuron-ethyl, rimsulfuron, sulfometuron, sulfometuron-methyl, sulfosulfuron, thifensulfuron, thifensulfuron-methyl, triasulfuron, tribenuron, tribenuron-methyl, trifloxysulfuron, triflusulfuron, triflusulfuron-methyl, tritosulfuron), imazamethabenz, imazamethabenz-methyl, imazamox, imazapic, imazapyr, imazaquin, imazethapyr, triazolopyrimidine herbicides (chloransulam, cloransulam-methyl, diclosulam, flumetsulam, florasulam, metosulam, penoxsulam), pyrimisulfan, pyroxsulam, bispyribac, bispyribac-sodium, pyribenzoxim, pyriftalid, pyriminobac, pyriminobac-methyl, pyrithiobac, pyrithiobac-sodium, flucarbazone, flucarbazone-sodium, propoxycarbazone, propoxycarbazone-sodium, thiencarbazone, thiencarbazone-methyl, triazine herbicides (chlorotriazines, triazinones, triazindiones, methylthiotriazines and pyridazinones, such as ametryn, atrazine, chloridazone, cyanazine, desmetryn, dimethametryn, hexazinone, metribuzin, prometon, prometryn, propazin, simazin, simetryn, terbumeton, terbuthylazin, terbutryn and trietazin), aryl ureas (for example, chlorobromuron, chlorotoluron, chloroxuron, dimefuron, diuron, fluometuron, isoproturon, isouron, linuron, metamitron, methabenzthiazuron, metobenzuron, metoxuron, monolinuron, neburon, siduron, tebuthiuron and thiadiazuron), phenyl carbamates (for example, desmedipham, karbutilate, phenmedipham and phenmedipham-ethyl), nitrile herbicides (for example, bromofenoxim, bromoxynil or its salt or ester, and ioxynil or its salt or ester), uracils (for example, bromacil, lenacil and terbacil), bentazon, bentazon-sodium, pyridate, pyridafol, pentanochlor, propanil, photosynthesis inhibitors (for example, diquat, diquat-dibromide, paraquat, paraquat dichloride, paraquat-dimethylsulfate, acifluorfen, acifluorfen-sodium, azafenidin, bencarbazone, benzfendizone, bifenox, butafenacil, carfentrazone, carfentrazone-ethyl, chlomethoxyfen, cinidon-ethyl, fluazolate, flufenpyr, flufenpyr-ethyl, flumiclorac, flumiclorac-pentyl, flumioxazin, fluoroglycofen, fluoroglycofen-ethyl, fluthiacet, fluthiacet-methyl, fomesafen, halosafen, lactofen, oxadiargyl, oxadiazon, oxyfluorfen, pentoxazone, profluazol, pyraclonil, pyraflufen, pyraflufen-ethyl, saflufenacil, sulfentrazone, thidiazimin, beflubutamid, diflufenican, fluridone, flurochloridone, flurtamone, norflurazon, picolinafen, aclonifen, amitrole, clomazone, flumeturon, glyphosate and its salt, bialaphos, bilanaphos-sodium, glufosinate, glufosinate-P, glufosinate-ammonium, asulam, dinitroanilines (for example, benfluralin, butralin, dinitramine, ethalfluralin, fluchloralin, oryzalin, pendimethalin, prodiamine and trifluralin), phosphoramidate herbicides (for example, amiprophos, amiprophos-methyl and butamiphos), benzoic acid herbicides (for example, chlorthal and chlorthal-dimethyl), pyridines (for example, dithiopyr and thiazopyr), benzamides (for example, propyzamide and tebutam), chloroacetamides (for example, acetochlor, alachlor, butachlor, dimethachlor, dimethenamid, dimethenamid-P, metazachlor, metolachlor, metolachlor-S, pethoxamid, pretilachlor, propachlor, propisochlor and thenylchlor), oxyacetanilides (for example, flufenacet and mefenacet), acetanilides (for example, diphenamid, naproanilide and napropamide), tetrazolinones (for example, fentrazamide), anilofos, cafenstrole, fenoxasulfone, ipfencarbazone, piperophos, pyroxasulfone, chlorthiamid, dichlobenil, flupoxam, isoxaben, dinoseb, dinoterb, 4,6-dinitro-o-cresol (DNOC) and its salt, 2,4-D and it salt or ester, 2,4-DB and its salt or ester, aminopyralid and its salts (for example aminopyralid-tris(2-hydroxypropyl)ammonium) and esters of these, benazolin, benazolin-ethyl, chloramben and its salt or ester, chlomeprop, clopyralid and its salt or ester, dicamba and its salt or ester, dichlorprop and its salt or ester, dichlorprop-P and its salt or ester, fluroxypyr and its salt or ester, 2-methyl-4-chlorophenoxyacetic acid (MCPA) and its salt or ester, MCPA-thioethyl, 4-(2-methyl-4-chlorophenoxy)butyric acid (MCPB) and its salt or ester, mecoprop and its salt or ester, mecoprop-P and its salt or ester, picloram and its salt or ester, quinclorac, quinmerac, 2,3,6-trichlorobenzoic acid (TBA(2,3,6)) and its salt or ester, triclopyr and its salt or ester, aminocyclopyrachlor and its salt or ester, diflufenzopyr and its salt, naptalam and its salt, bromobutide, chlorflurenol, chlorflurenol-methyl, cinmethylin, cumyluron, dalapon, dazomet, difenzoquat, difenzoquat-methyl sulfate, dimethipin, disodium methanearsonate (DSMA), dymron, endothal and its salt, etobenzanid, flamprop, flamprop-isopropyl, flamprop-methyl, flamprop-M-isopropyl, flamprop-M-methyl, flurenol, flurenol-butyl, flurprimidol, fosamine, fosamine-ammonium, indanofan, indaziflam, maleic hydrazide, mefluidide, metam, methiozolin, methyl azide, methyl bromide, methyl-dymron, methyl iodide, MSMA, oleic acid, oxaziclomefone, pelargonic acid, pyributicarb, quinoclamine, triaziflam, tridiphane, and 6-chloro-3-(2-cyclopropyl-6-methylphenoxy)-4-pyridazinol (CAS 499223-49-3) and its salt or ester.


Examples of the agent for controlling insect parasites of animals used in admixture or in combination include organic phosphate ester compounds, carbamate compounds, nereistoxin compounds, organochlorine compounds, pyrethroid compounds, benzoyl urea compounds, juvenile hormone-type compounds, molting hormone-type compounds, neonicotinoid compounds, nerve cell sodium channel blockers, insecticidal macrolactones, gamma-aminobutyric acid (GABA) antagonists, ryanodine receptor agonists, insecticidal ureas and the like. More desirable specific examples are dichlorvos, EPN, fenitrothion, fenamifos, prothiofos, profenofos, pyraclofos, chlorpyrifos-methyl, diazinon, trichlorfon, tetrachlorvinphos, bromofenofos, cythioate, fenthion and other organic phosphate ester compounds; methomyl, thiodicarb, aldicarb, oxamyl, propoxur, carbaryl, fenobucarb, ethiofencarb, fenothiocarb, pirimicarb, carbofuran, benfuracarb and other carbamate compounds; cartap, thiocyclam and other nereistoxin compounds; dicofol, tetradifon and other organochlorine compounds; allethrin, d•d-T allethrin, dl•d-T80 allethrin, pyrethrins, phenothrin, flumethrin, cyfluthrin, d•d-T80 prarethrin, phthalthrin, transfluthrin, resmethrin, cyphenothrin, pyrethrum extract, synepirin 222, synepirin 500, permethrin, tefluthrin, cypermethrin, deltamethrin, cyhalothrin, fenvalerate, fluvalinate, ethofenprox, silafluofen and other pyrethroid compounds; diflubenzuron, teflubenzuron, flufenoxuron, chlorfluazuron, lufenuron and other benzoyl urea compounds; methoprene and other juvenile hormone-type compounds; and chromafenozide and other molting hormone-type compounds. Examples of other compounds include amitraz, chlordimeform, fipronil, etoxazole, imidacloprid, clothianidin, thiamethoxam, acetamiprid, nitenpyram, thiacloprid, dinotefuran, spirodiclofen, pyriproxyfen, indoxacarb, spinosad, spinetoram, avermectin, milbemycin, metaflumizone, pyrafluprole, pyriprole, hydramethylnon, triazamate, sulfoxaflor, flupyradifurone, ivermectin, selamectin, moxidectin, doramectin, eprinomectin, milbemycin oxime, diethylcarbamazine citrate, deet, metoxadiazone, cyromazine, triflumuron, star anise oil, triclabendazole, flubendazole, fenbendazole, antimony sodium gluconate, levamisole hydrochloride, bithionol, dichlorophen, phenothiazine, piperazine carbon bisulfide, piperazine phosphate, piperazine adipate, piperazine citrate, melarsomine dihydrochloride, metyridine, santonin, pyrantel pamoate, pyrantel, praziquantel, febantel, emodepside, derquantel, monepantel, emamectin benzoate, cycloxaprid, and a compound represented by the following Formula (VI), or acid addition salts of these that are allowable as agricultural and veterinary chemicals. Examples of acid addition salts of these include hydrochloride salts, nitrate salts, sulfate salts, phosphate salts or acetate salts or the like.


[Synthesis Method of Compound of the Present Invention]

A compound represented by the following Formula (I-1)




embedded image


may be obtained by reacting a compound represented by the following Formula (II-1) with a compound represented by ArCH2X [the definition of Ar, A, Y and R1 has the same meaning as the definition described above, and X represents a halogen atom or OTs, OMs and the like] in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction, and when the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol, propanol and isopropyl alcohol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but N,N-dimethylformamide and the like are preferably used.


The reaction may be performed usually at from 0° C. to 200° C., and it is preferred that reagents are added at from 20° C. to 40° C. and the reaction is performed at from 60° C. to 80° C.


The compound represented by Formula (II-1) may be obtained by reacting a compound represented by R1-C(═O)X, R1-C(═O)OC(═O)R1, R1C(═O)OR′ [X represents a halogen atom or OTs, OMs and the like, R′ represents a C1 to C6 alkyl group, and the definition of R1, Aand Y has the same meaning as the definition described above] and the like with a compound represented by in the following Formula (III) in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction. When the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol and propanol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, and water, either alone or in combination of two or more thereof, but toluene, N,N-dimethylformamide, acetonitrile, ethers, dichloromethane, chloroform and the like are preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 50° C.


The compound represented by Formula (II-1) may be obtained by reacting the compound represented by the Formula (III) with a carboxylic acid represented by R1-COOH [the definition of R1 has the same meaning as the definition described above] using a dehydration condensation agent in the presence or absence of a base, or may be obtained by performing the reaction using phosphorus pentaoxide, sulfuric acid, polyphosphoric acid, thionyl chloride, phosphorus oxychloride and oxalyl dichloride in the absence of a base.


It is possible to use a carbodiimide-based compound such as dicyclohexylcarbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and the like as the dehydration condensation agent.


When the reaction is performed in the presence of a base, it is possible to use, for example, a carbonate such as potassium carbonate or sodium carbonate and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction is preferably performed by using a solvent, and it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but N,N-dimethylformamide, acetonitrile, ethers, dichloromethane, chloroform and the like are preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 50° C.


The compound represented by Formula (I-1) may be obtained by reacting a compound represented by R1-C(═O)X, R1-C(═O)OC(═O)R1, R1C(═O)OR′ [X represents a halogen atom or OTs, OMs and the like, R′ represents a C1 to C6 alkyl group, and the definition of Ar, A, Y and R1 has the same meaning as the definition described above] and the like with a compound represented by the following Formula (IV) in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction. When a solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether, and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol, and propanol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, and water, either alone or in combination of two or more thereof, toluene, N,N-dimethylformamide, acetonitrile, ethers, dichloromethane, chloroform or the like is preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 50° C. The compound represented by Formula (I-1) may be obtained by reacting the above-described compound represented by Formula (IV) with a carboxylic acid represented by R1-COOH [the definition of R1—has the same meaning as the definition described above] using a dehydration condensation agent in the presence or absence of a base, or may be obtained by performing the reaction using phosphorus pentaoxide, sulfuric acid, polyphosphoric acid, thionyl chloride, phosphorus oxychloride and oxalyl dichloride in the absence of a base.


It is possible to use a carbodiimide-based compound such as dicyclohexylcarbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and the like as the dehydration condensation agent.


When the reaction is performed in the presence of a base, it is possible to use, for example, a carbonate such as potassium carbonate or sodium carbonate and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction is preferably performed by using a solvent, and it is possible to use, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but dichloromethane, chloroform or the like is preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 50° C. The compound represented by Formula (IV) may be obtained by reacting the above-described compound represented by Formula (III) with a compound represented by ArCH2X [the definition of Ar and X has the same meaning as the definition described above] in the presence or absence of a base.


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride, a carbonate such as potassium carbonate or sodium carbonate, an alkali metal hydroxide such as potassium hydroxide and sodium hydroxide, tertiary amines such as triethylamine and 1,8-diazabicyclo[4.3.0]non-5-ene, and unsubstituted or substituent-containing pyridines, such as pyridine and 4-dimethylaminopyridine as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction. When the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol and propanol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, and water, either alone or in combination of two or more thereof, but N,N-dimethylformamide, acetonitrile, ethers, dichloromethane, chloroform and the like is preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 80° C.


When Formula (I-1) is synthesized via Formula (II-1) from the compound represented by Formula (III), or when Formula (I-1) is synthesized via Formula (IV) from the compound represented by Formula (III), the reaction may be continuously performed without taking out Formula (II-1) or Formula (IV), or the reactions from Formula (III) to Formula (I-1) may be simultaneously performed in the same vessel.




embedded image


The compound represented by Formula (I-2) may be obtained by reacting a compound represented by the following Formula (I-2a) with a compound represented by ArCH2X [the definition of Ar, A, Y and R2 has the same meaning as the definition described above, and X represents a halogen atom or OTs, OMs and the like] in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction, and when the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol, propanol and isopropyl alcohol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but N,N-dimethylformamide and the like are preferably used.


The reaction may be performed usually at from 0° C. to 200° C., and it is preferred that reagents are added at from 20° C. to 40° C. and the reaction is performed at from 60° C. to 80° C.


The compound represented by Formula (I-2a) may be obtained by reacting the above-described compound represented by Formula (III) with a compound represented by R2OC(═O)X (the definition of R2 and X has the same meaning as the definition described above) or represented by the following Formula (I-2b) in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction, and when the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol, propanol, and isopropyl alcohol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but acetonitrile, dichloromethane, and the like are preferably used.


The reaction may be performed usually at from 0° C. to 200° C., and is performed preferably at from 20° C. to 80° C.


The compound represented by Formula (I-2) may be obtained by reacting the above-described compound represented by Formula (IV) with a compound represented by R2OC(═O)X (the definition of R2 and X has the same meaning as the definition described above) or represented by the above-described Formula (I-2b) in the presence or absence of a base.


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction, and when the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol, propanol, and isopropyl alcohol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but acetonitrile, dichloromethane, and the like are preferably used.


The reaction may be performed usually at from 0° C. to 200° C., and is performed preferably at from 20° C. to 80° C.




embedded image


The compound represented by Formula (I-3) may be synthesized by acting a sulfurizing reagent on a compound (the definition of Ar, A, Y and R3 has the same meaning as the definition described above) represented by the following Formula (II-3a), which may be synthesized in the same manner as described in Formula (I-1), in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base, but potassium carbonate, sodium carbonate or the like is preferably used.


As the sulfurizing reagent, phosphorus pentasulfide, Lawesson's reagent, hydrogen sulfide and the like may be used.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction, and when the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol and propanol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but toluene, tetrahydrofuran, and the like are preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 80° C.


The compound represented by Formula (I-3) may be obtained by reacting a compound represented by the following Formula (II-3b) with a compound represented by ArCH2X [the definition of Ar, A, Y and R3 has the same meaning as the definition described above, and X represents a halogen atom or OTs, OMs and the like] in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction, and when the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol propanol, and isopropyl alcohol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but N,N-dimethylformamide is preferably used.


The reaction may be performed usually at from 0° C. to 200° C., and it is preferred that reagents are added at from 20° C. to 40° C. and the reaction is performed at from 60° C. to 80° C.


A compound represented by the following Formula (II-3b) may be synthesized by acting a sulfurizing reagent on a compound (the definition of A, Y and R3 has the same meaning as the definition described above) represented by the following Formula (II-3c), which may be synthesized in the same manner as described in Formula (II-1), in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base, but potassium carbonate, sodium carbonate or the like is preferably used.


As the sulfurizing reagent, phosphorus pentasulfide, Lawesson's reagent, hydrogen sulfide and the like may be used.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction, and when the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol and propanol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but toluene, N,N-dimethylformamide, acetonitrile, ethers, dichloromethane and chloroform are preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 80° C.




embedded image


The compound represented by Formula (I-4) may be obtained by reacting a compound represented by the following Formula (II-4a), which may be synthesized in the same manner as described in Formula (I-3), with a compound represented by R4-NH2 (the definition of Ar, A, Y, R4 and R5 has the same meaning as the definition described above)




embedded image


The reaction may be performed without a solvent or using a solvent which does not affect the reaction, and when the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol, and propanol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but alcohols such as methanol, ethanol, and the like are preferably used.


The reaction, if performed in the presence of silver carbonate, copper carbonate and the like, progresses quickly, but may proceed without the compound.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 80° C.


The compound represented by Formula (I-4) may be obtained by reacting a compound represented by the following Formula (I-4b) or salts thereof with R4-X, R4-O—R4 and R4-OR′ (the definition of R4, R′, Ar, A, Y and R5 has the same meaning as the definition described above, and X represents a halogen atom) in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction. When a solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol and propanol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, and water, either alone or in combination of two or more thereof, but toluene, dimethylformamide, acetonitrile, ethers, dichloromethane, chloroform and the like are preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 50° C.


The compound represented by Formula (I-4b) may be obtained by reacting a compound represented by Formula (II-4a) with ammonia or an alcohol solution thereof, ammonium chloride and the like.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction. When the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol and propanol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, and water, either alone or in combination of two or more thereof, but alcohols such as methanol and ethanol are preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 50° C.




embedded image


The compound represented by Formula (I-5) may be obtained by reacting a compound represented by the following Formula (II-5b) with R6-X (the definition of AR, A, Y, R6 and R7 has the same meaning as the definition described above, and X represents a halogen atom), R6-O—R6 or R6-OR′ (the definition of R′ has the same meaning as the definition described above) in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction. When the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol and propanol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, and water, either alone or in combination of two or more thereof, but toluene, N,N-dimethylformamide, acetonitrile, ethers, dichloromethane, and chloroform, and the like are preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 50° C.


When R6 represents —C(═O)R6a (R6a has the same meaning as described above), the compound represented by Formula (I-5) may be obtained by reacting the compound represented by Formula (II-5b) with a carboxylic acid represented by R6a-C(═O)OH (the definition of R6a has the same meaning as the definition described above) using a dehydration condensation agent in the presence or absence of a base, or may be obtained by performing the reaction using phosphorus pentaoxide, sulfuric acid, polyphosphoric acid, thionyl chloride, phosphorus oxychloride and oxalyl dichloride in the absence of a base.


It is possible to use a carbodiimide-based compound such as dicyclohexylcarbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and the like as the dehydration condensation agent.


When the reaction is performed in the presence of a base, it is possible to use, for example, a carbonate such as potassium carbonate or sodium carbonate and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction is preferably performed by using a solvent, and it is possible to use, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but dichloromethane and chloroform, and the like is preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 50° C.


When R6 represents CONR6eR6f (the definition of R6e and R6f has the same meaning as the definition described above, and R6e or R6f represents a hydrogen atom) or CSNR6gR6h (the definition of R6g and R6h has the same meaning as the definition described above, and R6g or R6h represents a hydrogen atom), the compound of Formula (I-5) may be obtained by reacting Formula (II-5b) with a compound represented by R″N═C═O (R″ represents a C1 to C6 alkyl group which may be substituted with a halogen atom, a C2 to C6 alkenyl group which may be substituted with a halogen atom, a C2 to C6 alkynyl group which may be substituted with a halogen atom, a (C1 to C4) alkoxy (C1 to C5) alkyl group, a (C1 to C4) alkylthio (C1 to C5) alkyl group, a substituted or unsubstituted (C6 to C10) aryl group, and a substituted or unsubstituted 5- to 10-membered heterocycle) in the presence or absence of a base.


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction is preferably performed by using a solvent, and it is possible to use, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but nitriles such as acetonitrile are preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 80° C.


When R6 represents CONR6eR6f (the definition of R6e and R6f has the same meaning as the definition described above), the compound of Formula (I-5) may be obtained by reacting the above-described compound represented by Formula (II-5b) with a compound represented by the following Formula (II-5c) in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction is preferably performed by using a solvent, and it is possible to use, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but nitriles such as acetonitrile are preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 80° C.


The compound represented by Formula (II-5b) may be obtained by reacting the compound (the definition of Ar, A, Y and R7 has the same meaning as the definition described above) represented by Formula (II-5a), which may be synthesized in the same manner as described in Formula (I-3) with hydroxylamine or salts thereof in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction. When the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol and propanol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, and water, either alone or in combination of two or more thereof, but toluene, N,N-dimethylformamide, acetonitrile, ethers, dichloromethane, and chloroform, and the like are preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 80° C.


The compound represented by Formula (I-5) may also be obtained by reacting the compound represented by Formula (II-5a) with a compound represented by R6-ONH2 or salts thereof in the presence or absence of a base.


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction. When the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol and propanol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, and water, either alone or in combination of two or more thereof, but alcohols such as methanol and ethanol are preferably used.


The reaction may be performed usually at from −80° C. to 100° C., and is performed preferably in a range from 20° C. to 80° C.


The reaction, if performed in the presence of silver carbonate, copper carbonate and the like, progresses quickly, but may proceed without the compound.


The compound represented by Formula(I-6)




embedded image


[the definition of Ar, A, Y and Y1, Y2, Ry has the same meaning as the definition described above] may be obtained by reacting according to Phosphorus, sulfur, and silicon and the related elements (2006) 181, 2337-2344.


The compound represented by Formula (I-7)




embedded image


[the definition of Ar, A, Y, n, Rz has the same meaning as the definition described above] may be obtained by reacting a compound represented by the following Formula (II-7a) with a compound represented by ArCH2X [the definition of Ar has the same meaning as the definition described above, and X represents a halogen atom or OTs, OMs and the like] in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction, and when the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol, propanol and isopropyl alcohol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but N,N-dimethylformamide and the like are preferably used.


The reaction may be performed usually at from 0° C. to 200° C., and it is preferred that reagents are added at from 20° C. to 40° C. and the reaction is performed at from 60° C. to 80° C.


The compound represented by Formula (II-7a) may be obtained by reacting a compound represented by (II-7b) [X represents a halogen atom, and the definition of Rz has the same meaning as the definition described above] with a compound represented by in the following Formula (III) in the presence or absence of a base.




embedded image


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction, and when the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol, propanol and isopropyl alcohol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but N,N-dimethylformamide and the like are preferably used.


The reaction may be performed usually at from 0° C. to 200° C., and it is preferred that reagents are added at from 20° C. to 40° C. and the reaction is performed at from 60° C. to 80° C.


The compound represented by Formula (I-7) may be obtained by reacting a compound represented by (II-7b) [X represents a halogen atom, and the definition of Rz has the same meaning as the definition described above] with a compound represented by in the following Formula (IV) in the presence or absence of a base.


When the reaction is performed in the presence of a base, it is possible to use, for example, an alkali metal hydride such as sodium hydride and the like, a carbonate such as potassium carbonate or sodium carbonate and the like, an alkali metal hydroxide such as potassium hydroxide, sodium hydroxide and the like, tertiary amines such as triethylamine, 1,8-diazabicyclo[4.3.0]non-5-ene and the like, and unsubstituted or substituent-containing pyridines, such as pyridine, 4-dimethylaminopyridine and the like, as the base.


The reaction may be performed without a solvent or using a solvent which does not affect the reaction, and when the solvent is used, it is possible to use solvents such as, for example, amides such as N,N-dimethylformamide and N,N-dimethylacetamide, nitriles such as acetonitrile, sulfoxides such as dimethyl sulfoxide, ethers such as diethyl ether and tetrahydrofuran, esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene, xylene and toluene, alcohols such as methanol, ethanol, propanol and isopropyl alcohol, ketones such as acetone and methyl ethyl ketone, aliphatic hydrocarbons such as hexane, heptane and octane, and halogen hydrocarbons such as dichloromethane, chloroform, chlorobenzene and dichlorobenzene, either alone or in combination of two or more thereof, but N,N-dimethylformamide and the like are preferably used.


The reaction may be performed usually at from 0° C. to 200° C., and it is preferred that the reaction is performed at from 0° C. to 80° C.


EXAMPLES

Subsequently, the present invention will be specifically described with reference to Examples, but the present invention is not limited to the Examples.


Reference Example 1
N-[1-((6-chloropyridine-3-yl)methyl)pyridine-2(1H)-ylidene-2,2,2-trifluoroacetamide (Compound P212)

(1) 25 g (270 mmol) of 2-aminopyridine was dissolved in 200 ml of anhydrous dichloromethane, 41 ml (30 g, 300 mmol) of triethylamine was added thereto, and the mixture was cooled to 0° C. 38 ml (57 g, 270 mmol) of anhydrous trifluoroacetic acid was added dropwise thereto over 15 minutes, and the resulting mixture was stirred at room temperature for 2 hours. After the reaction was completed, the reaction solution was injected into about 100 ml of iced water, and the mixture was stirred for 10 minutes. The mixture was transferred to a separatory funnel to perform liquid separation, and the organic layer was washed twice with 150 ml of water and twice with 150 ml of a 1% HCl aqueous solution, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 36 g (yield 71%) of


2,2,2-trifluoro-N-(pyridin-2(1H)-ylidene)acetamide

1H-NMR (CDCl3, δ, ppm): 7.20 (1H, ddd), 7.83 (1H, td), 8.20 (1H, d), 8.35 (1H, d), 10.07 (1H, brs)


13C-NMR (CDCl3, δ, ppm): 115.3, 115.5 (q), 121.6, 139.1, 147.9, 149.5, 155.3 (q)


MS:m/z=191 (M+H)


(2) 20 g (126 mmol) of 2-chloro 5-chloromethyl pyridine was dissolved in 200 ml of anhydrous acetonitrile, 24 g (126 mmol) of 2,2,2-trifluoro-N-(pyridin-2(1H)-ylidene)acetamide obtained by the above-described method and 21 g (151 mmol) of potassium carbonate were added thereto, and the resulting mixture was heated and refluxed for 6 hours, and then stirred at room temperature for 10 hours. After the reaction was completed, the reaction solution was filtered and the filtrate was concentrated under reduced pressure. Diethyl ether was added thereto for crystallization, and the crystals thus obtained were collected and washed well with diethyl ether and water. The crystals thus obtained were dried under reduced pressure at 60° C. for 1 hour to obtain the subject material. Amount obtained 26 g (yield 66%).


1H-NMR (CDCl3, δ, ppm): 5.57 (2H, s), 6.92 (1H, td), 7.31 (1H, d), 7.80 (1H, td), 7.87 (1H, dd), 7.99 (1H, dd), 8.48 (2H, m)


13C-NMR (CDCl3, δ, ppm): 53.8, 115.5, 117.2 (q), 122.1, 124.7, 130.0, 139.2, 140.0, 142.5, 149.7, 151.8, 158.9, 163.5 (q)


MS: m/z=316(M+H)


(3) Powder X-Ray Crystal Analysis


In the powder X-ray diffraction, measurement was performed under the following conditions.


Device name: RINT-2200 (Rigaku Corporation)


X-ray: Cu-Kα (40 kV, 20 mA)


Scanning range: 4 to 40°, sampling width: 0.02° and scanning rate: 1°/min


The results are as follows.


Diffraction angle (2θ) 8.7°, 14.2°, 17.5°, 18.3°, 19.8°, 22.4°, 30.9° and 35.3°


(4) Differential Scanning Calorimetry (DSC)


In the differential scanning calorimetry, measurement was performed under the following conditions.


Device name: DSC-60


Sample cell: aluminum


Temperature range: 50° C. to 250° C. (heating rate: 10° C./min)


As a result, the melting point was observed at 155° C. to 158° C.


Another Method of Reference Example 1


3.00 g (18.6 mmol) of 2-chloro-5-chloromethyl pyridine was dissolved in 20 ml of anhydrous DMF, 1.75 g (18.6 mmol) of 2-aminopyridine was added thereto, and the resulting mixture was stirred at 80° C. for 8 hours and at room temperature for 5 hours. After the reaction was completed, DMF was distilled off under reduced pressure, acetonitrile was added thereto to precipitate a solid, and the solid was collected, washed well with acetonitrile and dried to obtain 2.07 g (yield 44%) of 1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-imine hydrochloride.


1H-NMR (DMSO-d6, δ, ppm): 5.65 (2H, s), 6.96 (1H, t), 7.23 (1H, m), 7.57 (1H, d), 7.80 (1H, m), 7.91 (1H, m), 8.28 (1H, m), 8.49 (1H, d), 9.13 (2H, brs)


50 mg (0.20 mmol) of the 1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-imine hydrochloride obtained by the above-described method was dissolved in 5 ml of anhydrous dichloromethane, 122 mg (1.00 mmol) of DMAP and 50 mg (0.24 mmol) of anhydrous trifluoroacetic acid were added thereto in sequence under ice cold conditions, and the resulting mixture was stirred at room temperature for 1 hour. After the reaction was completed, the reaction solution was diluted with dichloromethane, washed with 1% hydrochloric acid, and then dried over anhydrous magnesium sulfate. Dichloromethane was distilled off under reduced pressure to obtain the subject material. Amount obtained 42 mg (yield 67%). NMR was the same as that of the above-described method.


Reference Example 2
2,2-dibromo-N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-acetamide (Compound P241)

200 mg (0.78 mmol) of the 1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-imine hydrochloride obtained by the method described in another method of Reference Example 1, 238 mg (1.95 mmol) of DMAP and 224 mg (1.17 mmol) of EDC-HCl were dissolved in 10 ml of anhydrous dichloromethane, 101 μl (202 mg, 1.17 mmol) of dibromoacetic acid was added thereto, and the resulting mixture was stirred at room temperature overnight. After the reaction was completed, the reaction solution was diluted with dichloromethane, washed once with water and twice with a 1% HCl aqueous solution, and then dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain the subject material. Amount obtained 50 mg (yield 15%)


1H-NMR (CDCl3, δ, ppm): 5.56 (2H, s), 5.99 (1H, s), 6.78 (1H, td), 7.33 (1H, d), 7.69 (1H, td), 7.76 (1H, dd), 7.93 (1H, dd), 8.39 (1H, d), 8.50 (1H, d)


13C-NMR (CDCl3, δ, ppm): 44.6, 53.1, 113.7, 121.9, 124.8, 130.1, 138.2, 139.7, 141.2, 149.5, 152.0, 159.4, 172.2


Reference Example 3
N-[1-((6-chloro-5-fluoropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide (Compound P227)

4.00g (27.6 mmol) of 2-chloro-3-fluoro-5-methyl pyridine was dissolved in 80 ml of carbon tetrachloride, 7.37g (41.4 mmol) of N-bromosuccinimide and 20 mg of benzoyl peroxide were added thereto, and the resulting mixture was heated and refluxed overnight. After the reaction was completed, the reaction solution was returned to room temperature, concentrated under reduced pressure and purified by silica gel column chromatography (hexane:ethyl acetate=19:1) to obtain 3.06 g (yield 51%) of 5-(bromomethyl)-2-chloro-3-fluoropyridine.


1H-NMR (CDCl3, δ, ppm): 4.45 (2H, s), 7.54 (1H, td), 8.23 (1H, s)


50 mg (0.22 mmol) of the 5-(bromomethyl)-2-chloro-3-fluoropyridine obtained by the aforementioned method was dissolved in 5 ml of anhydrous acetonitrile, 42 mg (0.22 mmol) of 2,2,2-trifluoro-N-(pyridin-2(1H)-ylidene)acetamide obtained by the method described in (1) of Reference Example 1 and 36 mg (0.26 mmol) of potassium carbonate were added thereto in sequence, and the resulting mixture was heated and refluxed for 7 hours. After the reaction was completed, the reaction solution was returned to room temperature to filter insoluble materials, and the filtrate was concentrated under reduced pressure. Diethyl ether was added thereto to precipitate a solid, and thus the solid was collected, washed with diethyl ether, and then dried under reduced pressure in a desiccator to obtain the subject material. Amount obtained 29 mg (yield 40%).


1H-NMR (CDCl3, δ, ppm): 5.54 (2H, s), 6.89 (1H, td), 7.76 (1H, dd), 7.80 (1H, td), 7.85 (1H, d), 8.29 (1H, d), 8.57 (1H, d)


Reference Example 4
N-[1-((6-fluoropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide (Compound P229)

500 mg (4.50 mmol) of 2-fluoro-5-methyl pyridine was dissolved in 50 ml of carbon tetrachloride, 1.20 g (6.76 mmol) of N-bromosuccinimide and 20 mg of benzoyl peroxide were added thereto, and the resulting mixture was heated and refluxed for 2.5 hours. After the reaction was completed, the reaction solution was returned to room temperature, and the solvent was distilled off under reduced pressure and purified by silica gel column chromatography (hexane:ethyl acetate=19:1) to obtain 300 mg (yield 35%) of 5-bromomethyl-2-fluoropyridine.


57 mg (0.30 mmol) of the 5-bromomethyl-2-fluoropyridine obtained by the aforementioned method was dissolved in 10 ml of anhydrous acetonitrile, 57 mg (0.30 mmol) of 2,2,2-trifluoro-N-(pyridin-2(1H)-ylidene)acetamide synthesized by the method described in (1) of Reference Example 1 and 69 mg (0.50 mmol) of potassium carbonate were added thereto in sequence, and the resulting mixture was heated and refluxed for 6 hours. After the reaction was completed, the reaction solution was returned to room temperature to filter insoluble materials, and the filtrate was concentrated under reduced pressure. The filtrate was purified by silica gel column chromatography (hexane:ethyl acetate=1:1→3:1) to obtain the subject material. Amount obtained 21 mg (yield 23%)


1H-NMR (CDCl3, δ, ppm): 5.56 (2H, s), 6.89 (1H, td), 6.94 (1H, d), 7.79 (1H, td), 7.87 (1H, d), 8.03 (1H, m), 8.31 (1H, s), 8.54 (1H, d)


MS: m/z=300(M+H)


Reference Example 5
N-[1-((6-bromopyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2, 2,2-trifluoroacetamide (Compound P231)

500 mg (2.92 mmol) of 2-bromo-5-methylpyridine was dissolved in 15 ml of carbon tetrachloride, 623 mg (3.50 mmol) of N-bromosuccinimide and 10 mg of benzoyl peroxide were added thereto, and the resulting mixture was heated and refluxed for 19 hours. After the reaction was completed, the reaction solution was returned to room temperature, concentrated under reduced pressure and purified by silica gel column chromatography (hexane:ethyl acetate=19:1) to obtain 143 mg (yield 20%) of 2-bromo-5-bromomethylpyridine.


1H-NMR (CDCl3, δ, ppm): 4.42 (2H, s), 7.47 (1H, d), 7.59 (1H, dd), 8.38 (1H, d)


70 mg (0.28 mmol) of the 2-bromo-5-bromomethylpyridine obtained by the aforementioned method was dissolved in 10 ml of anhydrous acetonitrile, 54 mg (0.28 mmol) of 2,2,2-trifluoro-N-(pyridin-2(1H)-ylidene)acetamide synthesized by the method described in (1) of Reference Example 1 and 46 mg (0.34 mmol) of potassium carbonate were added thereto in sequence, and the resulting mixture was heated and refluxed for 6 hours. After the reaction was completed, the reaction solution was returned to room temperature to filter insoluble materials, and the filtrate was concentrated under reduced pressure. Diethyl ether was added thereto to precipitate a solid, and thus the solid was collected, washed with diethyl ether, and then dried under reduced pressure in a desiccator to obtain the subject material. Amount obtained 81 mg (yield 82%).


1H-NMR (CDCl3, δ, ppm): 5.52 (2H, s), 6.88 (1H, t), 7.48 (1H, d), 7.78 (2H, m), 7.84 (1H, d), 8.44 (1H, d), 8.53 (1H, d)


MS:m/z=360(M+H)


Reference Example 6
2-chloro-N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-acetamide (Compound P236)

70 mg (0.27 mmol) of the 1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-imine hydrochloride obtained by the method described in another method of Reference Example 1 was dissolved in 4 ml of anhydrous dichloromethane, 82 mg (0.67 mmol) of DMAP, 25 mg (0.27 mmol) of chloroacetic acid and 62 mg (0.32 mmol) of EDC-HCl were added thereto in sequence, and the resulting mixture was stirred at room temperature overnight. After the reaction was completed, dichloromethane was added thereto to dilute the mixture, and the mixture was washed with water and a 1% HCl aqueous solution, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain the subject material. Amount obtained 4 mg (yield 5%).


1H-NMR (CDCl3, δ, ppm): 4.17 (2H, s), 5.46 (2H, s), 6.64 (1H, td), 7.31 (1H, d), 7.60 (1H, td), 7.64 (1H, dd), 7.80 (1H, dd), 8.32 (1H, d), 8.45 (1H, d)


MS:m/z=296(M+H)


Reference Example 7
N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2 (1H)-ylidene]-2,2-difluoroacetamide (Compound P238)

400 mg (4.26 mmol) of 2-aminopyridine was dissolved in 10 ml of anhydrous dichloromethane, 322 μl (490 mg, 5.11 mmol) of difluoroacetic acid, 982 mg (5.10 mmol) of EDC-HCl and 622 mg (5.11 mmol) of DMAP were added thereto, and the resulting mixture was stirred at room temperature for 61 hours. After the reaction was completed, the reaction solution was diluted with dichloromethane, washed once with water and twice with a 1% HCl aqueous solution, and then dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 102 mg (yield 14%) of 2,2-difluoro-N-(pyridin-2(1H)-ylidene)acetamide.


1H-NMR (CDCl3, δ, ppm): 6.03 (1H, t), 7.15 (1H, m), 7.78 (1H, td), 8.20 (1H, d), 8.34 (1H, dd), 8.72 (1H, br s)


100 mg (0.58 mmol) of the 2,2-difluoro-N-(pyridin-2(1H)-ylidene)acetamide obtained by the aforementioned method was dissolved in 10 ml of anhydrous acetonitrile, 94 mg (0.58 mmol) of 2-chloro-5-chloromethylpyridine was dissolved in 5 ml of anhydrous acetonitrile and added thereto, and subsequently, 84 mg (0.63 mmol) of potassium carbonate was added thereto and the resulting mixture was heated and refluxed for 140 minutes. After the reaction was completed, the reaction solution was returned to room temperature to filter off insoluble materials, and the filtrate was concentrated under reduced pressure. Ether was added thereto to precipitate a solid, and thus the solid was collected and dried well to obtain the subject material. Amount obtained 63 mg (yield 37%).


1H-NMR (CDCl3, δ, ppm): 5.52 (2H, s), 5.90 (1H, t), 6.79 (1H, td), 7.33 (1H, d), 7.71 (1H, m), 7.77 (1H, dd), 7.85 (1H, dd), 8.45 (1H, d), 8.50 (1H, d)


13C-NMR (DMSO-d6, δ, ppm): 53.0, 111.0 (t), 115.2, 120.7, 124.7, 131.7, 140.6, 141.6, 143.2, 150.4, 150.9, 158.3, 169.4 (t)


MS:m/z=298(M+H)


Reference Example 8
2-chloro-N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2-difluoroacetamide (Compound P239)

200 mg (2.13 mmol) of 2-aminopyridine was dissolved in 5 ml of dichloromethane, 491 mg (2.55 mol) of EDC-HCl, 311 mg (2.55 mmol) of DMAP and 187 μl (2.23 mmol, 290 mg) of chlorodifluoroacetic acid were added thereto in sequence, and the resulting mixture was stirred overnight. After the reaction was completed, the reaction solution was diluted with dichloromethane, washed with water and 1% hydrochloric acid, and then dried over anhydrous magnesium sulfate to obtain 105 mg (yield 24%) of 2-chloro-2,2-difluoro-N-(pyridin-2(1H)-ylidene)acetamide.


1H-NMR (CDCl3, δ, ppm): 7.19 (1H, dd), 7.82 (1H, m), 8.18 (1H, d), 8.36 (1H, d), 9.35 (1H, brs)


53 mg (0.33 mmol) of 2-chloro-5-chloromethyl pyridine dissolved in 6 ml of anhydrous acetonitrile was added to 68 mg (0.33 mmol) of the 2-chloro-2,2-difluoro-N-(pyridin-2(1H)-ylidene)acetamide synthesized by the aforementioned method, and subsequently, 50 mg (0.36 mmol) of potassium carbonate was added thereto and the resulting mixture was heated and refluxed for 1 hour. After the reaction was completed, the reaction solution was returned to room temperature and then concentrated under reduced pressure. Diethyl ether was added thereto to precipitate a solid, and thus the solid was collected and dried to obtain the subject material. Amount obtained 49 mg (yield 45%).


1H-NMR (CDCl3, δ, ppm): 5.56 (2H, s), 6.92 (1H, t), 7.33 (1H, d), 7.82 (1H, m), 7.91 (1H, dd), 8.02 (1H, d), 8.45 (1H, d), 8.48 (1H, d)


13C-NMR (CDCl3, δ, ppm): 53.8, 115.2, 120.1 (t), 122.1, 124.8, 139.0, 140.0, 142.3, 150.0, 151.9, 159.1, 159.1, 165.8 (t)


MS:m/z=332(M+H)


Reference Example 9
2,2,2-trichloro-N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-acetamide (Compound P235)

70 mg (0.27 mmol) of the 1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-imine hydrochloride obtained by the method described in another method of Reference Example 1 was dissolved in 4 ml of anhydrous dichloromethane, 94 μl (0.68 mmol, 68 mg) of triethylamine and 33 μg (0.27 mmol, 49 mg) of trichloroacetyl chloride were added thereto in sequence, and the resulting mixture was stirred at room temperature for 1 hour. After the reaction was completed, water was added thereto to stop the reaction and liquid separation was performed with dichloromethane and water. The organic layer was washed once with water and twice with 1% hydrochloric acid, dried over anhydrous magnesium sulfate and concentrated under reduced pressure. Diethyl ether was added thereto to precipitate a solid, and thus the solid was collected and dried to obtain the subject material. Amount obtained 61 mg (yield 62%).


1H-NMR (CDCl3, δ, ppm): 5.59 (2H, s), 6.86 (1H, t), 7.32 (1H, d), 7.78 (1H, td), 7.91 (2H, m), 8.43 (1H, d), 8.50 (1H, d)


MS:m/z=364(M+H)


Reference Example 10
N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,3,3,3-pentafluoropropanamide (Compound P242)

300 mg (3.19 mmol) of 2-aminopyridine was dissolved in 15 ml of anhydrous dichloromethane, 919 mg (4.78 mol) of EDC-HCl, 583 mg (4.78 mmol) of DMAP and 397 μl (628 mg, 3.83 mmol) of pentafluoropropionic acid were added thereto in sequence, and the resulting mixture was stirred at room temperature overnight. After the reaction was completed, the reaction solution was diluted with dichloromethane, washed once with water and twice with 1% hydrochloric acid, and then dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 85 mg (yield 11%) of 2,2,3,3,3-pentafluoro-N-(pyridin-2(1H)-ylidene)propanamide.


52 mg (0.32 mmol) of 2-chloro-5-chloromethylpyridine dissolved in 8 ml of anhydrous acetonitrile and 49 mg (0.35 mmol) of potassium carbonate were added to 77 mg (0.32 mmol) of the 2,2,3,3,3-pentafluoro-N-(pyridin-2(1H)-ylidene)propanamide obtained by the aforementioned method, and the resulting mixture was heated and refluxed for 11 hours. After the reaction was completed, the reaction solution was returned to room temperature to filter insoluble materials, and the filtrate was concentrated under reduced pressure. The filtrate was purified by silica gel column chromatography (hexane:ethyl acetate=1:3) to obtain the subject material. Amount obtained 12 mg (yield 10%).


1H-NMR (CDCl3, δ, ppm): 5.56 (2H, s), 6.90 (1H, td), 7.32 (1H, d), 7.79 (2H, m), 7.84 (1H, d), 8.43 (1H, d), 8.56 (1H, d)


MS:m/z=366(M+H)


Reference Example 11
N-[1-((2-chloropyrimidin-5-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide (Compound P243)

1.04 g (8.13 mmol) of 2-chloro-5-methyl pyrimidine was dissolved in 30 ml of carbon tetrachloride, 1.73 g (9.75 mmol) of N-bromosuccinimide and 20 mg of benzoyl peroxide were added thereto, and the resulting mixture was heated and refluxed for 6 hours. After the reaction was completed, the reaction solution was returned to room temperature, concentrated under reduced pressure and purified by silica gel column chromatography (hexane:ethyl acetate=3:1) to obtain 641 mg (yield 38%) of 5-bromomethyl-2-chloropyridine.


1H-NMR (CDCl3, δ, ppm): 4.42 (2H, s), 8.66 (2H, s)


104 mg (0.50 mmol) of the 5-bromomethyl-2-chloropyridine obtained by the aforementioned method was dissolved in 6 ml of anhydrous acetonitrile, 96 mg (0.50 mmol) of 2,2,2-trifluoro-N-(pyridin-2(1H)-ylidene)acetamide obtained by the method described in (1) of Reference Example 1 and 76 mg (0.55 mmol) of potassium carbonate were added thereto, and the resulting mixture was heated and refluxed for 1 hour. After the reaction was completed, the reaction solution was returned to room temperature to filter off insoluble materials, and the filtrate was concentrated under reduced pressure. Diethyl ether was added thereto to precipitate a solid, and thus the solid was collected, washed with diethyl ether, and then dried under reduced pressure in a desiccator to obtain the subject material. Amount obtained 92 mg (yield 58%)


1H-NMR (CDCl3, δ, ppm): 5.54 (2H, s), 6.98 (1H, m), 7.87 (1H, m), 8.18 (1H, m), 8.48 (1H, m), 8.83 (2H, m)


13C-NMR (CDCl3, δ, ppm): 60.0, 115.6, 117.1 (q), 122.1, 127.5, 139.2, 142.9, 158.8, 160.3 (2C), 161.4, 163.8 (q)


MS:m/z=317(M+H)


Compounds P213 to P226, P228, P230, P232 to P234, P240 and P244 described in the Tables 1 and 2 were obtained in the same manner as in Reference Examples 1 to 11.


Synthetic Example 1
2,2-difluoro-N-[1-((6-fluoropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]acetamide (Compound 3-3)



embedded image


(1) 400 mg (4.26 mmol) of 2-aminopyridine was dissolved in 10 ml of anhydrous dichloromethane, 322 μl (490 mg, 5.11 mmol) of difluoroacetic acid, 982 mg (5.10 mmol) of EDC-HCl and 622 mg (5.11 mmol) of DMAP were added thereto, and the resulting mixture was stirred at room temperature for 61 hours. After the reaction was completed, the reaction solution was diluted with dichloromethane, washed once with water and twice with a 1% HCl aqueous solution, and then dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 102 mg (yield 14%) of 2,2-difluoro-N-(pyridin-2(1H)-ylidene)acetamide.


1H-NMR (CDCl3, δ, ppm): 6.03 (1H, t), 7.15 (1H, m), 7.78 (1H, td), 8.20 (1H, d), 8.34 (1H, dd), 8.72 (1H, brs)


(2) 128 mg (0.75 mmol) of 5-bromomethyl-2-fluoropyridine was dissolved in 3 ml of anhydrous DMF, 116 mg (0.68 mmol) of 2,2-difluoro-N-[pyridin-2(1H)-ylidene]acetamide was dissolved in 3 ml of anhydrous DMF and added thereto, and subsequently, 103 mg (0.75 mmol) of potassium carbonate was added thereto and the resulting mixture was stirred at 65° C. for 2 hours. After the reaction was completed, the reaction solution was returned to room temperature, and ethyl acetate and water were added thereto to perform liquid separation. The organic layer was washed with 1% hydrochloric acid, then dried over anhydrous magnesium sulfate and concentrated under reduced pressure. A small amount of hexane and diethyl ether were added thereto to precipitate crystals, and thus the crystals were collected and dried to obtain the subject material. Amount obtained 50 mg (yield 26%).


Synthetic Example 2
N-[1-((6-chloropyridin-3-yl)methyl)pyrimidin-2(1H)-ylidene]-2,2,2-trifluoroacetamide (Compound 190-2)



embedded image


(1) 300 mg (1.86 mmol) of 2-chloro-5-chloromethylpyridine was dissolved in 6 ml of anhydrous DMF, 118 mg (1.24 mmol) of 2-aminopyrimidine was added thereto, and the resulting mixture was stirred at 80° C. for 8 hours. After the reaction was completed, the reaction solution was returned to room temperature to distill off DMF under reduced pressure. Diethyl ether was added thereto, and thus crystallization occurred on the wall surface of an eggplant flask. Diethyl ether was removed by decantation and dried well to obtain 1-((6-chloropyridin-3yl)methyl)pyrimidin-2(1H)-imine hydrochloride. Amount obtained 107 mg (yield 34%)


(2) 71 mg (0.27 mmol) of the 1-((6-chloropyridin-3-yl)methyl)pyrimidin-2(1H)-imine hydrochloride obtained by the aforementioned method was suspended in 5 ml of anhydrous dichloromethane, 114 l (0.83 mmol, 83 mg) of triethylamine and 53 μl (0.38 mmol) of trifluoroacetic anhydride were added thereto in sequence, and the resulting mixture was stirred at room temperature for 2 hours. After the reaction was completed, dichloromethane and water were added to the reaction solution to perform liquid separation, and the organic layer was dried over anhydrous magnesium sulfate and then concentrated under reduced pressure. A small amount of diethyl ether was added thereto to precipitate crystals, and thus the crystals were collected, washed with a small amount of diethyl ether, and then dried to obtain the subject material. Amount obtained 24 mg (yield 28%)


Synthetic Example 3
2,2,2-trifluoroethyl-[1-((6-chloropyridin-3-yl)methyl)pyridin-(2H)-ylidene]carbamate (Compound 1-17)



embedded image


(1) 3.00 g (18.6 mmol) of 2-chloro-5-chloromethylpyridine was dissolved in 20 ml of anhydrous DMF, 1.75 g (18.6 mmol) of 2-aminopyridine was added thereto, and the resulting mixture was stirred at 80° C. for 8 hours and at room temperature for 5 hours. After the reaction was completed, DMF was distilled off under reduced pressure, acetonitrile was added thereto to precipitate a solid, and the solid was collected, washed well with acetonitrile and then dried to obtain 2.07 g (yield 44%) of 1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-imine hydrochloride.


1H-NMR (DMSO-d6, δ, ppm): 5.65 (2H, s), 6.96 (1H, t), 7.23 (1H, m), 7.57 (1H, d), 7.80 (1H, m), 7.91 (1H, m), 8.28 (1H, m), 8.49 (1H, d)


(2) 10 ml of anhydrous acetonitrile was added to 150 mg (0.66 mmol) of the 1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-imine hydrochloride obtained by the aforementioned method, 177 mg (0.66 mmol) of 4-nitrophenyl(2,2,2-trifluoroethyl)carbamate and 200 mg (1.46 mmol) of potassium carbonate were added, and the resulting mixture was stirred at 50° C. for 2 hours. After the reaction was completed, the reaction solution was returned to room temperature to filter off insoluble materials, and the filtrate was concentrated under reduced pressure. Dichloromethane and water were added thereto to perform liquid separation, and the organic layer was washed with 1% hydrochloric acid, then dried over anhydrous magnesium sulfate and concentrated under reduced pressure. A small amount of diethyl ether was added thereto to precipitate crystals, and thus the crystals were collected and dried well to obtain the subject material. Amount obtained 48 mg (yield 21%)


Synthetic Example 4
N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroethanethioamide (Compound 1-20)



embedded image


(1) 25 g (270 mmol) of 2-aminopyridine was dissolved in 200 ml of anhydrous dichloromethane, 41 ml (30 g, 300 mmol) of triethylamine was added thereto, and the mixture was cooled to 0° C. 38 ml (57 g, 270 mmol) of anhydrous trifluoroacetic acid was added dropwise thereto over 15 minutes, and the resulting mixture was stirred at room temperature for 2 hours. After the reaction was completed, the reaction solution was injected into about 100 ml of iced water, and the mixture was stirred for 10 minutes. The mixture was transferred to a separatory funnel to perform liquid separation, and the organic layer was washed twice with 150 ml of water and twice with 150 ml of a 1% HCl aqueous solution, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 36 g (yield 71%) of 2,2,2-trifluoro-N-(pyridin-2(1H)-ylidene)acetamide.


1H-NMR (CDCl3, δ, ppm): 7.20 (1H, m), 7.83 (1H, m), 8.20 (1H, d), 8.35 (1H, d), 10.07 (1H, brs)


13C-NMR (CDCl3, δ, ppm): 115.3, 115.5 (q), 121.6, 139.1, 147.9, 149.5, 155.3 (q)


(2) 20 g (126 mmol) of 2-chloro 5-chloromethylpyridine was dissolved in 200 ml of anhydrous acetonitrile, 24 g (126 mmol) of 2,2,2-trifluoro-N-(pyridin-2(1H)-ylidene)acetamide obtained by the above-described method and 21 g (151 mmol) of potassium carbonate were added thereto, and the resulting mixture was heated and refluxed for 6 hours, and then stirred at room temperature for 10 hours. After the reaction was completed, the reaction solution was filtered and the filtrate was concentrated under reduced pressure. Diethyl ether was added thereto for crystallization, and the crystals thus obtained were collected and washed well with diethyl ether and water. The crystals thus obtained were dried under reduced pressure at 60° C. for 1 hour to obtain N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide. Amount obtained 26 g (yield 66%).


1H-NMR (CDCl3, δ, ppm): 5.57 (2H, s), 6.92 (1H, td), 7.31 (1H, d), 7.80 (1H, td), 7.87 (1H, dd), 7.99 (1H, dd), 8.48 (2H, m)


13C-NMR (CDCl3, δ, ppm): 53.8, 115.5, 117.2 (q), 122.1, 124.7, 130.0, 139.2, 140.0, 142.5, 149.7, 151.8, 158.9, 163.5 (q)


MS:m/z=316(M+H)


(3) 180 ml of toluene was added to 16.3 g (36.7 mmol) of phosphorus pentasulfide, 6.72 g (63.4 mmol) of sodium carbonate was added thereto and the resulting mixture was stirred at room temperature for 5 minutes. 20.0 g (63.4 mmol) of the N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide obtained by the above-described method was added thereto, and the resulting mixture was stirred at 50° C. for 19 hours. 150 ml of ethyl acetate was added to the reaction solution, the resulting mixture was stirred at 50° C. for 10 minutes, then insoluble materials were filtered off, and 250 ml of ethyl acetate was used to wash the mixture. The mixture was transferred to a separatory funnel, washed therein with 300 ml of a saturated sodium bicarbonate water and 200 ml of a saturated saline solution, and then concentrated under reduced pressure. 200 ml of water added thereto to precipitate crystals.


The mixture was stirred at room temperature for 1 hour, and then the crystals were collected, subjected to slurry washing twice with 150 ml of water and twice with 150 ml of hexane, and dried at 60° C. under reduced pressure for 2 hours to obtain the subject material. Amount obtained 19.5 g (yield 94%).


1H-NMR (CDCl3, δ, ppm): 5.48 (2H, s), 7.12 (1H, td), 7.34 (1H, d), 7.77 (1H, dd), 7.96 (1H, m), 8.05 (1H, dd), 8.45 (1H, d), 8.56 (1H, d)


MS:m/z=332(M+H)


Synthetic Example 5
N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoro-N′-methylacetimidamide (Compound 1-42)



embedded image


150 mg (0.45 mmol) of the N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroethanethioamide synthesized by the method in Synthetic Example 4 was dissolved in 5 ml of methanol, 105 μl (42 mg, 1.36 mmol) of methylamine (40% methanol solution) and 124 mg (0.45 mmol) of silver carbonate were added thereto, and the resulting mixture was stirred at 50° C. for 1 hour. After the reaction was completed, the reaction solution was returned to room temperature and subjected to suction filtration by using celite to remove insoluble materials. Ethyl acetate and water were added thereto to perform liquid separation, and the organic layer was dried over anhydrous magnesium sulfate, then concentrated under reduced pressure and purified by silica gel column chromatography (hexane:ethyl acetate=1:1) to obtain the subject material. Amount obtained 81 mg (yield 56%).


Synthetic Example 6
N′-(aryloxy)-N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetimidamide (Compound 1-507)



embedded image


30 mg (0.09 mmol) of the N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroethanethioamide synthesized by the method in Synthetic Example 4 was dissolved in 5 ml of ethanol, 50 mg (0.45 mmol) of O-ally hydroxylamine hydrochloride, 62 μl (0.45 mmol, 45 mg) of triethylamine and 25 mg (0.09 mmol) of silver carbonate were added thereto, and the resulting mixture was stirred at 50° C. for 5 hours and 20 minutes. After the reaction was completed, the reaction solution was returned to room temperature to filter off insoluble materials. The filtrate was concentrated under reduced pressure to perform liquid separation with ethyl acetate and 1% hydrochloric acid, and then the ethyl acetate layer was washed with a saturated saline solution, dried over anhydrous magnesium sulfate and then concentrated under reduced pressure. The ethyl acetate layer was purified by a TLC plate (one sheet of 0.5 mm plate, evolved with hexane:ethyl acetate=1:1) to obtain the subject material. Amount obtained mg (yield 45%).


Synthetic Example 7
N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2 (1H)-ylidene]-2,2,2-trifluoro-N′-hydroxyacetimidamide (Compound 1-499)



embedded image


25 ml of ethanol was added to 1.00 g (3.00 mmol) of the N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroethanethioamide (1-20) synthesized by the method in Synthetic Example 4, 1.04 g (15.0 mmol) of hydroxylamine hydrochloride and 2.00 ml (1.50 g, 15.0 mmol) of triethylamine were added thereto in sequence, and the resulting mixture was stirred at 50° C. for 21 hours and 30 minutes. After the reaction was completed, ethyl acetate and 1% hydrochloric acid were added to the reaction solution to perform liquid separation, and the organic layer was washed with water, dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The organic layer was purified by silica gel column chromatography (hexane:ethyl acetate=1:1) to obtain the subject material. Amount obtained 625 mg (yield 63%)


Synthetic Example 8
N-(benzoyloxy)-N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2 (1H)-ylidene]-2,2,2-trifluoroacetimidamide (Compound 1-519)



embedded image


30 mg (0.09 mmol) of the N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoro-N′-hydroxyacetamide (1-499) synthesized by the method in Synthetic Example 7 was dissolved in 3 ml of anhydrous acetonitrile, 24 μl (17 mg, 0.17 mmol) of triethylamine and 20 μg (22 mg, 0.17 mmol) of benzoyl chloride were added thereto in sequence, and the resulting mixture was stirred at room temperature for 10 minutes. After the reaction was completed, ethyl acetate and 1% hydrochloric acid were added to the reaction solution to perform liquid separation, and the organic layer was washed with water, dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The organic layer was purified by a TLC plate (one sheet of 0.5 mm plate, evolved with hexane:ethyl acetate=1:1) to obtain the subject material. Amount obtained 26 mg (yield 67%).


Synthetic Example 9
N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoro-N′-((propylcarbamoyl)oxy)acetimidamide (Compound 1-534)



embedded image


5 ml of anhydrous acetonitrile was added to 11 mg (0.13 mmol) of normal propyl isocyanate, 40 mg (0.12 mmol) of the N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoro-N′-hydroxyacetamide (1-499) synthesized by the method in Synthetic Example 7 and 4 mg (0.04 mmol) of potassium-t-butoxide were added thereto, and the resulting mixture was stirred at room temperature for 1 hour. After the reaction was completed, the reaction solution was concentrated under reduced pressure, and ethyl acetate and a saturated saline solution were added thereto to perform liquid separation. The ethyl acetate layer was dried over anhydrous magnesium sulfate, concentrated under reduced pressure and purified by a TLC plate (one sheet of 0.5 mm plate, evolved with hexane:ethyl acetate=1:3) to obtain the subject material. Amount obtained 16 mg (yield 32%)


Synthetic Example 10
Diisopropyl 1-((6-chloropyridin-3-yl)methyl)pyridyn-2(1H)-ylidenphospholamide trithioate (Compound 1-702)



embedded image


4.0g (15.7 mmol) of 1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-imine hydrochloride obtained by the above-described method was suspended in 24.6 ml of dichloromethane, and under ice-cooling 1.35 ml of phosphorus trichloride over 10 mins, following 3.16g(31.2 mmol) of triethylamine dissolved in 37 ml of dichloromethane was added thereto. After the mixture was stirred for 2 hours at room temperature, 499 mg(15.6 mmol) of sulfur was added to the mixture, and the mixture was stirred over night at room temperature. Under ice-cooling 3.16g(31.2 mmol) of triethylamine, following 2.38g(31.2 mmol) of 2-propanethiol dissolved in 10 ml of dichloromethane were added to the mixture, additionally the mixture was stirred for a day. After the reaction was completed, the reaction solution was concentrated under reduced pressure, and was extracted by 100 ml of diethylether twice. The ether solution was concentrated under reduced pressure, and 2.49g of crude compounds was obtained. 186 mg of crude compound was purified by a TLC plate (5 sheets of 0.5 mm plate, evolved with ethyl acetate) to obtain the subject material(47 mg. yield 9%) and (1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene)phosphoramidothioic dichloride (19 mg. yield 5%).




embedded image


(1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene)phosphoramidothioic dichloride
Synthetic Example 11
N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-1,1,1-trifluoromethanesulfinamide (Compound 1-703)



embedded image


330 mg(2 mmol) of sodium trifluoromethanesulfonate was added by 2 ml of ethylacetate and 154 mg(1 mmol) of phosphorus oxychloride and stirred for 5 min at room temperature. And 220 mg (0.86 mmol) of 1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-imine hydrochloride obtained by the above-described method was added to the mixture, and stirred for 2 hours. After the reaction was completed, the reaction mixture was purified by silica-gel column chromatography(eluent ethylacetate:hexane=1:1) to obtain the subject material (115 mg. yield 39%)


The preparation conditions of the compounds obtained in Synthetic Examples 1 to 11 and the compounds obtained in the same manner are shown in Tables 41 to 47 and the spectrum data are shown in the following Tables 48 to 53.


Further, the synthetic methods in the Table are described as follows.


A: the same method as in Synthetic Example 1


B: the same method as in Synthetic Example 2


C: the same method as in Synthetic Example 3


D: the same method as in Synthetic Example 4


E: the same method as in Synthetic Example 5


F: the same method as in Synthetic Example 6


G: the same method as in Synthetic Examples 7 and 8


H: the same method as in Synthetic Example 9
















TABLE 41










Reaction




Compound


Base and

temperature,
Synthetic
Yield


No.
Raw material 1
Raw material 2
the like
Solvent
Time
Method
(%)







266-2
69 mg (0.43 mmol) of
84 mg (0.43 mmol)
71 mg (0.52
Acetonitrile
reflux,
A
32



2-chloro-5-
of 2,2,2-trifluoro-
mmol) of

20 h



(chloromethyl)pyridine
N-(1,3,4-thiadiazol-
potassium




2(3H)-
carbonate




ylidene))acetamide


444-2
56 mg (0.41 mmol) of
66 mg (0.34 mmol)
56 mg (0.41
Acetonitrile
reflux,
A
21



2-chloro-5-
of 2,2,2-trifluoro-
mmol) of

20 h



(chloromethyl)thiazole
N-(1,3,4-thiadiazol-
potassium




2(3H)-
carbonate




ylidene))acetamide


190-2
71 mg (0.27 mmol) of
53 μl (0.38 mmol)
53 μl (0.38
Dichloromethane
Room
B
28



1-((6-chloropyridin-3-
of anhydrous
mmol) of

temperature,



yl)methyl)pyrimidin-
trifluoroacetic
triethylamine

1 h



2(1H)-imine
acid



hydrochloride


201-2
120 mg (0.47 mmol) of
99 μl (0.71 mmol)
160 μl (1.17
Dichloromethane
Room
B
11



1-((6-chloropyridin-
of anhydrous
mmol) of

temperature,



3-yl)methyl)pyrazin-
trifluoroacetic
triethylamine

30 min



2(1H)-imine
acid



hydrochloride


223-2
530 mg (2.07 mmol) of
390 μl (2.79 mmol)
537 μl (2.79
Dichloromethane
Room
B
14



2-chloro-2-((6-
of anhydrous
mmol) of

temperature,



chloropyridin-3-
trifluoroacetic
triethylamine

2 h



yl)methyl)pyridazin-
acid



3(2H)-imine hydrochloride


146-2
113 mg (0.70 mmol) of
145 mg (0.70 mmol)
116 mg (0.84
Acetonitrile
reflux,
A
15



2-chloro-5-
of 2,2,2-trifluoro-
mmol) of

13 h



(chloromethyl)pyridine
N-(3-hydroxypyridin-
potassium




2(1H)-
carbonate




ylidene))acetamide


224-2
190 mg (0.73 mmol) of
168 μl (1.20 mmol)
220 μl (1.60
Dichloromethane
Room
B
16



2-((2-chlorothiazol-5-
of anhydrous
mmol) of

temperature,



yl)methyl)pyridazin-
trifluoroacetic acid
triethylamine

5 min



3(2H)-imine hydrochloride


102-2
116 mg (0.72 mmol) of
155 mg (0.72 mmol)
109 mg (0.79
Acetonitrile
reflux,
A
22



2-chloro-5-
of N-(3-cyanopyridin-
mmol) of

8 h



(chloromethyl)pyridine
2(1H)-ylidene))2,2,2-
potassium




trifluoroacetamide
carbonate


212-2
59 mg (0.37 mmol) of
70 mg (0.37 mmol)
55 mg (0.40
Acetonitrile
reflux,
A
32



2-chloro-5-
of 2,2,2-trifluoro-
mmol) of

7 h



(chloromethyl)pyridine
N-(pyrimidin-4(3H)-
potassium




ylidene))acetamide
carbonate


1-20
20.0 g (63.4 mmol) of
16.3 g (36.7 mmol)
6.72 mg (63.4
Toluene
50° C.,
D
94



N-[1-((6-chloropyridin-3-
of phosphorus
mmol) of

19 h



yl)methyl)pyridin-2(1H)-
pentasulfide
sodium



ylidene]-2,2,2-

carbonate



trifluoroacetamide


12-2
78 mg (0.38 mmol) of
73 mg (0.38 mmol)
58 mg (0.42
Acetonitrile
reflux,
A
44



2-chloro-4-
of 2,2,2-trifluoro-
mmol) of

3.5 h



(bromomethyl)pyridine
N-(pyridin-2(1H)-
potassium




ylidene))acetamide
carbonate


213-2
79 mg (0.47 mmol) of
90 mg (0.47 mmol)
72 mg (0.52
Acetonitrile
reflux,
A
42



2-chloro-5-
of 2,2,2-trifluoro-
mmol) of

12 h



(chloromethyl)thiazole
N-(pyrimidin-4(3H)-
potassium




ylidene))acetamide
carbonate


1-17
150 mg (0.66 mmol) of
177 mg (0.66 mmol)
200 mg (1.46
Acetonitrile
50° C.,
C
21



1-[(6-chloropyridin-3-
of 4-nitrophenyl(2,2,2-
mmol) of

2 h



yl)methyl]pyridin-2(1H)-
trifluoroethyl)carbamate
potassium



imine hydrochloride

carbonate


1-18
150 mg (0.66 mmol) of
184 mg (0.66 mmol)
200 mg (1.46
Acetonitrile
50° C.,
C
30



1-[(6-chloropyridin-3-
of 4-nitrophenyl(1,1,1-
mmol) of

2 h



yl)methyl]pyridin-2(1H)-
trifluoropropan-2-
potassium



imine hydrochloride
yl)carbamate
carbonate


1-19
150 mg (0.66 mmol) of
220 mg (0.66 mmol)
200 mg (1.46
Acetonitrile
50° C.,
C
27



1-[(6-chloropyridin-3-
of 1,1,1,3,3,3-
mmol) of

3 h



yl)methyl]pyridin-
hexafluoropropan-
potassium



2(1H)-imine
2-yl(4-
carbonate



hydrochloride
nitrophenyl)carbamate


7-2
116 mg (0.72 mmol) of
137 mg (0.72 mmol)
110 mg (0.80
Acetonitrile
reflux,
A
49



2-chloro-5-
of 2,2,2-trifluoro-
mmol) of

5 h



(chloromethyl)pyrazine
N-(pyridin-2(1H)-
potassium




ylidene))acetamide
carbonate


1-13
200 mg (0.78 mmol) of
103 μl (1.17 mmol)
EDC-
Dichloromethane
Room
B
21



1-[(6-chloropyridin-3-
of 2,2,2-
HCl225 mg

temperature,



yl)methyl]pyridin-
trifluoropropionic
(1.17 mmol),

12 h



2(1H)-imine
acid
DMAP238 mg(1.95



hydrochloride

mmol)























TABLE 42










Reaction




Compound


Base and

temperature,
Synthetic
Yield


No.
Raw material 1
Raw material 2
the like
Solvent
Time
Method
(%)






















168-2
273 mg (1.70 mmol) of
350 g (1.70 mmol)
248 mg (1.80
DMF
65° C.,
A
15



2-chloro-5-
of 2,2,2-trifluoro-
mmol) of

2 h



(chloromethyl)pyridine
N-(5-hydroxypyridin-
potassium




2(1H)-
carbonate




ylidene))acetamide


1-21
23 mg (0.077 mmol) of
41 mg (0.092 mmol)
10 mg (0.092
THF
Room
D
49



N-[1-((6-chloropyridin-3-
of phosphorus
mmol) of

temperature,



yl)methyl)pyridin-2(1H)-
pentasulfide
sodium

2 h



ylidene]-2,2-

carbonate



difluoroacetamide


3-20
30 mg (0.10 mmol) of
49 mg (0.11 mmol)
12 mg (0.11
THF
Room
D
49



N-[1-((6-fluoropyridin-3-
of phosphorus
mmol) of

temperature,



yl)methyl)pyridin-2(1H)-
pentasulfide
sodium

3 h



ylidene]-2,2,2-

carbonate



trifluoroacetamide


4-20
30 mg (0.083 mmol) of
41 mg (0.09 mmol)
10 mg (0.09
THF
Room
D
61



N-[1-((6-bromopyridin-3-
of phosphorus
mmol) of

temperature,



yl)methyl)pyridin-2(1H)-
pentasulfide
sodium

3 h



ylidene]-2,2,2-

carbonate



trifluoroacetamide


3-3
116 mg (0.72 mmol) of
116 mg (0.68 mmol)
110 mg (0.80
Acetonitrile
reflux,
A
27



2-fluoro-5-
of 2,2-difluoro-N-
mmol) of

6 h



(bromomethyl)pyridine
(pyridin-2(1H)-
potassium




ylidene))acetamide
carbonate


4-3
50 mg (0.20 mmol) of
35 mg (0.20 mmol)
33 mg (0.24
Acetonitrile
reflux,
A
53



2-bromo-5-
of 2,2-difluoro-N-
mmol) of

6 h



(bromomethyl)pyridine
(pyridin-2(1H)-
potassium




ylidene))acetamide
carbonate


5-5
46 mg (0.21 mmol) of
50 mg (0.21 mmol)
35 mg (0.25
Acetonitrile
reflux,
A
26



5-(bromomethyl)-2-chloro-
of 2,2,3,3,3-
mmol) of

2 h



3-fluoropyridine
pentafluoro-N-
potassium




(pyridin-2(1H)-
carbonate




ylidene))propanamide


6-5
43 mg (0.21 mmol) of
50 mg (0.21 mmol)
35 mg (0.25
Acetonitrile
reflux,
A
21



5-(bromomethyl)-2-
of 2,2,3,3,3-
mmol) of

2 h



chloropyrimidine
pentafluoro-N-
potassium




(pyridin-2(1H)-
carbonate




ylidene))propanamide


1-22
37 mg (0.11 mmol) of
49 mg (0.11 mmol)
12 mg (0.11
THF
Room
D
31



2-chloro-N-[1-((6-
of phosphorus
mmol) of

temperature,



chloropyridin-3-
pentasulfide
sodium

4 h



yl)methyl)pyridin-2(1H)-

carbonate



ylidene]-2,2-



difluoroacetamide


1-23
31 mg (0.085 mmol) of
38 mg (0.085 mmol)
9 mg (0.0854
THF
Room
D
59



N-[1-((6-chloropyridin-3-
of phosphorus
mmol) of

temperature,



yl)methyl)pyridin-2(1H)-
pentasulfide
sodium

4 h



ylidene]-2,2,3,3,3-

carbonate



pentafluoropropanamide


5-20
36 mg (0.11 mmol) of
49 mg (0.11 mmol)
12 mg (0.11
THF
Room
D
100



N-[1-((6-chloro-5-
of phosphorus
mmol) of

temperature,



fluoropyridin-3-
pentasulfide
sodium

4 h



yl)methyl)pyridin-2(1H)-

carbonate



ylidene]-2,2,2-



trifluoroacetamide


5-3
65 mg (0.29 mmol) of
50 mg (0.29 mmol)
48 mg (0.35
Acetonitrile
reflux,
A
38



5-(bromomethyl)-2-chloro-
of 2,2-difluoro-N-
mmol) of

3 h



3-fluoropyridine
(pyridin-2(1H)-
potassium




ylidene))acetamide
carbonate


6-3
60 mg (0.29 mmol) of 5-
50 mg (0.29 mmol)
48 mg (0.35
Acetonitrile
reflux,
A
37



(bromomethyl)-2-
of 2,2-difluoro-N-
mmol) of

3 h



chloropyrimidine
(pyridin-2(1H)-
potassium




ylidene))acetamide
carbonate


8-2
73 mg (0.45 mmol) of
97 mg (0.51 mmol)
83 mg (0.60
DMF
65° C.,
A
32



3-chloro-6-
of 2,2,2-trifluoro-
mmol) of

3 h



(chloromethyl)pyridazine
N-(pyridin-2(1H)-
potassium




ylidene))acetamide
carbonate


5-4
54 mg (0.24 mmol) of
50 mg (0.24 mmol)
41 mg (0.30
Acetonitrile
reflux,
A
51



5-(bromomethyl)-2-chloro-
of 2-chloro-2,2-
mmol) of

6 h



3-fluoropyridine
difluoro-N-(pyridin-
potassium




2(1H)-
carbonate




ylidene))acetamide


4-4
60 mg (0.24 mmol) of
50 mg (0.24 mmol)
41 mg (0.30
Acetonitrile
reflux,
A
48



2-bromo-5-
of 2-chloro-2,2-
mmol) of

6 h



bromomethylpyridine
difluoro-N-(pyridin-
potassium




2(1H)-
carbonate




ylidene))acetamide


6-4
49 mg (0.24 mmol) of
50 mg (0.24 mmol)
41 mg (0.30
Acetonitrile
reflux,
A
55



5-(bromomethyl)-2-
of 2-chloro-2,2-
mmol) of

6 h



chloropyrimidine
difluoro-N-(pyridin-
potassium




2(1H)-
carbonate




ylidene))acetamide


4-5
65 mg (0.26 mmol) of
50 mg (0.26 mmol)
41 mg (0.30
Acetonitrile
reflux,
A
8



2-bromo-5-
of 2,2,3,3,3-
mmol) of

2 h



bromomethylpyridine
pentafluoro-N-
potassium




(pyridin-2(1H)-
carbonate




ylidene))propanamide























TABLE 43










Reaction




Compound


Base and

temperature,
Synthetic
Yield


No.
Raw material 1
Raw material 2
the like
Solvent
Time
Method
(%)







2-20
70 mg (0.22 mmol) of N-
107 mg (0.24 mmol)
25 mg (0.24
THF
Room
D
11



[1-((2-chlorothiazol-5-
of phosphorus
mmol) of

temperature,



yl)methyl)pyridin-
pentasulfide
sodium

4 h



2(1H)-ylidene]-2,2,2-

carbonate



trifluoroacetamide


10-20
130 mg (0.37 mmol) of
181 mg (0.41 mmol)
43 mg (0.41
THF
Room
D
93



2,2,2-trifluoro-N-[1-
of phosphorus
mmol) of

temperature,



((6-trifluoromethyl)pyridin-
pentasulfide
sodium

4 h



3-yl)methyl)pyridin-

carbonate



2(1H)-ylidene]-



acetamide


3-4
110 mg (0.58 mmol) of
105 mg (0.51 mmol)
103 mg (0.75
DMF
65° C.,
A
63



2-fluoro-5-
of 2-chloro-2,2-
mmol) of

2 h



(bromomethyl)pyridine
difluoro-N-
potassium




(pyridin-2(1H)-
carbonate




ylidene))acetamide


3-5
110 mg (0.58 mmol) of
139 mg (0.58 mmol)
88 mg (0.63
DMF
65° C.,
A
22



2-fluoro-5-
of 2,2,3,3,3-
mmol) of

2 h



(bromomethyl)pyridine
pentafluoro-N-
potassium




(pyridin-2(1H)-
carbonate




ylidene)propanamide


11-20
40 mg (0.15 mmol) of
65 mg (0.11 mmol)
16 mg (0.15
THF
Room
D
53



2,2,2-trifluoro-N-[1-
of phosphorus
mmol) of

temperature,



((tetrahydrofuran-3-
pentasulfide
sodium

4 h



yl)methyl)pyridin-

carbonate



2(1H)-ylidene]acetamide


1-14
200 mg (0.78 mmol) of
76 μl (0. 94 mmol)
32 μl (0.23
Acetonitrile
reflux,
B
28



1-[(6-chloropyridin-3-
of acrylic acid
mmol) of

1 h



yl)methyl]pyridin-
chloride
triethylamine



2(1H)-imine



hydrochloride


1-37
78 mg (0.28 mmol) of N-
125 mg (0.28 mmol)
30 mg (0.28
THF
Room
D
21



[1-((6-chloropyridin-3-
of phosphorus
mmol) of

temperature,



yl)methyl)pyridin-
pentasulfide
sodium

2 h



2(1H)-ylidene]-

carbonate



propionamide


1-39
180 mg (0.96 mmol) of N-
341 mg (0.75 mmol)
102 mg (0.96
THF
Room
D
29



[1-((6-chloropyridin-
of phosphorus
mmol) of

temperature,



3-yl)methyl)pyridin-
pentasulfide
sodium

2 h



2(1H)-ylidene]-

carbonate



isobutyramide


1-40
54 mg (0.19 mmol) of N-
54 mg (0.19 mmol)
20 mg (0.19
THF
Room
D
12



[1-((6-chloropyridin-3-
of phosphorus
mmol) of

temperature,



yl)methyl)pyridin-
pentasulfide
sodium

2 h



2(1H)-ylidene]-

carbonate



cyclopropane



carboxyamide


1-15
200 mg (0.78 mmol) of
83 mg (0.94 mmol)
320 μl (2.34
Acetonitrile
reflux,
B
19



1-[(6-chloropyridin-3-
of propyol
mmol) of

5 h



yl)methyl]pyridin-2(1H)-
oxychloride
triethylamine



imine hydrochloride


1-35
26 mg (0.074 mmol) of N-
26 mg (0.06 mmol)
8 mg (0.074
THF
Room
D
23



[1-((6-chloropyridin-3-
of phosphorus
mmol) of

temperature,



yl)methyl)pyridin-2(1H)-
pentasulfide
sodium

1.5 h



ylidene]-3-

carbonate



phyenylpropanamide


1-501
100 mg (0.30 mmol) of N-
145 mg (1.50 mmol)
205 μl (1.50
Ethanol
50° C.,
F
14



[1-((6-chloropyridin-3-
of O-ethyl
mmol) of

19.5 h



yl)methyl)pyridin-2(1H)-
hydroxylamine
triethylamine



ylidene]-2,2,2-
hydrochloride



trifluoroethanethioamide


1-499
1.00 g (3.00 mmol) of N-
1.04 g (15.0 mmol)
2.00 ml (15.0
Ethanol
50° C.,
F
63



[1-((6-chloropyridin-3-
of hydroxylamine
mmol) of

21 h



yl)methyl)pyridin-2(1H)-
hydrochloride
triethylamine



ylidene]-2,2,2-



trifluoroethanethioamide


1-510
100 mg (0.30 mmol) of N-
239 mg (1.50 mmol)
205 μl (1.50
Ethanol
50° C.,
F
20



[1-((6-chloropyridin-3-
of O-benzyl
mmol) of

19.5 h



yl)methyl)pyridin-2(1H)-
hydroxylamine
triethylamine



ylidene]-2,2,2-
hydrochloride



trifluoroethanethioamideL


1-511
30 mg (0.09 mmol) of N-
20 μl (0.28 mmol)
38 μl (0.28
Acetonitrile
Room
G
72



[1-((6-chloropyridin-3-
of acetyl chloride
mmol) of

temperature,



yl)methyl)pyridin-

triethylamine

15 min



2(1H)-ylidene]-2,2,2-



trifluoro-N′-



hydroxyacetimidamide























TABLE 44










Reaction




Compound


Base and

temperature,
Synthetic
Yield


No.
Raw material 1
Raw material 2
the like
Solvent
Time
Method
(%)






















1-519
30 mg (0.09 mmol) of
20 μl (0.17 mmol)
24 μl (0.17
Acetonitrile
Room
G
67



N-[1-((6-
of benzoyl
mmol) of

temperature,



chloropyridin-3-
chloride
triethylamine

10 min



yl)methyl)pyridin-



2(1H)-ylidene]-2,2,2-



trifluoro-N′-



hydroxyacetimidamide


1-523
30 mg (0.09 mmol) of
20 μl (0.26 mmol)
36 μl (0.26
Acetonitrile
Room
G
49



N-[1-((6-
of methyl
mmol) of

temperature,



chloropyridin-3-
chloroformate
triethylamine

20 min



yl)methyl)pyridin-



2(1H)-ylidene]-2,2,2-



trifluoro-N′-



hydroxyacetimidamide


1-528
30 mg (0.09 mmol) of
20 μl (0.18 mmol)
25 μl (0.18
Acetonitrile
Room
G
100



N-[1-((6-
of methanesulfonyl
mmol) of

temperature,



chloropyridin-3-
chloride
triethylamine

20 min



yl)methyl)pyridin-



2(1H)-ylidene]-2,2,2-



trifluoro-N′-



hydroxyacetimidamide


1-531
30 mg (0.09 mmol) of
28 ml (0.15 mmol)
21 μl (0.15
Acetonitrile
Room
G
100



N-[1-((6-
of 4-
mmol) of

temperature,



chloropyridin-3-
methylbenzenesufonyl
triethylamine

12 h



yl)methyl)pyridin-
chloride



2(1H)-ylidene]-



2,2,2-trifluoro-N′-



hydroxyacetimidamide


1-507
30 mg (0.09 mmol) of
50 mg (0.45 mmol)
62 μl (0.45
Ethanol
50° C.,
F
45



N-[1-((6-
of O-allyl
mmol) of

5 h



chloropyridin-3-
hydroxylamine
triethylamine,



yl)methyl)pyridin-
hydrochloride
25 mg (0.09



2(1H)-ylidene]-

mmol) of silver



2,2,2-

carbonate



trifluoroethanethioamide


1-516
30 mg (0.09 mmol) of
20 μl (0.25 mmol)
34 μl (0.25
Acetonitrile
Room
G
64



N-[1-((6-
of acryloyl
mmol) of

temperature,



chloropyridin-3-
chloride
triethylamine

20 min



yl)methyl)pyridin-



2(1H)-ylidene]-



2,2,2-trifluoro-N′-



hydroxyacetimidamide


1-518
30 mg (0.09 mmol) of
15 mg (0.18 mmol)
EDC-
Dichloromethane
Room
G
22



N-[1-((6-
of 3-butynoate
HCl35 mg(0.18

temperature,



chloropyridin-3-

mmol),

21 h



yl)methyl)pyridin-

DMAP22 mg(0.18



2(1H)-ylidene]-

mmol)



2,2,2-trifluoro-N′-



hydroxyacetimidamide


1-527
30 mg (0.09 mmol) of
20 μl (0.16 mmol)
22 μl (0.16
Acetonitrile
Room
G
54



N-[1-((6-
of phenyl
mmol) of

temperature,



chloropyridin-3-
chloroformate
triethylamine

1.5 h



yl)methyl)pyridin-



2(1H)-ylidene]-



2,2,2-trifluoro-N′-



hydroxyacetimidamide


1-521
30 mg (0.09 mmol) of
20 mg (0.14 mmol)
40 μl (0.28
Acetonitrile
Room
G
46



N-[1-((6-
of nicotinic acid
mmol) of

temperature,



chloropyridin-3-
chloride
triethylamine

1.5 h



yl)methyl)pyridin-
hydrochloride



2(1H)-ylidene]-



2,2,2-trifluoro-N′-



hydroxyacetimidamide


1-43
100 mg (0.30 mmol) of
Ethylamine (30%
90 μl (0. 60
Ethanol
50° C.,
E
57



N-[1-((6-
methanol
mmol) of

1.5 h



chloropyridin-3-
solution, 0.60
triethylamine,



yl)methyl)pyridin-
mmol)
91 mg (0.33



2(1H)-ylidene]-

mmol) of silver



2,2,2-

carbonate



trifluoroethanethioamide


1-536
50 mg (0.15 mmol) of
20 μl (0.17 mmol)
TBuOK
Acetonitrile
Room
H
30



N-[1-((6-
of benzyl
5 mg (0.04 mmol)

temperature,



chloropyridin-3-
isocyanate


1 h



yl)methyl)pyridin-



2(1H)-ylidene]-



2,2,2-trifluoro-N′-



hydroxyacetimidamide























TABLE 45










Reaction




Compound


Base and

temperature,
Synthetic
Yield


No.
Raw material 1
Raw material 2
the like
Solvent
Time
Method
(%)







1-42
150 mg (0.45 mmol) of N-
Methylamine
124 mg (0.45
Ethanol
50° C.,
E
56



[1-((6-chloropyridin-3-
(40% methanol
mmol) of silver

1 h



yl)methyl)pyridin-2(1H)-
solution,
carbonate



ylidene]-2,2,2-
1.36 mmol)



trifluoroethanethioamide


1-500
50 mg (0.15 mmol) of N-
63 mg (0.75 mmol)
103 μl (0.75
Ethanol
50° C.,
F
50



[1-((6-chloropyridin-3-
of O-methyl
mmol) of

5 h



yl)methyl)pyridin-2(1H)-
hydroxylamine
triethylamine,



ylidene]-2,2,2-
hydrochloride
41 mg (0.15



trifluoroethanethioamide

mmol) of silver





carbonate


1-504
50 mg (0.15 mmol) of N-
95 mg (0.75 mmol)
165 μl (1.20
Ethanol
50° C.,
F
19



[1-((6-chloropyridin-3-
of O-t-butyl
mmol) of

5 h



yl)methyl)pyridin-2(1H)-
hydroxylamine
triethylamine,



ylidene]-2,2,2-
hydrochloride
62 mg (0.23



trifluoroethanethioamide

mmol) of silver





carbonate


1-534
40 mg (0.12 mmol) of N-
11 mg (0.13 mmol)
137 mg (0.50
Acetonitrile
Room
H
32



[1-((6-chloropyridin-3-
of n-propyl
mmol) of silver

temperature,



yl)methyl)pyridin-2(1H)-
isocyanate
carbonate

1 h



ylidene]-2,2,2-trifluoro-



N′-hydroxyacetimidamide


1-535
40 mg (0.12 mmol) of N-
14 mg (0.13 mmol)
91 mg (0.33
Acetonitrile
Room
H
54



[1-((6-chloropyridin-3-
of chloroethyl
mmol) of silver

temperature,



yl)methyl)pyridin-2(1H)-
isocyanate
carbonate

1 h



ylidene]-2,2,2-trifluoro-



N′-hydroxyacetimidamide


1-72
150 mg (0.45 mmol) of N-
74 μl (0.68 mmol)
91 mg (0.33
Ethanol
50° C.,
E
45



[1-((6-chloropyridin-3-
of benzylamine
mmol) of silver

3 h



yl)methyl)pyridin-2(1H)-

carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-150
100 mg (0.30 mmol) of N-
56 μl (0.60 mmol)
30 μl (0.22
Ethanol
50° C.,
E
50



[1-((6-chloropyridin-3-
of
mmol) of

5 h



yl)methyl)pyridin-2(1H)-
methylthioethylamine
triethylamine



ylidene]-2,2,2-



trifluoroethanethioamide


1-67
100 mg (0.30 mmol) of N-
74 μl (1.20 mmol)
91 mg (0.33
Ethanol
50° C.,
E
49



[1-((6-chloropyridin-3-
of 2-
mmol) of silver

2 h



yl)methyl)pyridin-2(1H)-
aminoethanol
carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-515
30 mg (0.09 mmol) of N-
40 μl (0.44 mmol)
34 μl (0.25
Acetonitrile
50° C.,
G
67



[1-((6-chloropyridin-3-
of cyclopropane-
mmol) of

2 h



yl)methyl)pyridin-2(1H)-
carboxylic
triethylamine



ylidene]-2,2,2-trifluoro-
acid chloride



N′-hydroxyacetimidamide


1-56
100 mg (0.30 mmol) of N-
38 μl (0.60 mmol)
27 μl (0.20
Ethanol
50° C., 2 h→
E
57



[1-((6-chloropyridin-3-
of propargylamine
mmol) of

reflux, 2 h



yl)methyl)pyridin-2(1H)-

triethylamine



ylidene]-2,2,2-



trifluoroethanethioamide


1-512
30 mg (0.09 mmol) of N-
20 μl (0.23 mmol)
91 mg (0.33
Acetonitrile
Room
G
32



[1-((6-chloropyridin-3-
of propionyl
mmol) of silver

temperature,



yl)methyl)pyridin-2(1H)-
chloride
carbonate

30 min



ylidene]-2,2,2-trifluoro-



N′-hydroxyacetimidamide


1-514
30 mg (0.09 mmol) of N-
20 μl (0.19 mmol)
27 μl (0.20
Acetonitrile
Room
G
61



[1-((6-chloropyridin-3-
of isopropionyl
mmol)

temperature,



yl)methyl)pyridin-2(1H)-
chloride


2 h



ylidene]-2,2,2-trifluoro-



N′-hydroxyacetimidamide


1-50
100 mg (0.30 mmol) of N-
48 μl (1.20 mmol)
91 mg (0.33
Ethanol
50° C., 1.5 h→
E
44



[1-((6-chloropyridin-3-
of
mmol)

reflux, 4.5 h



yl)methyl)pyridin-2(1H)-
cyclopropylamine



ylidene]-2,2,2-



trifluoroethanethioamide























TABLE 46










Reaction




Compound


Base and

temperature,
Synthetic
Yield


No.
Raw material 1
Raw material 2
the like
Solvent
Time
Method
(%)







1-114
80 mg (0.30 mmol) of N-
48 μl (0.36 mmol)
73 mg (0.33
Ethanol
50° C.,
E
52



[1-((6-chloropyridin-3-
of 2-
mmol) of silver

3.5 h



yl)methyl)pyridin-2(1H)-
phenyloxyethylamine
carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-44
80 mg (0.30 mmol) of N-
60 μl (0.72 mmol)
73 mg (0.33
Ethanol
50° C.,
E
55



[1-((6-chloropyridin-3-
of n-propylamine
mmol) of silver

2 h



yl)methyl)pyridin-2(1H)-

carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-118
100 mg (0.30 mmol) of N-
62 μl (0.60 mmol)
91 mg (0.33
Ethanol
50° C.,
E
70



[1-((6-chloropyridin-3-
of 2-
mmol) of silver

5 h



yl)methyl)pyridin-2(1H)-
aminomethylpyridine
carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-119
100 mg (0.30 mmol) of N-
62 μl (0.60 mmol)
91 mg (0.33
Ethanol
50° C.,
E
58



[1-((6-chloropyridin-3-
of 3-
mmol) of silver

5 h



yl)methyl)pyridin-2(1H)-
aminomethylpyridine
carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-47
100 mg (0.30 mmol) of N-
44 mg (0.60 mmol)
91 mg (0.33
Ethanol
50° C.,
E
49



[1-((6-chloropyridin-3-
of n-butylamine
mmol) of silver

5 h



yl)methyl)pyridin-2(1H)-

carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-55
100 mg (0.30 mmol) of N-
CH2═CHCH2NH2
91 mg (0.33
Ethanol
50° C., 2 h→
E
53



[1-((6-chloropyridin-3-
34 mg (0.60 mmol)
mmol) of silver

reflux, 1 h



yl)methyl)pyridin-2(1H)-

carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-122
100 mg (0.30 mmol) of N-
H2NCH2-(2-thienyl)
91 mg (0.33
Ethanol
50° C., 2 h→
E
30



[1-((6-chloropyridin-3-
68 mg(0.60 mmol)
mmol) of silver

reflux, 1 h



yl)methyl)pyridin-2(1H)-

carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-45
100 mg (0.30 mmol) of N-
70 mg (1.20 mmol)
91 mg (0.33
Ethanol
50° C., 2 h→
E
35



[1-((6-chloropyridin-3-
of isopropylamine
mmol) of silver

reflux, 5 h



yl)methyl)pyridin-2(1H)-

carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-124
100 mg (0.30 mmol) of N-
H2NCH2-(2-furanyl)
91 mg (0.33
Ethanol
50° C.,
E
56



[1-((6-chloropyridin-3-
58 mg(0.60 mmol)
mmol) of silver

2.5 h



yl)methyl)pyridin-2(1H)-

carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-126
100 mg (0.30 mmol) of N-
H2NCH2-(2-
91 mg (0.33
Ethanol
50° C.,
E
43



[1-((6-chloropyridin-3-
tetrahyldrofuranyl)
mmol) of silver

1 h



yl)methyl)pyridin-2(1H)-
61 mg(0.60 mmol)
carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-64
100 mg (0.30 mmol) of N-
110 mg (1.20 mmol)
91 mg (0.33
Ethanol
50° C., 1 h→
E
22



[1-((6-chloropyridin-3-
of aminoacetonitrile
mmol) of silver

reflux, 6 h



yl)methyl)pyridin-2(1H)-
hydrochloride
carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-146
100 mg (0.30 mmol) of N-
CH3OCH2CH2NH2
91 mg (0.33
Ethanol
50° C.,
E
30



[1-((6-chloropyridin-3-
45 mg(0.60 mmol)
mmol) of silver

5 h



yl)methyl)pyridin-2(1H)-

carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-52
100 mg (0.30 mmol) of N-
51 mg (0.60 mmol)
91 mg (0.33
Ethanol
50° C.,
E
30



[1-((6-chloropyridin-3-
of cyclopentylamine
mmol) of silver

4 h



yl)methyl)pyridin-2(1H)-

carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-121
100 mg (0.30 mmol) of N-
65 mg (0.60 mmol)
91 mg (0.33
Ethanol
60° C.,
E
33



[1-((6-chloropyridin-3-
of 4-aminomethyl
mmol) of silver

4 h



yl)methyl)pyridin-2(1H)-
pyridine
carbonate



ylidene]-2,2,2-



trifluoroethanethioamide























TABLE 47










Reaction




Compound


Base and

temperature,
Synthetic
Yield


No.
Raw material 1
Raw material 2
the like
Solvent
Time
Method
(%)







1-53
100 mg (0.30 mmol) of N-
59 mg (0.60 mmol)
91 mg (0.33
Ethanol
60° C.,
E
28



[1-((6-chloropyridin-3-
of cyclohexylamine
mmol) of silver

2 h



yl)methyl)pyridin-2(1H)-

carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


1-76
100 mg (0.30 mmol) of N-
73 mg (0.60 mmol)
91 mg (0.33
Ethanol
60° C.,
E
60



[1-((6-chloropyridin-3-
of phenethylamine
mmol) of silver

4 h



yl)methyl)pyridin-2(1H)-

carbonate



ylidene]-2,2,2-



trifluoroethanethioamide


















TABLE 48





Compound

MS or IR


No.
1H-NMR (CDCl3, δ, ppm)
(KBr, v, cm−1)







266-2
5.62 (2H. s). 7.33 (1H, d), 7.83
m/z = 323



(1H, d). 8.57 (2H, m)
(M + H)


444-2
5.73 (2H, s). 7.69 (1H, s), 8.56
m/z = 329



(1H, s)
(M + H)


190-2
5.39 (2H, s), 6.87 (1H, dd),
m/z = 317



7.36 (1H, d), 7.91 (1H, dd),
(M + H)



8.39 (1H, d), 8.49 (1H, s). 8.79



(1 H, d)


201-2
5.45 (2H, s), 7.37 (1H, d), 7.65
m/z = 317



(1H, d), 7.87 (1H, dd), 7.99
(M + H)



(1H, d), 8.49 (1H, d), 9.80 (1 H,



d)


223-2
5.69 (2H, s), 7.31 (1H, d), 7.55
m/z = 317



(1H, dd), 7.92 (1H, dd), 8.28
(M + H)



(1H, dd), 8.59 (1H, d), 8.78



(1H, dd)


146-2
5.64 (2H, s), 7.14 (1H, dd),
m/z = 332



7.33 (1H, d), 7.47 (1H, dd),
(M + H)



7.71 (1H, dd), 7.74 (1H, dd),



8.42 (1H, d), 11.64 (1H, br s)


224-2
5.78 (2H, s), 7.57, 7.63 (1H,
m/z = 323



dd × 2), 7.70 (1H, s), 8.26, 8.41
(M + H)



(1H, dd × 2), 8.82, 9.04 (1H,



dd × 2)


102-2
5.56 (2H, s), 7.15 (1H, m), 7.38
m/z = 341



(1H, d), 7.84 (1H, dd), 8.26
(M + H)



(1H, dd), 8.48 (1H, d), 8.60



(1H, d)


212-2
5.43 (2H, s), 7.35 (1H, d), 7.87
m/z = 317



(1H, dd), 8.20 (1H, d), 8.29
(M + H)



(1H, d), 8.51 (1H, d), 8.77 (1H,



s)


1-20
5.48 (2H, s), 7.12 (1H, td),
m/z = 332



7.34 (1H, d), 7.77 (1H, dd),
(M + H)



7.96 (1H, m), 8.05 (1H, dd),



8.45 (1H, d), 8.56 (1H, d)


12-2
5.54 (2H, s), 6.96 (1H, m), 7.21
m/z = 316



(1H, d), 7.87 (1H, m), 7.97 (1H,
(M + H)



m), 8.34 (1H, d), 8.50 (1H, d)


213-2
5.51 (2H, s), 7.69 (1H, s), 8.25
m/z = 323



(1H, d), 8.30 (1H, d), 8.57 (1H,
(M + H)



s)


1-17
4.52 (2H, q), 5.44 (2H, s), 6.85
m/z = 346



(1H, td), 7.31 (1H, d), 7.57 (2H,
(M + H)



m), 7.79 (1H, dd), 8.14 (1H, d),



8.40 (1H, d)


1-18
1.44 (3H, d), 5.31 (1H, m), 5.42
m/z = 360



(2H, q), 6.54 (1H, td), 7.30 (1H,
(M + H)



d), 7.53 (2H, m), 7.79 (1H, dd),



8.10 (1H, d), 8.40 (1H, d)


1-19
5.47 (2H, s), 5.81 (1H, m), 6.69
m/z = 414



(1H, m), 7.31 (1H, d), 7.65 (1H,
(M + H)



m), 7.68 (1H, dd), 7.85 (1H, dd),



8.17 (1H, d), 8.40 (1H, d)


7-2
5.57 (2H, s), 6.91 (1H, m), 7.80



(1H, m), 8.10 (1H, m), 8.47 (1H,



s), 8.49 (1H, d), 8.72 (1H, d)


1-13
3.22 (2H, q), 5.46 (2H, s), 6.65
m/s = 330



(1H, td), 7.31 (1H, d), 7.62 (1H,
(M + H)



m), 7.66 (1H, dd), 7.70 (1H, dd),



8.35 (1H, d), 8.41 (1H, d)


168-2
5.11 (2H, s), 7.40 (2H, m), 7.75
m/z = 332.0426



(1H, dd), 8.09 (1H, d), 8.15 (1H,
(M + H)



d), 8.46 (1H, d), 8.81 (1H, br s)


1-21
5.49 (2H, s), 6.21 (1H, t), 7.05
m/z = 314.0346



(1H, td), 7.34 (1H, d), 7.82 (1H,
(M + H)



dd), 7.90 (1H, m), 7.94 (1H, dd),



8.45 (1H, d), 8.49 (1H, d)


3-20
5.51 (2H, s), 6.95 (1H, d), 7.15
m/z = 316.0559



(1H, td), 7.96 (2H, m), 8.09 (1H,
(M + H)



d), 8.29 (1H, d), 8.52 (1H, d)


4-20
5.47 (2H, s), 7.13 (1H, m), 7.50
m/z = 375.9



(1H, m), 7.66 (1H, m), 7.97 (1H,
(M + H)



m), 8.07 (1H, m), 8.43 (1 H, s),



8.54 (1H, m)


3-3
5.54 (2H, s), 5.92 (1H, t), 6.79



(1H, td), 6.94 (1H, dd), 7.70



(1H, m), 7.78 (1H, dd), 8.03 (1H,



td), 8.30 (1H, d), 8.50 (1H, d)


4-3
5.50 (2H, s), 5.90 (1H, t), 6.79
m/z = 342



(1H, m), 7.48 (1H, d), 7.74 (3H,
(M + H)



m), 8.43 (1H, d), 8.50 (1H, d)


5-5
5.56 (2H, s), 6.91 (1H, m), 7.69
m/z = 384.0372



(1H, dd), 7.82 (2H, m), 8.26 (1H,
(M + H)



d), 8.60 (1H, d)


6-5
5.52 (2H, s), 6.93 (1H, m), 7.86
m/z = 367.0687



(2H, m). 8.61 (1H, d), 8.75 (2H,
(M + H)



s)


1-22
5.49 (2H, s), 7.09 (1H, td),
m/z = 347.9972



7.35 (1H, d), 7.78 (1H, dd),
(M + H)



7.95 (2H, m), 8.46 (1H, d), 8.55



(1H, d)


1-23
5.47 (2H, s), 7.10 (1H, td),
m/z = 382.0246



7.34 (1H, d), 7.68 (1H, dd),
(M + H)



7.95 (2H, m), 8.41 (1H. d), 8.55



(1 H, dd)


5-20
5.49 (2H, s), 7.10 (1H, m), 7.65
m/z = 350.0188



(1H, dd), 7.96 (1H, m), 8.00
(M + H)



(1H, m), 8.27 (1H, d), 8.63 (1H,



d)


5-3
5.53 (2H, s), 5.90 (1H, t), 6.80
m/z = 316.0507



(1H, td), 7.76 (2H, m), 8.29
(M + H)



(1H, d), 8.52 (1H, d)


















TABLE 49





Compound

MS or IR


No.
1H-NMR (CDCl3, δ, ppm)
(KBr, v, cm−1)







6-3
5.45 (2H, s), 5.89 (1H, t), 6.83
m/z = 299.0532



(1H, td), 7.75 (1H, m), 7.82
(M + H)



(1H, dd), 8.52 (1H, d), 8.81



(2H, s)


8-2
5.73 (2H, s), 6.90 (1H, td),



7.54 (1H, d), 7.81 (1H, td),



7.97 (1H, d), 8.22 (1H, d), 8.53



(1H, d)


5-4
5.54 (2H, s), 6.86 (1H, td),
m/z = 350.0082



7.99 (3H, m), 8.30 (1H, d), 8.54
(M + H)



(1H, d)


4-4
5.52 (2H, s), 6.86 (1H, td),
m/z = 375.96



7.49 (1H, d), 7.77 (2H, m), 7.83
(M + H)



(1H, dd), 8.45 (1H, d), 8.52



(1H, d)


6-4
5.49 (2H, s), 6.90 (1H, td),
m/z = 333.0121



7.82 (1H, td), 7.87 (1H, dd),
(M + H)



8.54 (1H, d), 8.81 (2H, s)


4-5
5.53 (2H, s), 6.89 (1H, td),
m/z = 410



7.48 (1H, d), 7.70 (1H, dd),
(M + H)



7.82 (2H, m), 8.41 (1H, d), 8.58



(1H, d)


2-20
5.57 (2H, s), 7.12 (1H, m), 7.68
m/z = 338



(1H, s), 7.97 (1H, m), 8.12 (1H,
(M + H)



d), 8.67 (1H, d)


10-20
5.58 (2H, s), 7.12 (1H, m), 7.70
m/z = 366



(1H, d), 7.97 (2H, m), 8.02 (1H,
(M + H)



d), 8.62 (1H, d), 8.77 (1H, s)


3-4
5.55 (2H, s), 6.86 (1H, td),
m/z = 316



6.95 (1H, dd), 7.77 (1H, td),
(M + H)



7.85 (1H, dd), 8.06 (1H, td),



8.31 (1H, d), 8.53 (1H, d)


3-5
5.56 (2H, s), 6.89 (1H, m), 6.94
m/z = 350



(1H, dd), 7.80 (2H, m), 7.97
(M + H)



(1H, td), 8.27 (1H, d), 8.58



(1H, d)


11-20
1.69 (1H, m), 2.07 (1H, m), 2.84
m/z = 291



(1H, m), 3.59 (1H, dd), 3.71
(M + H)



(1H, dd), 3.77 (1H, m), 3.96



(1H, m), 4.13 (1H, dd), 4.42



(1H, dd), 7.11 (1H, m), 7.92



(1H, dd), 7.98 (1H, m), 8.40



(1H, d)


1-14
5.44 (2H, s), 5.61 (1H, dd),
m/z = 274



6.28 (1H, dd), 6.36 (1H, dd),
(M + H)



6.52 (1H, m), 7.30 (1H, d), 7.52



(1H, m), 7.57 (1H, d), 7.73 (1H,



dd), 8.28 (1H, d), 8.44 (1H, d)


1-37
1.28 (3H, t), 2.88 (2H, q), 5.41
m/z = 292



(2H, s), 6.86 (1H, t), 7.35 (1H,
(M + H)



d), 7.75 (3H, m), 8.10 (1H, d),



8.44 (1H, d)


1-39
1.26 (6H, d), 2.55 (1H, m), 5.51
m/z = 306



(2H, s), 6.98 (1H, m), 7.36 (1H,
(M + H)



d), 7.76 (1H, dd), 7.77 (2H, m),



8.08 (1H, d), 8.44 (1H, d)


1-40
0.92 (2H, m), 1.22 (2H, m), 2.40
m/z = 304



(1H, m), 5.36 (2H, s), 6.77 (1H,
(M + H)



td), 7.34 (1H, d), 7.66 (2H, m),



7.71 (1H, dd), 8.14 (1H, d),



8.41 (1H, d)


1-15
5.08 (2H, d), 5.40 (2H, s), 5.84
m/z = 286



(1H, t), 6.50 (1H, m), 7.30 (1H,
(M + H)



d), 7.50 (1H, m), 7.56 (1H, m),



7.80 (1H, dd), 8.25 (1H, d),



8.47 (1H, d)


1-35
3.18 (4H, m), 5.05 (2H, s), 6.83
m/z = 368



(1H, td), 7.05 (1H, t), 7.25
(M + H)



(2H, m), 7.38 (3H, m), 7.59 (1H,



dd), 7.67 (1H, d), 7.72 (1H,



td), 7.99 (1H, d), 8.30 (1H, d)


1-501
1.20 (3H, t), 4.10 (2H, q), 5.22
m/z = 359



(2H, s), 6.15 (1H, td), 6.27
(M + H)



(1H, d), 7.13 (1H, m), 7.27 (2H,



m), 7.79 (1H, dd), 8.37 (1H, d)


1-499
5.26 (2H, s), 6.11 (1H, d), 6.31
m/z = 331



(1H, m), 7.31 (1H, m), 7.50 (1H,
(M + H)



d), 7.83 (1H, dd), 7.90 (1H,



dd), 8.44 (1H, d), 11.0 (1H, s)


1-510
5.07 (2H, s), 5.19 (2H, s), 6.13
m/z = 421



(1H, td), 6.22 (1H, d), 7.07
(M + H)



(1H, m), 7.18-7.40 (8H, m), 7.69



(1H, dd), 8.34 (1H, d)


1-511
1.99 (3H, s), 5.27 (2H, s), 6.37
m/z = 373



(2H, m), 7.31 (2H, m), 7.44 (1H,
(M + H)



dd), 7.76 (1H, dd), 8.37 (1H, d)


1-519
5.31 (2H, s), 6.36 (1H, t), 6.51
m/z = 435



(1H, d), 7.17 (1H, d), 7.25 (4H,
(M + H)



m), 7.50 (3H, m), 7.78 (1H, dd),



8.41 (1H, d)


1-523
3.84 (3H, s), 5.26 (2H, s), 6.35
m/z = 389



(1H, m), 6.40 (1H, d), 7.30 (2H,
(M + H)



m), 7.37 (1H, dd), 7.73 (1H,



dd), 8.37 (1H, d)


1-528
3.14 (3H, s), 5.27 (2H, s), 6.44
m/z = 409



(1H, td), 6.54 (1H, dd), 7.32
(M + H)



(1H, d), 7.41 (2H, m), 7.68 (1H,



dd), 8.39 (1H, d)


1-531
2.45 (3H, s), 5.23 (2H, s), 6.37
m/z = 485



(1H, d), 6.42 (1H, td), 7.29
(M + H)



(4H, m), 7.45 (1H, d), 7.70 (1H,



dd), 7.80 (2H, d), 8.35 (1H, d)


1-507
4.54 (2H, m), 5.16 (2H, m), 5.22
m/z = 371



(2H, s), 5.91 (1H, m), 6.17 (1H,
(M + H)



td), 6.29 (1H, d), 7.15 (1H, m),



7.27 (2H, m), 7.79 (1H, dd),



8.37 (1H, d)


















TABLE 50





Compound

MS or IR


No.
1H-NMR (CDCl3, δ, ppm)
(KBr, v, cm−1)







1-516
5.27 (2H, s), 5.76 (1H, dd), 5.91
m/z = 385



(1H, dd), 6.22 (1H, dd), 6.36 (1H,
(M + H)



m), 6.42 (1H, d), 7.29 (2H, m), 7.42



(1H, d), 7.76 (1H, dd), 8.37 (1H, d)


1-518
1.25 (1H, s), 1.98 (2H, s), 5.28
m/z = 397



(2H, s), 6.38 (2H, m), 7.30 (2H, m),
(M + H)



7.41 (1H, d), 7.75 (1H, dd), 8.38



(1H, d)


1-527
5.28 (2H, s), 6.39 (1H, m), 6.50
m/z = 451



(1H, d), 7.13 (1H, d), 7.22-7.41
(M + H)



(7H, m), 7.76 (1H, dd), 8.40 (1H, d)


1-521
5.30 (2H, s), 6.42 (1H, t), 6.52
m/z = 436



(1H, d), 7.20 (1H, d), 7.32 (2H, m),
(M + H)



7.53 (1H, dd), 7.75 (1H, dd), 8.01



(1H, dd), 8.41 (1H, d), 8.54 (1H,



d), 8.71 (1H. dd)


1-43
1.13 (3H, t), 3.03 (2H, q), 5.15 (2H,
m/z = 343



s), 6.12 (1H, m), 6.19 (1H, d),
(M + H)



7.14 (1H, m), 7.27 (1H, m), 7.33 (1H,



d), 7.72 (1H, dd), 8.37 (1H, d)


1-536
4.48 (2H, d), 5.25 (2H, s), 6.36
m/z = 464



(1H, td), 6.41 (1H, d), 6.79 (1H,
(M + H)



m), 7.41 (7H, m), 7.73 (1H, dd),



8.40 (1H, d)


1-42
2.86 (3H, s), 5.16 (2H, s), 6.15
m/z = 329



(2H, m), 7.16 (1H, m), 7.26 (1H,
(M + H)



dd), 7.31 (1H, d), 7.73 (1H, dd),



8.38 (1H, d)


1-500
3.86 (3H, s), 5.22 (2H, s), 6.17
m/z = 345



(1H, m), 6.26 (1H, d), 7.14 (1H, m),
(M + H)



7.23 (1H, dd), 7.30 (1H, d), 7.78



(1H, dd), 8.39 (1H, d)


1-504
1.23 (9H, s), 5.23 (2H, s), 6.10
m/z = 387



(1H, m), 6.22 (1H, d), 7.09 (1H, m),
(M + H)



7.20 (1H, dd), 7.26 (1H, m), 7.79



(1H, dd), 8.35 (1H, d)


1-534
0.95 (3H, t), 1.61 (2H, m), 3.23
m/z = 416



(2H, t), 5.24 (2H, s), 6.32 (1H, t),
(M + H)



6.39 (1H, d), 6.48 (1H, m), 7.33 (3H,



m), 7.74 (1H, dd), 8.40 (1H, d)


1-535
3.65 (4H, m), 5.25 (2H, s), 6.36
m/z = 436



(1H, t), 6.41 (1H, d), 6.82 (1H,
(M + H)



m), 7.36 (3H, m), 7.74 (1H, dd),



8.41 (1H, d)


1-72
4.22 (2H, s), 5.13 (2H, s), 6.14
m/z = 405



(1H, m), 6.21 (1H, d), 7.13 (1H,
(M + H)



m), 7.26 (7H, m), 7.68 (1H, dd),



8.36 (1H, d)


1-150
2.08 (3H, s), 2.70 (2H, t), 3.22
m/z = 389



(2H, t), 5.15 (2H, s), 6.16 (1H,
(M + H)



t), 6.22 (1H, d), 7.17 (1H, m),



7.29 (1H, d), 7.33 (1H, d), 7.70



(1H, dd), 8.38 (1H, d)


1-67
3.13 (2H, m), 3.73 (2H, t), 5.15
m/z = 359



(2H, s), 6.18 (2H, m), 7.17 (1H,
(M + H)



m), 7.33 (2H, m), 7.71 (1H, dd),



8.37 (1H, d)


1-515
0.82 (2H, m), 0.93 (2H, m), 1.40
m/z = 399



(1H, m), 5.27 (2H, s), 6.35 (1H,
(M + H)



m), 6.42 (1H, d), 7.31 (2H, m),



7.41 (1H, d), 7.77 (1H, dd),



8.38 (1H, d)


1-56
2.13 (1H, t), 3.85 (2H, d), 5.18
m/z = 353



(2H, s), 6.21 (1H, t), 6.25 (1H,
(M + H)



d), 7.18 (1H, m), 7.29 (1H, d),



7.33 (1H, d), 7.70 (1H, dd),



8.38 (1H, d)


1-512
1.02 (3H, t), 2.23 (2H, q), 5.26
m/z = 387



(2H, s), 6.34 (1H, m), 6.39 (1H,
(M + H)



m), 7.29 (2H, m), 7.40 (1H, d),



7.75 (1H, dd), 8.37 (1H, d)


1-514
0.97 (6H, s), 2.37 (1H, m), 5.26
m/z = 399



(2H, s), 6.35 (1H, m), 6.40 (1H,
(M + H)



d), 7.27 (2H, m), 7.42 (1H, dd),



7.77 (1H, dd), 8.38 (1H, d)


1-50
0.74 (2H, m), 0.85 (2H, m), 2.51
m/z = 355



(1H, m), 5.18 (2H, s), 6.12 (1H,
(M + H)



m), 6.30 (1H, d), 7.15 (1H, m),



7.27 (1H, m), 7.31 (1H, d), 7.79



(1H, dd), 8.39 (1H, d)


1-114
3.44 (2H, td), 4.18 (2H, t),
m/z = 435



5.14 (2H, s), 6.15 (1H, td),
(M + H)



6.26 (1H, d), 6.86 (2H, d), 6.92



(1H, m), 7.16 (1H, m), 7.28 (4H,



m), 7.71 (1H, dd), 8.38 (1H, d)


1-44
0.83 (3H, t), 1.55 (2H, m), 2.91
m/z = 357



(2H, m), 5.14 (2H, s), 6.12 (1H,
(M + H)



td), 6.18 (1H, d), 7.13 (1H, m),



7.30 (2H, m), 7.71 (1H, dd),



8.36 (1H, d)


1-118
4.41 (2H, s), 5.15 (2H, s), 6.18
m/z = 406



(1H, t), 6.24 (1H, d), 7.14 (2H,
(M + H)



m), 7.26 (2H, m), 7.54 (1H, d),



7.68 (1H, dd), 7.71 (1H, dd),



8.38 (1H, d), 8.47 (1H, d)


1-119
4.22 (2H, s), 5.16 (2H, s), 6.20
m/z = 406



(2H, m), 7.15-7.30 (3H, m), 7.34
(M + H)



(1H, dd), 7.61 (1H, d), 7.79



(1H, dd), 8.37 (1H, d), 8.42



(1H, d), 8.46 (1H, d)


















TABLE 51





Compound

MS or IR


No.
1H-NMR (CDCl3, δ, ppm)
(KBr, v, cm−1)







1-47
0.85 (3H, t), 1.25 (2H, m), 1.53
m/z = 371



(2H, m), 2.96 (2H, m), 5.14 (2H,
(M + H)



s), 6.10 (1H, m), 6.17 (1H, d),



6.99 (1H, m), 7.27 (2H, m), 7.70



(1H, dd), 8.36 (1H, d)


1-55
3.65 (2H, m), 5.04 (2H, m), 5.15
m/z = 355



(2H, s), 5.90 (1H, m), 6.13 (1H,
(M + H)



m), 6.20 (1H, d), 7.13 (1H, m),



7.28 (2H, m), 7.71 (1H, dd),



8.36 (1H, d)


1-122
4.41 (2H, s), 5.17 (2H, s), 6.17
m/z = 411



(2H, m), 6.82 (1H, m), 6.91 (1H,
(M + H)



m), 7.16 (2H, m), 7.30 (2H, m),



7.70 (1H, dd), 8.38 (1H, d)


1-45
1.02 (6H, d), 3.34 (1H, m), 5.13
m/z = 357



(2H, s), 6.10 (1H, m), 6.24 (1H,
(M + H)



d), 7.11 (1H, m), 7.26 (1H, m),



7.31 (1H, d), 7.68 (1H, dd),



8.35 (1H, d)


1-124
4.20 (2H, s), 5.17 (2H, s),
m/z = 395



6.13-6.29 (4H, m), 7.17 (1H, m),
(M + H)



7.30 (3H, m), 7.71 (1H, dd),



8.38 (1H, d)


1-126
1.49 (1H, m), 1.84 (2H, m), 1.99
m/z = 399



(1H, m), 2.98 (1H, ddd), 3.14
(M + H)



(1H, ddd), 3.73 (2H, m), 4.09



(1H, m), 5.13 (2H, m), 6.13 (1H,



m), 6.20 (1H, d), 7.14 (1H, m),



7.30 (2H, m), 7.70 (1H, dd),



8.37 (1H, d)


1-64
4.01 (2H, s), 5.24 (2H, s), 6.34
m/z = 354



(2H, m), 7.34 (2H, m), 7.41 (1H,
(M + H)



dd), 7.66 (1H, dd), 8.36 (1H, d)


1-146
3.21 (2H, m), 3.34 (2H, s), 3.57
m/z = 373



(2H, t), 5.14 (2H, s), 6.15 (1H,
(M + H)



m), 6.21 (1H, m), 7.15 (1H, m),



7.30 (2H, m), 7.72 (1H, dd),



8.37 (1H, d)


1-52
1.40-1.77 (8H, m), 3.48 (1H, m),
m/z = 383



5.12 (2H, s), 6.09 (1H, m), 6.23
(M + H)



(1H, d), 7.12 (1H, m), 7.24 (1H,



m), 7.31 (1H, d), 7.69 (1H, dd),



8.35 (1H, d)


1-121
4.18 (2H, s), 5.14 (2H, s), 6.20
m/z = 406



(2H, m), 7.19 (3H, m), 7.26 (1H,
(M + H)



m), 7.35 (1H, dd), 7.75 (1H,



dd), 8.36 (1H, d), 8.51 (2H, m)


1-53
0.98-1.72 (10H, m), 2.91 (1H,
m/z = 397



m), 5.11 (2H, s), 6.11 (1H, td),
(M + H)



6.24 (1H, d), 7.11 (1H, m), 7.29



(3H, m), 7.66 (1H, dd), 8.34



(1H, d)


1-76
2.90 (2H, t), 3.24 (2H, td),
m/z = 419



5.07 (2H, s), 6.01 (1H, d), 6.09
(M + H)



(1H, td), 7.02-7.30 (8H, m),



7.61 (1H, dd), 8.34 (1H, d)


267-2
4.34 (1H, d), 4.62 (1H, d), 6.40
1730, 1689,



(1H, d), 7.20 (1H, d), 7.51 (2H,
1556, 1467,



m), 7.59 (1H, dd), 7.63 (2H, m),
1440, 1418



7.82 (1H, d), 8.23 (1H, d)


253-2
5.31 (2H, s), 7.28 (2H, m), 7.50
1644, 1557,



(1H, d), 7.72 (3H, m), 7.85 (1H,
1508, 1483



m), 8.25 (1H, d), 8.45 (1H, d)


251-2
5.20 (2H, s), 7.26 (2H, m), 7.63
3065, 1696,



(2H, m), 7.85 (2H, m), 8.02 (1H,
1463, 1403



d), 8.23 (2H, m)


13-2
5.76 (2H, s), 6.91 (1H, m), 7.46
3060, 2226,



(1H, m), 7.60 (1H, m), 7.70 (1H,
1641, 1556,



d), 7.80 (2H, m), 8.12 (1H, d),
1509



8.53 (1H, d)


1-1
5.49 (2H, s), 6.67 (1H, m), 7.30




(1H, m), 7.60 (1H, m), 7.72 (2H,



m), 7.81 (1H, dd), 8.42 (1H, d),



9.06 (1H, s)


1-41
5.64 (2H, s), 7.50 (2H, m), 7.70
m/z = 315.16



(1H, d), 7.78 (1H, dd), 8.27
(M + H)



(1H, m), 8.37 (1H, d), 8.78 (1H,



d) (methanol-d4)


















TABLE 52





Compound

MS or IR


No.
1H-NMR (CDCl3, δ, ppm)
(KBr, v, cm−1)







2-2
2.47 (2H, m), 4.17 (2H, t), 5.07
m/z = 322



(1H, d), 5.15 (1H, dd), 5.39 (2H,
(M + H)



s), 5.85 (1H, m), 6.43 (1H, td),



7.30 (1H, d), 7.44 (2H, m), 7.75



(1H, dd), 8.08 (1H, d), 8.40 (1H, d)


1-647
2.47 (2H, m), 4.17 (2H, t), 5.07
m/z = 318.1013



(1H, d), 5.15 (1H, dd), 5.39 (2H,
(M + H)



s), 5.85 (1H, m), 6.43 (1H, td),



7.30 (1H, d), 7.44 (2H, m), 7.75



(1H, dd), 8.08 (1H, d), 8.40 (1H, d)


1-670
3.35 (2H, tdd), 5.17 (2H, s), 6.02
m/z = 379



(1H, tt), 6.23 (2H, m), 7.22 (1H,
(M + H)



m), 7.33 (2H, m), 7.69 (1H, dd),



8.37 (1H, d)


157-2
5.51 (2H, s), 6.63 (1H, dd), 7.42
m/z = 332



(1H, d), 7.77 (1H, d), 7.84 (1H,
(M + H)



dd), 8.26 (1H, d), 8.45 (1H, d)


1-10
1.61 (1H, m), 2.29 (2H, m), 4.73
m/z = 324



(2H, s), 7.26 (1H, m), 7.31 (1H, m),
(M + H)



7.69 (1H, m), 7.79 (1H, m), 8.23



(1H, d), 8.40 (1H, d), 8.57 (1H, d)


580-2
5.47 (2H, s), 6.89 (1H, m), 7.47
m/z = 332



(2H, m), 7.82 (2H, m), 8.41 (1H, s),
(M + H)



8.56 (1H, d)


1-671
0.87 (3H, t), 1.28 (10H, m), 1.55
m/z = 427



(2H, m), 2.96 (2H, t), 5.14 (2H, s),
(M + H)



6.13 (1H, t), 6.18 (1H, d), 7.13



(1H, m), 7.30 (2H, m), 7.71 (1H,



dd), 8.37 (1H, d)


1-658
0.87 (3H, t), 1.25 (26H, m), 1.55
m/z = 539



(2H, m), 2.96 (2H, t), 5.14 (2H, s),
(M + H)



6.11 (1H, t), 6.17 (1H, d), 7.13



(1H, m), 7.30 (2H, m), 7.70 (1H,



dd), 8.36 (1H, d)


1-659
0.87 (3H, t), 1.26 (18H, m), 1.53
m/z = 483



(2H, m), 2.95 (2H, t), 5.14 (2H, s),
(M + H)



6.12 (1H, t), 6.18 (1H, d), 7.13



(1H, m), 7.31 (2H, m), 7.71 (1H,



dd), 8.36 (1H, d)


1-660
0.74 (3H, t), 0.97 (3H, d), 1.42
m/z = 371



(2H, m), 3.08 (1H, m), 5.12 (2H,
(M + H)



dd), 6.09 (1H, t), 6.23 (1H, d),



7.11 (1H, m), 7.24 (1H, m), 7.30



(1H, d), 7.67 (1H, dd), 8.35



(1H, d)


1-681
0.77, 0.90 (6H, t × 2), 1.40 (4H,
m/z = 385



m), 2.97 (1H, m), 5.11 (2H, s),
(M + H)



6.10 (1H, t), 6.25 (1H, d), 7.11



(1H, m), 7.24 (1H, d), 7.32 (1H,



d), 7.66 (1H, dd), 8.34 (1H, d)


1-686
0.81, 0.91 (6H, t × 2), 1.02-1.45
m/z = 413



(8H, m), 3.19 (1H, m), 5.12 (2H,
(M + H)



s), 6.10 (1H, t), 6.25 (1H, d),



7.11 (1H, m), 7.22 (1H, d), 7.30



(1H, d), 7.64 (1H, dd), 8.33



(1H, d)


1-661
0.81 (3H, t), 0.97 (3H, d),
m/z = 385



0.90-1.50 (4H, m), 3.19 (1H, m),
(M + H)



5.07 (1H, d), 5.15 (1H, d), 6.09



(1H, t), 6.24 (1H, d), 7.11 (1H,



m), 7.27 (2H, m), 7.66 (1H, dd),



8.34 (1H, d)


1-662
0.75 (3H, d), 0.80 (3H, d), 0.94
m/z = 385



(3H, d), 1.61 (1H, m), 2.86 (1H,
(M + H)



m), 5.11 (2H, s), 6.09 (1H, t),



6.23 (1H, d), 7.11 (1H, t), 7.25



(1H, d), 7.30 (1H, d), 7.66 (1H,



dd), 8.34 (1H, d)


1-663
1.35 (3H, d), 4.33 (1H, q), 5.05
m/z = 419



(1H, d), 5.11 (1H, d), 6.00 (1H,
(M + H)



d), 6.08 (1H, t), 6.96 (1H, m),



7.15-7.26 (7H, m), 7.63 (1H,



dd), 8.33 (1H, d)


1-664
1.55-1.75 (3H, m), 1.95 (1H, m),
m/z = 445



2.70-2.88 (2H, m), 4.36 (1H, t),
(M + H)



5.05 (1H, d), 5.20 (1H, d), 6.13



(1H, t), 6.38 (1H, d), 6.96 (1H,



m), 7.02-7.20 (5H, m), 7.28 (1H,



d), 7.62 (1H, dd), 8.3 (1H, d)


1-665
1.57 (3H, d), 4.78 (1H, d), 4.91
m/z = 469



(1H, d), 5.18 (1H, q), 5.80 (1H,
(M + H)



d), 5.93 (1H, t), 6.72 (1H, m),



7.05 (1H, d), 7.14 (1H, d), 7.38



(3H, m), 7.54 (1H, dd), 7.62



(1H, d), 7.66 (1H, d), 7.80 (1H,



d), 7.84 (1H, d), 8.28 (1H, d)


1-666
0.74 (3H, t), 1.75 (2H, m), 4.03
m/z = 433



(1H, t), 5.06 (2H, dd), 5.85
(M + H)



(1H, d), 6.05 (1H, m), 6.86 (1H,



m), 7.10-7.28 (7H, m), 7.63 (1H,



dd), 8.33 (1H, d)


1-667
1.34 (3H, d), 4.45 (1H, q), 5.11
m/z = 409



(1H, d), 5.16 (1H, d), 6.07 (1H,
(M + H)



m), 6.14 (1H, td), 6.26 (2H, m),



7.11 (1H, m), 7.28 (3H, m), 7.67



(1H, dd), 8.36 (1H, d)


1-676
5.06 (2H, s), 5.37 (1H, s), 5.38
m/z = 481



(1H, d), 6.07 (1H, t), 6.85 (1H,
(M + H)



t), 7.10-7.28 (12H, m), 7.61



(1H, d), 8.33 (1H, s)


















TABLE 53





Compound

MS or IR


No.
1H-NMR (CDCl3, δ, ppm)
(KBr, v, cm−1)







1-668
0.79 (9H, s), 0.85 (3H, d), 2.89
m/z = 399



(1H, q), 5.11 (2H, s), 6.08 (1H,
(M + H)



t), 6.23 (1H, d), 7.10 (1H, t),



7.23 (1H, d), 7.30 (1H, d), 7.65



(1H, d), 8.34 (1H, s)


47-2
5.68 (2H, d), 6.57 (1H, m), 7.34
m/z = 334



(1H, d), 7.80 (1H, m), 7.97 (1H,
(M + H)



dd), 8.39 (1H, d), 8.57 (1H, s)


91-2
5.92 (2H, s), 6.95 (1H, d), 7.30
m/z = 350



(1H, d), 7.69 (1H, m), 7.86 (1H,
(M + H)



dd), 8..49 (1H, dd), 8.53 (1H, d)


478-2
2.59 (3H, s), 5.77 (2H, s), 6.75
m/z = 330



(1H, d), 7.31 (1H, d), 7.63 (1H,
(M + H)



dd), 7.72 (1H, m), 8.33 (1H, d),



8.45 (1H, d)


479-2
2.73 (3H, s), 5.71 (2H, s), 6.73
m/z = 336



(1H, d), 7.63 (1H, s), 7.69 (1H,
(M + H)



t), 8.44 (1H, d)


1-51
1.60 (2H, m), 1.73 (1H, m), 2.03
m/z = 369



(4H, m), 3.75 (1H, m), 5.12 (2H,
(M + H)



s), 6.12 (1H, t), 6.16 (1H, d),



7.10 (1H, m), 7.25 (1H, d), 7.32



(1H, d), 7.71 (1H, dd), 8.37



(1H, d)


566-2
4.09 (3H, s), 5.71 (2H, s), 6.25
m/z = 346



(1H, d), 7.29 (1H, d), 7.74 (1H,
(M + H)



t), 7.97 (1H, dd), 8.17 (1H, d),



8.50 (1H, d)


488-2
1.77 (1H, m), 2.11 (1H, m), 2.62
m/z = 289



(3H, s), 2.98 (1H, m), 3.53 (1H,
(M + H)



dd), 3.67 (1H, dd), 3.78 (1H,



m), 3.98 (1H, m), 4.22 (1H, m),



4.65 (1H, m), 6.73 (1H, d), 7.66



(1H, t), 8.32 (1H, d)


511-2
5.58 (2H, s), 7.38 (1H, d), 7.86
m/z = 361



(1H, dd), 8.40 (1H, dd), 8.47
(M + H)



(1H, d), 8.55 (1H, d), 8.93 (1H, d)


1-669
1.42 (3H, d), 4.65 (1H, q), 5.12
m/z = 425



(2H, s), 6.13 (2H, m), 6.75 (1H,
(M + H)



d), 6.88 (1H, dd), 7.07 (1H, m),



7.11 (1H, d), 7.26 (2H, m), 7.65



(1H, dd), 8.35 (1H, d)


179-2
5.30 (2H, s), 6.43 (1H, dd),
m/z = 332



6.66 (1H, dd), 7.40 (1H, d),
(M + H)



7.60 (2H, m), 8.20 (1H, d)


555-2
3.87 (3H, s), 5.60 (2H, s), 7.51
m/z = 346



(1H, d), 7.88 (1H, dd), 7.93
(M + H)



(1H, dd), 8.34 (1H, d), 8.49



(1H, d), 8.56 (1H, d) (DMSO-d6)


577-2
5.65 (2H, s), 6.87 (1H, td),
m/z = 349



7.30 (1H, d), 7.81 (1H, m), 8.08
(M + H)



(1H, dd), 8.13 (1H, d), 8.54



(1H, d)


544-2
3.93 (3H, s), 5.45 (2H, s), 6.49
m/z = 346



(1H, dd), 7.31 (1H, d), 7.66
(M + H)



(1H, d), 7.83 (1H, dd), 8.13



(1H, d), 8.42 (1H, d)


168-2
5.62 (2H, s), 7.43 (1H, d), 7.64
m/z = 332



(1H, dd), 7.88 (1H, dd), 7.94
(M + H)



(1H, d), 8.26 (1H, d), 8.49 (1H, d)


1-644
4.18 (2H, s), 4.68 (2H, s),
m/z = 368



5.36 (2H, s), 6.55 (1H, m),
(M + H)



7.16 (1H, d), 7.29 (1H, d),



7.35 (2H, m), 7.40 (2H, m),



1.52 (2H, m), 7.75 (1H, dd),



8.28 (1H, d), 8.40 (1H, d)


578-644
4.19 (2H, s), 4.69 (2H, s),
m/z = 334



5.42 (2H, s), 6.52 (1H, m),
(M + H)



7.20 (1H, m), 7.30 (1H, m),



7.32 (2H, m), 7.40 (2H, m),



7.55 (2H, m), 7.72 (1H, dd),



8.30 (1H, dd), 8.52 (1H, dd),



8.62 (1H, d)


1-703
5.20 (1H, d), 5.45 (1H, d),
1715, 1636,



6.55 (1H, m) 7.34 (1H, m),
1552, 1505,



7.50 (1H, m), 7.60 (1H, m),
1457, 1174,



7.79 (1H, dd), 8.39 (1H, d)
1144


1-707
5.43 (2H, s), 6.93 (1H, m),
(EI-HRMS)



7.36 (1H, d), 7.77-7.85 (3H,
m/z = 351.0084



m), 7.95 (1H, dd), 8.39 (1H, d)
(M+)


1-706
1.20 (6H, m), 2.67 (4H, m),
m/z = 298



5.22 (2H, s), 6.52 (1H, m),.
(M + H)



7.31 (1H, m), 7.51 (1H, m),



7.60 (1H, dd), 7.73 (1H, m),



7.84 (1H, d), 8.41 (1H, d)


1-692
1.11 (3H, t), 1.20 (3H, t), 3.76
m/z = 356



(2H, m), 3.92 (2H, m), 6.58 (1H,
(M + H)



m), 7.26 (1H, d)., 7.53 (2H, m),



7.74 (1H, dd), 8.12 (1H, d), 8.40



(1H, d) (DMSO-d6)


1-700
1.20 (6H, m), 2.67 (4H, m), 5.22
m/z = 404



(2H, s), 6.52 (1H, m),. 7.31 (1H,
(M + H)



m), 7.51 (1H, m), 7.60 (1H, dd),



7.73 (1H, m), 7.84 (1H, d), 8.41



(1H, d)


1-701
0.95 (6H, m), 1.56 (4H, m), 2.62
m/z = 432



(4H, m), 5.18 (2H, s), 6.52 (1H,
(M + H)



m), 7.34 (1H, m), 7.49 (1H, m),



7.59 (1H, m), 7.77 (1H, dd), 7.84



(1H, d), 8.42 (1H, d)


1-702
1.13-1.46 (m, 12H), 3.20 (m, 2H),
m/z = 432



5.27 (s, 2H), 6.51 (m, 1H), 7.31
(M + H)



(m, 1H), 7.52 (m, 1H), 7.63 (m,



1H), 7.78 (m, 2H), 8.43 (d, 1H)


1-646
1.31 (6H, d), 4.95 (1H, sep),
1646, 1620,



5.40 (2H, s), 6.40 (1H, m), 7.28
1548, 1504,



(1H, d), 7.40 (2H, m), 7.73 (1H,
1453,



dd) 8.05 (1H, m), 8.40 (1H, d)


1-645
5.18 (2H, s), 5.37 (2H, s), 6.43
1655, 1518,



(1H, m), 7.25-7.36 (4H, m),
1455, 1399,



7.41-7.46 (4H, m), 7.72 (1H,
1235



dd), 8.12 (1H, m), 8.38 (1H, d)


1-643
5.52 (2H, s), 6.78 (1H, m), 7.31
1633, 1601,



(1H, d), 7.68-7.75 (3H, m), 8.39
1541, 1502,



(1H, m), 8.56 (1H, s)
1482, 1453,




1384


2-643
5.51 (2H, s), 6.80 (1H, m), 7.60
1632, 1597,



(1H, s), 7.75 (2H, m), 8.57 (1H, m)
1541, 1506,




1483, 1455,




1388









Synthetic Example of Comparative Compound
Comparative Example 1
N-[1-chloropyridine-3-yl]methyl)pyridine-2(1H)-ylidene]cyanamide (Patent Document 5, Compound 20)



embedded image


128 mg (0.58 mmol) of the 1-[(6-chloropyridin-3-yl)methyl]pyridine-2(1H)-imine obtained by the above-described method was dissolved in 5 ml of anhydrous DMF, 40 mg (net 24 mg, 1.04 mmol) of NaH (oil phase, purity 60%) was added thereto, and the resulting mixture was stirred at room temperature for 30 minutes. 60 mg (0.57 mmol) of cyanogen bromide was added thereto and the resulting mixture was stirred overnight. After the reaction was completed, water and ethyl acetate were added to the reaction solution to perform liquid separation. The organic layer was dried over anhydrous magnesium sulfate, then concentrated under reduced pressure and purified by a TLC plate (one sheet of 0.5 mm plate, evolved with 100% ethyl acetate) to obtain the subject material. Amount obtained 14 mg (yield 10%).



1N-NMR (CDCl3, δ, ppm): 5.28 (2H, s), 6.55 (1H, m), 7.33 (2H, m), 7.56 (2H, m), 7.75 (1H, dd), 8.40 (1H, d)


Comparative Example 2
N-[1-((6-chloropyridine-3-yl)methyl)pyridine-2(2H)-ylidene]acetamide (Patent Document 3, Compound 2)



embedded image


20 ml of anhydrous dichloromethane was added to 118 mg (0.46 mmol) the 1-[(6-[chloropyridin-3-yl)methyl]pyridin-2(1H)-imine hydrochloride obtained by the above-described method, 159 μl (1.16 mmol, 116 mg) of triethylamine and 33 μl of acetyl chloride were added thereto, and the resulting mixture was stirred at room temperature for 15 minutes. Water was added to the reaction solution to stop the reaction and liquid separation was performed with chloroform and water. The organic layer was washed with a saturated ammonium chloride aqueous solution and then concentrated, hexane was added thereto to precipitate a solid, and thus the solid was collected, washed and subjected to bath drying to obtain the subject material. Amount obtained 21 mg (yield 17%).



1N-NMR (CDCl3, δ, ppm): 2.21 (3H, s), 5.35 (2H, s), 6.46 (1H, m), 7.32 (1H, d), 7.48 (2H, m), 7.75 (1H, d), 8.10 (1H, dd), 8.45 (1H, dd)


MS:m/z=322 (M+H)


Comparative Example 3
3-[1-((6-chloropyridine-3-yl)methyl)imidazolidine-2-ylidene]-1,1,1-trifluoropropane-2-on (Patent Document 2, Example 4)



embedded image


20 ml of ethylenediamine was added to 2.0 g (12.4 mmol) of 2-chloro-5-chloromethylpyridine, and the resulting mixture was stirred overnight. After the reaction was completed, the mixture was concentrated under reduced pressure and acetonitrile was added thereto to filter off insoluble materials. The mixture was concentrated under reduced pressure to obtain 2.45 g (yield: 100%) of N-((6-chloropyridin-3-yl)methyl)ethane-1,2-diamine.


77 mg (0.42 mmol) of the N-((6-chloropyridin-3-yl)methyl)ethan-1,2-diamine obtained by the aforementioned method was dissolved in 8 ml of anhydrous acetonitrile, the resulting solution was added to 60 mg (0.28 mmol) of the 1,1,1-trifluoro-4,4-bis(methylthio)-3-butylen-2-one obtained by the above-described method, and the resulting mixture was heated and refluxed for 40 minutes. After the reaction was completed, the reaction solution was returned to room temperature and concentrated under reduced pressure, and ethyl acetate and water were added thereto to perform liquid separation. The organic layer was washed with anhydrous magnesium sulfate, concentrated under reduced pressure, and purified by silica gel column chromatography (hexane:ethyl acetate=3:1) to obtain the subject material. Amount obtained 59 mg (yield 69%).



1N-NMR (CDCl3, δ, ppm): 3.49 (2H, t), 3.78 (2H, t), 4.40 (2H, s), 5.13 (1H, s), 7.37 (1H, d), 7.56 (1H, dd), 8.31 (1H, d), 9.34 (1H, br s)


m/z=306 (M+H)


Comparative Example 4
3-[3-((6-chloropyridine-3-yl)methyl)thiazoline-2-ylidene]-1,1,1-trifluoropropane-2-on (Patent Document 2, Example 3)



embedded image


15 ml of anhydrous DMF was added to 1.30 g (33.9 mmol, 780 mg) of NaH (oil phase, purity 60%) and the resulting mixture was cooled to 0° C. 1.52 ml (1.90 g, 17.0 mmol) of 1,1,1-trifluoroacetone was added dropwise thereto, and the resulting mixture was stirred at 0° C. for 10 minutes. 7.0 ml (110 mmol, 8.35 g) of carbon disulfide was added thereto and the resulting mixture was stirred at 5° C. for 1 hour. Subsequently, the reaction solution was cooled to 0° C., 2.1 ml (34.0 mmol, 4.81 g) of methyl iodide was added thereto, and the resulting mixture was stirred at room temperature overnight. After the reaction was completed, the reaction solution was injected into iced water, and the mixture was stirred until the ice was completely melted. The mixture was transferred to a separatory funnel and extracted with ethyl acetate, and the organic layer was washed with a saturated saline solution, then dried with anhydrous magnesium sulfate and concentrated under reduced pressure. The organic layer was purified by silica gel column chromatography (hexane:ethyl acetate=95:5) and a fraction including the subject material was collected and concentrated under reduced pressure. Hexane was added thereto to precipitate a solid, and thus the solid was collected, washed with hexane and then dried well to obtain 460 mg of 1,1,1-trifluoro-4,4-bis(methylthio)-3-butene-2-one (yield 13%).



1N-NMR (CDCl3, δ, ppm): 2.56 (3H, s), 2.58 (2H, s), 6.25 (1H, s)


36 mg (0.46 mmol) of 2-aminoethanethiol dissolved in 10 ml of ethanol was added to 100 mg (0.46 mmol) of the 1,1,1-trifluoro-4,4-bis(methylthio)-3-butene-2-one obtained by the aforementioned method, and the resulting mixture was heated and refluxed for 6 hours, and stirred at room temperature for 13 hours. After the reaction was completed, ethanol was distilled off under reduced pressure, and the mixture was dissolved in ethyl acetate and washed once with water. The mixture was dried over anhydrous magnesium sulfate and then concentrated under reduced pressure to obtain 73 mg (yield 81%) of 1,1,1-trifluoro-3-(thiazolidin-2-ylidene)propan-2-one.



1N-NMR (CDCl3, δ, ppm): 3.35 (2H, m), 4.02 (2H, m), 5.61 (1H, s), 10.40 (1H, br s)


80 mg (0.50 mmol) of 2-chloro-5-chloromethylpyridine dissolved in 8 ml of anhydrous acetonitrile and 69 mg (0.50 mmol) of potassium carbonate were added to 65 mg (0.33 mmol) of the 1,1,1-trifluoro-3-(thiazolidin-2-ylidene)propan-2-one obtained by the aforementioned method, and the resulting mixture was heated and refluxed for 2 hours. After the reaction was completed, the reaction solution was returned to room temperature to filter off insoluble materials, and the filtrate was concentrated under reduced pressure. The filtrate was purified by silica gel column chromatography (hexane:ethyl acetate=1:1→1:3) to obtain the subject material. Amount obtained 53 mg (yield 50%)



1N-NMR (CDCl3, δ, ppm): 3.20 (2H, t), 3.73 (2H, t), 4.61 (2H, s), 5.80 (1H, s), 7.36 (1H, d), 7.53 (1H, dd), 8.31 (1H, d)


MS: m/z=323 (M+H)


Comparative Example 5
3-[1-((6-chloropyridine-3-yl)methyl)imidazolidine-2-ylidene]-1,1,1,5,5,5-hexafluoropentane-2,4-dione (Patent Document 2, Example 5)



embedded image


31 mg (0.10 mmol) of the 3-[1-((6-[chloropyridin-3-yl)methyl)imidazolidin-2-ylidene]-1,1,1-trifluoropropan-2-one obtained by the above-described method was dissolved in 2 ml of anhydrous dichloromethane, 20 μl (0.25 mmol, 20 mg) of pyridine and 28 μl (0.20 mmol, 42 mg) of trifluoroacetic anhydride were added in sequence, and the resulting mixture was stirred at room temperature for 30 minutes. The progress of the reaction was confirmed by TLC and the raw material was remaining, and thus 84 μl (0.60 mmol, 62 mg) of trifluoroacetic anhydride was added thereto and the resulting mixture was stirred at room temperature for 1 hour. After the reaction was completed, the reaction solution was concentrated under reduced pressure and purified by a TLC plate (one sheet of 0.5 mm plate, evolved with hexane:ethyl acetate=2:8) to obtain the subject material. Amount obtained 30 mg (yield 75%).



1N-NMR (CD3OD, 6, ppm): 3.87 (4H, m), 4.51 (2H, s), 7.50 (1H, d), 7.82 (1H, dd), 8.35 (1H, d)


MS: m/z=402 (M+H)


Comparative Example 6
N-[1-((6-chloropyridine-3-yl)methyl)imidazolidine-2-ylidene]-2,2,2-trifluoroacetamide (Patent Document 2, Example 7)



embedded image


4.61 g (2.49 mmol) of N-((6-chloropyridin-3-yl)methyl)ethane-1,2-diamine was synthesized by the above-described method. The compound was dissolved in 40 ml of anhydrous acetonitrile, 4.60 g (21.3 mmol) of the dimethyl(2,2,2-trifluoroacetyl)carbonimidedithioate obtained by the above-described method was added thereto, and the resulting mixture was heated and refluxed for 90 minutes. After the reaction was completed, the reaction solution was returned to room temperature, the solvent was distilled off under reduced pressure, and the precipitated solid was collected and washed with a small amount of acetonitrile to obtain the subject material. Amount obtained 2.17 g (yield 33%).



1N-NMR (CDCl3, δ, ppm): 3.50 (2H, m), 3.76 (2H, m), 4.60 (2H, s), 7.34 (1H, d) 7.70 (1H, dd) 8.33 (1H, d)


Melting Point: 168-170° C.


Comparative Example 7
N-[3-((6-chloropyridine-3-yl)methyl)thiazoline-2-ylidene]-2,2,2-trifluoroacetamide (Patent Document 2, Example 6)



embedded image


20 ml of ethanol was added to 77 mg (1.0 mmol) of 2-aminoethanethiol, 216 mmol (1.0 mmol) of the dimethyl(2,2,2-trifluoroacetyl)carbonimidedithioate synthesized by the above-described method was added thereto, and the resulting mixture was stirred at room temperature overnight. After the reaction was completed, the solvent was distilled off under reduced pressure and purified by silica gel column chromatography (hexane:ethyl acetate=1:1) to obtain 100 mg (yield 51%) of 2,2,2-trifluoro-N-(thiazolidin-2-ylidene)acetamide. The reaction was performed again by the same synthetic method, and 2,2,2-trifluoro-N-(thiazolidin-2-ylidene)acetamide was put together to obtain 350 mg of the compound.


2 ml of DMF and 18 ml of THF were added to 162 mg (0.82 mmol) of the 2,2,2-trifluoro-N-(thiazolidin-2-ylidene)acetamide obtained by the above-described method, 150 mg (1.09 mmol) of potassium carbonate was added thereto, and the resulting mixture was heated and refluxed for 20 hours. After the reaction was completed, the reaction solution was returned to room temperature to filter insoluble materials, and the filtrate was concentrated under reduced pressure. The filtrate was purified by TLC plates (two sheets of 0.5 mm plates, evolved with 100% ethyl acetate) to obtain the subject material. Amount obtained 230 mg (yield 87%).



1N-NMR (CDCl3, δ, ppm): 3.27 (2H, m), 3.73 (2H, m), 4.86 (2H, s), 7.36 (1H, d) 7.72 (1H, dd) 8.36 (1H, d)


Melting Point: 96C


Comparative Example 8
1-[1-((6-chloropyridine-3-yl)methyl)pyridine-2(1H)-ylidene]-3-ethylthiourea (Patent Document 3, Japanese Patent Application Laid-Open No. 5-78323, Table 1, Compound No. 51)



embedded image


10 ml of acetonitrile was added to 200 mg (0.78 mmol) of 1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-imine hydrochloride synthesized by the method described in Synthetic Example 3, 118 μl (0.86 mmol) of triethylamine and 68 μl (0.78 mmol) of ethyl isothiocyanate were added thereto in sequence, and the resulting mixture was heated and refluxed for 11 hours. After the reaction was completed, the reaction solution was returned to room temperature and concentrated under reduced pressure, and liquid separation was performed with ethyl acetate and a 1% hydrochloric acid aqueous solution. A saturated sodium bicarbonate water was added to the water layer to make the layer basic, and the layer was extracted once with ethyl acetate. The layer was dried over anhydrous magnesium sulfate and then concentrated under reduced pressure to obtain a subject compound. Amount obtained 120 mg (yield 56%).


1H-NMR (CDCl3, δ, ppm): 1.06, 1.23 (3H, t×2), 3.21, 3.71 (2H, m×2), 5.23, 5.32 (2H, s×2), 6.25, 6.42 (1H, br s×2), 6.37, 6.51 (1H, m×2), 7.31-7.37 (2H, m), 7.47 (1H, m), 7.62 (1H, m), 8.14-8.22 (1H, m), 8.35 (1H, m)


MS: m/z=307 (M+H)


Melting point: 162-164° C.


Comparative Example 9
1-[1-((6-chloropyridine-3-yl)methyl)pyridine-2(1H)-ylidene]-3-ethoxycarbonylthiourea (Patent Document 3, Japanese Patent Application Laid-Open No. 5-78323, Table 1, Compound No. 56)



embedded image


10 ml of acetonitrile was added to 200 mg (0.78 mmol) of 1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-imine hydrochloride synthesized by the method described in Synthetic Example 3, 118 μl (0.86 mmol) of triethylamine and 96 μl (0.82 mmol) of ethoxycarbonyl isothiocyanate were added thereto, and the resulting mixture was heated and refluxed for 1 hour. After the reaction was completed, the reaction solution was returned to room temperature and concentrated under reduced pressure, and liquid separation was performed with ethyl acetate and a saturated sodium bicarbonate water. The organic layer was washed once with water, then dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain the subject material. Amount obtained 156 mg (yield 57%). 17 mg of the subject material obtained by purifying 30 mg of the subject material with a TLC plate (one sheet of 0.5 mm plate, evolved twice with hexane:ethyl acetate=1:3) was provided for the measurement of spectrum data and the biological test.


1H-NMR (CDCl3, δ, ppm): 1.27 (3H, t), 4.16 (2H, q), 5.52 (2H, s), 6.82 (1H, td), 8.34 (1H, d), 7.72 (2H, m), 7.94 (2H, m), 8.34 (1H, d), 8.46 (1H, d)


MS:m/z=351 (M+H)


Melting point: 141-143° C.


Preparation Example
Preparation Example 1 [Granules]



















Compound 1-20
5%
by weight



Bentonite
40%
by weight



Talc
10%
by weight



Clay
43%
by weight



Calcium ligninsulfonate
2%
by weight










The ingredients were homogeneously ground and mixed, water was added thereto to knead the ingredients thoroughly, and then the mixture was granulated and dried to obtain granules.


Preparation Example 2 [Granules]



















Compound 3-3
2%
by weight



SAN X(R) P-252
5%
by weight



Binder
1.5%
by weight



Granular improving agent
0.5%
by weight



Clay
91%
by weight










The ingredients were homogeneously ground and mixed, water was added thereto to knead the ingredients thoroughly, and then the mixture was granulated and dried to obtain granules.


Preparation Example 3 [Wettable Powder]



















Compound 1-42
30%
by weight



Clay
50%
by weight



White carbon
2%
by weight



Diatomaceous earth
13%
by weight



Calcium ligninsulfonate
4%
by weight



Sodium lauryl sulfate
1%
by weight










The ingredients were homogeneously mixed and ground to obtain wettable powder.


Preparation Example 4 [Water Dispersible Granule]



















Compound 1-499
30%
by weight



Clay
60%
by weight



Dextrin
5%
by weight



Alkyl maleate copolymer
4%
by weight



Sodium lauryl sulfate
1%
by weight










The ingredients were homogeneously ground and mixed, water was added thereto to knead the ingredients thoroughly, and then the mixture was granulated and dried to obtain water dispersible granules.


Preparation Example 5 [Flowables]
















Compound 1-21
25%
by weight


POE polystyrylphenyl ether sulfate
5%
by weight


Propylene glycol
6%
by weight


Bentonite
1%
by weight


1% xanthan-gum aqueous solution
3%
by weight


PRONALEX-300 (TOHO Chemical Industry Co.,
0.05%
by weight


Ltd.)


ADDAC827 (KI Chemical Industry Co., Ltd.)
0.02%
by weight








Water
added to 100%



by weight









All the ingredients except for the 1% xanthan gum aqueous solution and a suitable amount of water were premixed together from the blending, and the mixture was then ground by a wet grinder. Thereafter, the 1% xanthan gum aqueous solution and the remaining water were added thereto to obtain 100% by weight of flowables.


Preparation Example 6 [Emulsifiable Concentrate]


















Compound 212-2
15% by weight



N,N-dimethylformamide
20% by weight



Solvesso 150 (Exxon Mobil Corporation)
55% by weight



Polyoxyethylene alkyl aryl ether
10% by weight










The ingredients were homogeneously mixed and dissolved to obtain an emulsifiable concentrate.


Preparation Example 7 [Dust]



















Compound 1-20
2%
by weight



Clay
60%
by weight



Talc
37%
by weight



Calcium stearate
1%
by weight










The ingredients were homogeneously mixed to obtain dust.


Preparation Example 8 [DL Dust]



















Compound 168-2
2%
by weight



DL clay
94.5%
by weight



White carbon
2%
by weight



Calcium Stearate
1%
by weight



Light liquid paraffin
0.5%
by weight










The ingredients were homogeneously mixed to obtain dust.


Preparation Example 9 [Microgranule Fine]


















Compound 4-3
2% by weight



Carrier
94% by weight 



White carbon
2% by weight



Hisol SAS-296
2% by weight










The ingredients were homogeneously mixed to obtain dust.


Preparation Example 10 [Liquid Drops]



















Compound 1-20
10%
by weight



Benzyl alcohol
74.9%
by weight



Propylene carbonate
15%
by weight



BHT
0.1%
by weight










The ingredients were homogeneously stirred and dissolved to obtain liquid drops.


Preparation Example 11 [Liquid Drops]


















Compound 253-2
48% by weight



Ethanol
52% by weight










The ingredients were homogeneously mixed to obtain liquid drops.


In addition, examples of a mixed composition of the compound of the present invention and other pest control agents will be described as follows.


Preparation Example 12 [Granules]



















Compound 1-20
2%
by weight



Probenazole
24%
by weight



Binder
3.0%
by weight



Guanular improving agent
0.5%
by weight



Clay
70.5%
by weight










The ingredients were homogeneously ground and mixed, water was added thereto to knead the ingredients thoroughly, and then the mixture was granulated and dried to obtain granules.


Test Example
Test Example 1 Plutella xylostella Control Test

A leaf disk having a diameter of 5.0 cm was cut out from a cabbage in pot culture, and a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 50% acetone water (0.05% Tween20 available), was sprayed to the leaf disk. After an air drying process, second instar larvae were released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Three days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. Test in duplicate.





mortality larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


As a result, compounds 266-2, 224-2, 7-2, 1-21, 3-20, 4-20, 4-5, 1-501, 1-499, 1-511, 1-519, 1-523, 1-528, 1-531, 1-42, 1-500, 1-72, 1-150, 1-47, 1-55, 1-122, 1-124, 1-64, 1-52, 1-121, 1-53, 1-76, 1-670, 1-671, 1-658, 1-659, 1-660, 1-681, 1-686, 1-661, 479-2, and 179-2, exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 500 ppm.


Further, compounds 1-20, 1-21, 4-20, 3-3, 4-3, 5-5, 6-5, 1-22, 1-23, 5-20, 5-3, 6-3, 5-4, 4-4, 6-4, 4-5, 2-20, 3-4, 3-5, 1-501, 1-499, 1-511, 1-519, 1-523, 1-507, 1-516, 1-518, 1-527, 1-521, 1-43, 1-536, 1-42, 1-500, 1-534, 1-535, 1-72, 1-150, 1-67, 1-515, 1-56, 1-512, 1-514, 1-50, 1-114, 1-44, 1-118, 1-119, 1-122, 1-671, 1-658, 1-659, 1-663, 1-664, 1-665, 1-666 and 1-667 exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 100 ppm.


Meanwhile, Comparative Example 8 (Japanese Patent Application Laid-Open No. 5-78323, Compound No. 51 in Table 1) exhibited a mortality of 20% in the treatment at 500 ppm.


Test Example 2 Pest Control Test Against Spodoptera litura

A leaf disk having a diameter of 5.0 cm was cut out from a cabbage in pot culture, and a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 50% acetone water (0.05% Tween20 available), was sprayed to the leaf disk. After an air drying process, third instar larvae were released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Three days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. Test in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


As a result, compounds 1-21, 3-20, 4-20, 4-5, 1-499, 1-43, 1-67, 1-44, 1-47 and 1-55 exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 500 ppm. Further, compounds 1-20, 5-5, 4-5, 1-671, 478-2 and 479-2 exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 100 ppm.


Meanwhile, Comparative Example 8 (Japanese Patent Application Laid-Open No. 5-78323, Compound No. 51 in Table 1) and Comparative Example 9 (the same Compound 56) exhibited a mortality of 10% and 11% in the treatment at 500 ppm, respectively.


Test Example 3 Pest Control Test of Aphis gossypii

A leaf disk having a diameter of 2.0 cm was cut out from a cucumber in pot culture, and a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 50% acetone water (0.05% Tween20 available), was sprayed to the leaf disk. After an air drying process, first instar larvae were released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Three days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. Test in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


As a result, compounds 266-2, 444-2, 201-2, 212-2, 213-2, 1-17, 1-18, 1-19, 7-2, 1-13, 4-5, 11-20, 1-501, 1-499, 1-510, 1-511, 1-519, 1-523, 1-528, 1-531, 1-42, 1-500, 1-72, 1-150, 251-2, 13-2, 479-2, 566-2, 488-2, 511-2, 555-2, 577-2, 1-644, 578-644 and 1-646 exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 500 ppm.


Further, compounds 266-2, 444-2, 190-2, 201-2, 224-2, 102-2, 212-2, 1-20, 213-2, 1-17, 1-18, 7-2, 1-13, 1-21, 3-20, 4-20, 4-5, 3-3, 2-20, 10-20, 3-4, 11-20, 1-14, 1-37, 1-40, 1-15, 1-35, 1-501, 1-499, 1-511, 1-519, 1-523, 1-531, 1-507, 1-516, 1-518, 1-521, 1-43, 1-42, 1-500, 1-72, 1-150, 1-67, 1-515, 1-56, 1-512, 1-514, 1-50, 1-114, 1-44, 1-118, 1-119, 1-47, 1-55, 1-50, 1-114, 1-44, 1-118, 1-119, 1-47, 1-55, 1-122, 1-124, 1-64, 1-52, 1-121, 1-53, 1-76, 1-670, 157-2, 1-10, 1-671, 1-658, 1-659, 1-660, 1-681, 1-686, 1-661, 478-2, 479-2, 566-2, 488-2, 511-2, 555-2, 577-2, 1-644, 578-644 and 1-646 exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 100 ppm.


Further, compounds 266-2, 190-2, 102-2, 1-20, 7-2, 1-13, 1-21, 3-20, 4-5, 3-3, 2-20, 3-4, 3-5, 1-14, 1-37, 1-501, 1-511, 1-507, 1-516, 1-518, 1-43, 1-72, 1-150, 1-67, 1-515, 1-56, 1-512, 1-514, 1-114, 1-118, 1-119, 1-50, 1-118, 1-119, 1-47, 1-122, 1-124, 1-64, 1-121, 1-53, 1-76, 1-670, 580-2, 1-671, 1-658, 1-659, 478-2, 479-2, 1-644, 578-644, 1-646, 1-663, 1-664, 1-665, 1-666 and 1-667 exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 20 ppm.


Test Example 4 Pest Control Test of Aulacophora femoralis

A leaf disk having a diameter of 2.8 cm was cut out from a cucumber in pot culture, and a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 50% acetone water (0.05% Tween20 available), was sprayed to the leaf disk. After an air drying process, adults were released thereto. Thereafter, the adults were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Three days after the release, the adults were observed for survival or death, and the mortality of adults was calculated by the following equation. Test in duplicate.





Mortality of adults (%)={number of dead adults/(number of survived adults+number of dead adults)}×100


As a result, compounds 1-20 and 4-20 exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 10 ppm.


Test Example 5 Pest Control Test Against Callosobruchus chinensis

1 μL(/head) of a drug solution of the compound of the present invention prepared at a predetermined concentration with acetone was treated to the back of Callosobruchus chinensis adults. After the drug treatment, the adults were transferred to a plastic cup and left to stand in a thermostatic chamber at 25° C. Twenty four hours after the treatment, the adults were observed for survival or death, and the mortality of adults was calculated by the following equation.





Rate of agonized adults (%)={number of dead adults/(number of survived adults+number of dead adults)}×100


As a result, compound 1-20 exhibited insecticidal activity having a mortality of 80% or higher in the rate at 0.1 μg/head.


Test Example 6 Pest Control Test of Laodelphax striatella

A drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 50% acetone water (0.05% Tween20 available), was foliar sprayed to a rice seedling in pot culture. After an air drying process, second instar larvae were released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Six days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. Test in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


As a result, compounds 1-20, 1-42, 1-499, 1-519 and 4-20 exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 1.25 ppm.


Test Example 7 Pest Control Test of Frankliniella occidentalis

A leaf disk having a diameter of 2.8 cm was cut out from a kidney bean in pot culture, and a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 50% acetone water (0.05% Tween20 available), was sprayed to the leaf disk. After an air drying process, first instar larvae were released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Three days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. Test in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


As a result, compounds 266-2, 224-2, 212-2, 1-20, 1-21, 3-20, 4-20, 1-15, 1-501, 1-499, 1-511, 1-72, 1-150, 1-56, 1-50, 1-114, 1-119, 1-47, 1-55, 1-50, 1-114, 1-119, 1-47, 1-55, 1-122, 1-124, 1-64, 1-52, 1-121, 1-53, 1-76, 1-670, 1-671, 1-660, 1-681, 1-686, 478-2, 479-2, 566-2 and 488-2 exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 500 ppm.


Further, compounds 212-2, 1-20, 1-21, 3-3, 4-3, 5-3, 6-3, 1-56, 1-121, 1-76, 479-2 and 488-2 exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 100 ppm.


Meanwhile, Comparative Example 8 (Japanese Patent Application Laid-Open No. 5-78323, Compound No. 51 in Table 1) exhibited a mortality of 15% in the treatment at 500 ppm.


Test Example 8 Pest Control Test of Trigonotylus caelestialium

Wheat seedling leaves and stems four days after the dissemination of seedlings were dipped for 30 seconds in a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 50% acetone water (0.05% Tween20 available). After an air drying process, the wheat seedling leaves and stems were placed into a glass tube, and two second instar larvae of Trigonotylus caelestialium were released to the same glass tube. After the larvae were released, the tube was lidded to leave the larvae to stand in a thermostatic chamber at 25° C. In order to supply water to the wheat during the test, water was given to the wheat from the bottom of the glass tube. Three days after the treatment, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


As a result, compounds 102-2, 1-20, 1-13, 1-21, 3-20, 4-20, 4-5, 1-521, 1-150, 1-122, 1-124, 1-52, 1-121, 1-76 and 267-2 exhibited insecticidal activity having a mortality of 80% or higher by a dipping treatment of the drug solution at 50 ppm.


Further, compounds 102-2, 1-20, 1-21, 3-20, 4-20, 3-3, 4-3, 6-5, 1-22, 1-23, 6-3, 5-4, 4-4, 3-4 and 478-2 exhibited insecticidal activity having a mortality of 80% or higher by a dipping treatment of the drug solution at 10 ppm.


Test Example 9 Pest Control Test of Laodelphax striatella

Wheat seedling roots forty eight hours after the dissemination of seeds were treated with a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 10% acetone water. The drug was absorbed from the roots for 72 hours, and then ten second instar larvae of Laodelphax striatella were each released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Seven days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. The test was performed in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


As a result, compounds 102-2, 1-20, 7-2, 1-13, 1-21, 3-20, 4-20, 5-4, 4-4, 6-4, 4-5, 3-3, 2-20, 3-4, 3-5, 1-501, 1-499, 1-511, 1-519, 1-523, 1-528, 1-531, 1-42, 1-500, 1-534, 1-535, 1-72, 1-150, 1-67, 1-515, 1-56, 1-512, 1-514, 1-47, 1-55, 1-122, 1-124, 1-64, 1-52, 1-121, 1-53, 1-76, 1-647, 1-670 and 478-2 exhibited high insecticidal activity having a mortality of 80% or higher in the rate of 20 μg/seedling.


Further, compounds 102-2, 212-2, 1-20, 7-2, 1-21, 3-20, 4-20, 3-3, 4-3, 1-22, 1-23, 5-20, 5-3, 6-3, 8-2, 4-4, 3-5, 1-501, 1-499, 1-511, 1-519, 1-523, 1-528, 1-531, 1-507, 1-516, 1-518, 1-527, 1-521, 1-42, 1-44, 1-50, 1-114, 1-118, 1-119, 1-47, 1-55, 1-124, 1-64, 1-52, 1-121, 1-53, 1-76, 1-670 and 478-2 exhibited insecticidal activity having a mortality of 80% or higher in the rate of 2 μg/seedling.


Meanwhile, Comparative Example 8 (Japanese Patent Application Laid-Open No. 5-78323, Compound No. 51 in Table 1) exhibited a mortality of 50% in the rate of 20 μg/seedling.


<Soil Irrigation Treatment Test>


Test Example 10 Pest Control Test of Laodelphax striatellua

A rice seedling in pot culture was subjected to soil irrigation treatment with a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 10% acetone water. Three days after the treatment, ten second instar larvae of Laodelphax striatella were each released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Three days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. The test was performed in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


As a result, compounds 102-2, 1-20, 1-21, 3-20, 4-20, 3-3, 4-3, 1-22, 1-23, 5-20, 5-3, 6-3, 8-2, 5-4, 4-4, 6-4, 4-5, 3-4, 3-5, 1-150, 1-118, 1-122, 1-124, 1-64 and 1-121 exhibited high insecticidal activity having a mortality of 80% or higher in the rate of 0.05 mg/seedling.


Meanwhile, Comparative Example 8 (Patent Document 3 Japanese Patent Application Laid-Open No. 5-78323, Compound No. 51 in Table 1) and Comparative Example 9 (the same Compound No. 56) all exhibited a mortality of 0% in the treatment of 0.05 mg/seedling.


Test Example 11 Pest Control Test of Sogatella furcifera

A rice seedling in pot culture was subjected to soil irrigation treatment with a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 10% acetone water. Three days after the treatment, ten second instar larvae of Sogatella furcifera were each released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Three days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. The test was performed in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


As a result, compounds 1-20 and 4-20 exhibited insecticidal activity having a mortality of 80% or higher in the rate of 0.01 mg/seedling.


Test Example 12 Pest Control Test of Nilaparvata lugens

A rice seedling in pot culture was subjected to soil irrigation treatment with a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 10% acetone water. Three days after the treatment, ten second instar larvae of Nilaparvata lugens were each released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Three days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. The test was performed in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


As a result, compounds 1-20, 1-21, 3-20, 4-20, 1-23 and 5-20 exhibited insecticidal activity having a mortality of 80% or higher in the rate of 0.05 mg/seedling.


Meanwhile, Comparative Example 8 (Patent Document 3 Japanese Patent Application Laid-Open No. 5-78323, Compound No. 51 in Table 1) and Comparative Example 9 (the same Compound 56) exhibited a mortality of 15% and 0 in the treatment of 0.05 mg/seedling, respectively.


Test Example 13 Pest Control Test of Oulema oryzae

A rice seedling in pot culture was subjected to soil irrigation treatment with a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 10% acetone water. Three days after the treatment, two second instar larvae of Oulema oryzae were each released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Three days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. The test was performed in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


As a result, compound 1-20 exhibited insecticidal activity having a mortality of 80% or higher in the rate of 0.05 mg/seedling.


Test Example 14 Pest Control Test of Nephotettix cincticeps

A rice seedling in pot culture was subjected to soil irrigation treatment with a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 10% acetone water. Three days after the treatment, five second instar larvae of Nephotettix cincticeps were each released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Three days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. The test was performed in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


As a result, compound 1-20 exhibited insecticidal activity having a mortality of 80% or higher in the rate of 0.05 mg/seedling.


Effects Against Drug Resistant Pests


<Foliar Spray Test>


Test Example 15 Pest Control Test of Laodelphax striatella

A drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 50% acetone water (0.05% Tween20 available), was foliar sprayed to a rice seedling in pot culture. After an air drying process, ten second instar larvae of Laodelphax striatella exhibiting drug resistance to fipronil were released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Six days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. Test in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


Further, for the origin of test pests, insects of Laodelphax striatella collected outdoors within the Kumamoto prefecture in 2006 were used.


As a result, compound 1-20 exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 1.25 ppm.


Test Example 16 Pest Control Test of Nilaparvata lugens

A drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 50% acetone water (0.05% Tween20 available), was foliar sprayed to a rice seedling in pot culture. After an air drying process, second instar larvae of Nilaparvata lugens exhibiting drug resistance to imidacloprid were released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Six days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. Test in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


Further, for the origin of test pests, insects of Nilaparvata lugens collected outdoors within the Fukuoka prefecture in 2005 were used.


As a result, compound 1-20 exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 20 ppm.


Test Example 17 Pest Control Test of Sogatella furcifera

A drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 10% acetone water (0.05% Tween20 available), was foliar sprayed to a rice seedling in pot culture. After an air drying process, second instar larvae of Sogatella furcifera exhibiting drug resistance to fipronil were released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Four days after the release, the larvae were observed for survival or death, the mortality of larvae was calculated by the following equation. Test in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


Further, for the origin of test pests, insects of Sogatella furcifera collected outdoors within the city of Odawara in 2010 were used.


As a result, compound 1-20 exhibited insecticidal activity having a mortality of 80% or higher by a foliar treatment at 20 ppm.


<Soil Irrigation Test>


Test Example 18 Pest Control Test of Drug-Resistant Nilaparvata lugens

A rice seedling in pot culture was subjected to soil irrigation treatment with a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 10% acetone water. Three days after the treatment, ten second instar larvae of Nilaparvata lugens exhibiting drug resistance to imidacloprid were each released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Three days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. The test was performed in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


Further, for comparison, the test against some population of Nilaparvata lugens which is highly susceptible to imidacloprid was performed by the same method as described above, and the results thereof are shown in Table 43. As described in Table 43, compounds 1-20, 1-21, 1-22, 1-23, 3-20, 4-20 and 5-20 exhibited equivalent mortality of larvae against drug resistant populations and susceptible populations of Nilaparvata lugens. From the test, it became obvious that 1-20, 1-21, 1-22, 1-23, 3-20, 4-20 and 5-20 exhibited high insecticidal effects even against drug resistant Nilaparvata lugens.


Further, for the origin of test pests, bugs collected outdoors within the Kumamoto prefecture in 2007 as the drug resistant Nilaparvata lugens, and bugs collected within the Kagoshima prefecture and then successively reared indoors for a long time as the imidacloprid susceptible populations of Nilaparvata lugens were used.












TABLE 54









Insecticidal effects against





Nilaparvata lugens




(mortality of larvae %)












Susceptible
Drug resistant




populations
populations



Rate
three days after
three days after


Compounds
(mg/pot)
the treatment
the treatment













1-20
0.05
96
100



0.01
95
81


1-21
0.05
67
50


1-22
0.05
75
60


1-23
0.05
85
70


3-20
0.05
100
100


4-20
0.05
95
100


5-20
0.05
91
100


Comparative
0.05

45


Example 3


(Patent


Document 2


Example 4)


Comparative
0.05

25


Example 4


(Patent


Document 2


Example 3)


Comparative
0.05

25


Example 5


(Patent


Document 2


Example 5)


Comparative
0.05

20


Example 6


(Patent


Document 2


Example 7)


Comparative
0.05
15
13


Example 8


(Patent


Document 3


Compound 51)


Comparative
0.05
0
31


Example 9


(Patent


Document 3


Compound 56)


Imidacloprid
0.05
90
6



0.01
73
0









Test Example 19 Pest Control Test of Sogatella furcifera

A rice seedling in pot culture was subjected to soil irrigation treatment with a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 10% acetone water. Three days after the treatment, ten second instar larvae of Sogatella furcifera exhibiting drug resistance to fipronil were each released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Six days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. The test was performed in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


Further, for comparison, the test against a populations of Sogatella furcifera which is highly susceptible to fipronil was performed by the same method as described above, and the results thereof are shown in Table 44. As shown in Table 44, compound 1-20 exhibited equivalent mortality of larvae against drug resistant populations and susceptible populations of Sogatella furcifera. From the test, it became obvious that compound 1-20 exhibited high insecticidal effects even against drug resistant Sogatella furcifera.


In addition, for the origin of test pests, bugs collected within the city of Odawara in 2010 as the drug resistant Sogatella furcifera, and bugs collected within the city of Chigasaki in 1970 and then successively reared indoors for a long time as the susceptible populations of Sogatella furcifera were used.












TABLE 55









Insecticidal effects against





Sogatella furcifera




(mortality of larvae %)














Susceptible
Drug resistant





populations
populations




Rate
six days after
six days after



Compounds
(mg/pot)
the treatment
the treatment
















1-20
0.01
88
88




0.005
75
53



Fipronil
0.05

90




0.01
100
40




0.005
100




0.01
78










Test Example 20 Pest Control Test of Laodelphax striatella

A rice seedling in pot culture was subjected to soil irrigation treatment with a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared so as to be a 10% acetone water. Three days after the treatment, ten second instar larvae of Laodelphax striatella exhibiting drug resistance to fipronil were each released thereto. Thereafter, the larvae were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Six days after the release, the larvae were observed for survival or death, and the mortality of larvae was calculated by the following equation. The test was performed in duplicate.





Mortality of larvae (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100


Further, for comparison, the test against a populations of Laodelphax striatella which is highly susceptible to fipronil was performed by the same method as described above, and the results thereof are shown in Table 45. As shown in Table 45, compound 1-20 exhibited equivalent mortality of larvae against drug resistant populations and susceptible populations of Laodelphax striatella. From the test, it became obvious that compound 1-20 exhibited high insecticidal effects even against drug resistant Laodelphax striatella.


In addition, for the origin of test pests, bugs collected within the Kumamoto prefecture in 2006 as the drug resistant Laodelphax striatella, and bugs successively reared indoors for a long time as the susceptible populations of Laodelphax striatella were used.












TABLE 56









Insecticidal effects against





Laodelphax striatella




(mortality of larvae %)














Susceptible
Drug resistant





populations
populations




Rate
six days after
six days after



Compounds
(mg/pot)
the treatment
the treatment
















1-20
0.005
85
79



Fipronil
0.05

90




0.02

76




0.01
100




0.005
89










Test Example 21 Pest Control Test of Musca domestica

A drug solution of the compound of the present invention, which had been adjusted to be 50 ppm with a 40% sucrose liquid, was adsorbed on a pledget, and the pledget was put into a vial. Two adults reared indoors were released thereto. Thereafter, the adults were left to stand indoors at room temperature of 25° C. Four days after the release, the adults were observed for survival or death. When two adults were all agonized in death, it was judged to be effective.


As a result, compounds 223-2, 1-20, 1-21, 3-20, 4-20, 3-3, 4-3, 5-5, 6-5, 1-22, 1-23, 5-20, 6-3, 5-4, 4-4, 6-4, 4-5, 2-20, 3-4, 3-5, 1-531, 1-518, 1-43, 1-42, 1-500, 1-72, 1-150, 1-56, 1-50, 1-114, 1-44, 1-118 and 1-119 exhibited high activity that all the adults are agonized in death, in the rate at 50 ppm.


Test Example 22 Pest Control Test of Housefly Instar Larvae

Compound 1-20 was blended with an extremely small amount of DMSO, and then the resulting mixture was dissolved in deionized water to adjust the drug solution. 10 ml of the drug solution adjusted to be 30 ppm was added to 10 g of powder in which wheat bran, MF feed (Oriental Yeast Co., Ltd.) and dry yeast had been mixed in a ratio of 25:5:1, and the mixture was mixed well to prepare a bait for housefly instar larvae. A 50 ml Falcon tube was slightly filled with the bait including the compound, and 20 eggs were released thereto. The mouth of the Falcon tube was covered with a mesh-topped lid, and the tube was allowed to stand at 25° C. Twenty days after the drug treatment, the numbers of instar larvae, chrysalises and adults were measured, and the mortality of larvae, chrysalises and adults was calculated by the following equation. The test was performed by repeating each treatment twice.





Mortality of larvae, chrysalises and adults (%)={number of dead larvae, chrysalises and adults/(number of survived larvae, chrysalises and adults+number of dead larvae, chrysalises and adults)}×100


As a result, compound 1-20 exhibited a mortality of 100% in the rate at 30 ppm.


Test Example 23 Pest Control Test of Haemaphysalis longicornis

30 μL of a acetone solution of the compound of the present invention at 200 ppm and acetone at 10 ppm was put into a 4 mL glass vial. The glass vial was loaded into a shaker and blow-dried while being rotated to form a dry film of the compound on the internal wall of the vial. After the vial was dried for 24 hours or more, ten young mites of Haemaphysalis longicornis were released thereto and the lid of the vial was covered. The vial was allowed to stand in a thermostatic chamber under total dark conditions at 25° C. and the humidity of 85%. One day after the release, the insects were observed for survival or death, the mortality of insects was calculated by the following equation. The test was performed in duplicate.





Mortality of insects (%)={number of dead insects/(number of survived insects+number of dead insects)}×100


As a result, compounds 266-2, 444-2, 1-17, 1-18, 1-19, 7-2, 1-13, 1-21, 3-3, 4-3, 5-5, 6-5, 1-22, 1-23, 5-20, 5-3, 6-3, 5-4, 4-5, 2-20, 1-47, 1-122, 1-45, 1-124, 1-52, 1-670, 1-662, 1-665, 1-667, 1-676, 478-2, 479-2, 1-51 and 1-669 exhibited insecticidal activity having a mortality of 80% or higher in the rate at 200 ppm.


Test Example 24 Pest Control Test of Haemaphysalis longicornis

A capsule with a diameter of 2 cm and a height of 2 cm was adhered to the back of a mouse. 9.5 μg of the compound of the present invention was dissolved in ethanol, and the resulting mixture was added dropwise to the body surface of the mouse in the capsule. The capsule was sufficiently dried, then ten young mites of Haemaphysalis longicornis were released thereto, and the top of the capsule was hermetically sealed with a lid. The mouse was reared under conditions of 12 hours of light period and 12 hours of dark period at 25° C. in a cage. Five days after the release, the capsule was detached therefrom to measure the numbers of living and dead mites and blood-sucking individuals of young mites, and the rate of insects agonized in death was calculated according to the following equation.





Rate of insects agonized in death (%)={number of insects agonized in death/(number of survived insects+number of insects agonized in death)}×100


As a result, compounds 1-20, 5-4, 4-5, 4-20, 1-501, 1-499, 1-516, 1-43, 1-42, 1-500, 1-72, 1-150, 1-515, 1-56, 1-50, 1-114, 1-44, 1-118, 1-119, 1-47, 1-55, 1-122, 1-45, 1-124, 1-64, 1-52, 1-121, 1-53, 1-76, 1-670, 1-671, 1-658, 1-659, 1-681, 1-662, 1-663, 1-667, 1-51 and 1-669 exhibited insecticidal activity having a rate of insects agonized in death of 80% or higher in the 9.5 μg of rate.


Test Example 25 Pest Control Test of Haemaphysalis longicornis

Three petri dishes with a diameter of 9 cm and a height of 1 cm were adhered to the back of a dog. Compound 1-20 of the present invention was dissolved in ethanol so as to be 5.35 mg/mL, and the mixture was added dropwise to the body surface of the dog in the petri dish. The petri dish was sufficiently dried, and then thirty young mites of Haemaphysalis longicornis were released thereto. Each dog was housed in a cage and reared under conditions of 10 hours of light period and 14 hours of dark period at 23° C. Three days after the release, the petri dishes were detached therefrom to measure the numbers of living and dead mites and blood-sucking individuals of young mites, and the mortality of mites was calculated according to the following equation.





Mortality of mites (%)={number of dead mites/(number of survived mites+number of dead mites)}×100


As a result, compound 1-20 exhibited a mortality of 100%.


Test Example 26 Pest Control Test of Ctenocephalides felis

Three petri dishes with a diameter of 9 cm and a height of 1 cm were adhered to the back of a dog. Compound 1-20 of the present invention was dissolved in ethanol so as to be 5.35 mg/mL, and the mixture was added dropwise to the body surface of the dog in the petri dish. The petri dish was sufficiently dried, and then twenty insects of Ctenocephalides felis were released thereto. Each dog was housed in a cage and reared under conditions of 10 hours of light period and 14 hours of dark period at 23° C. Three days after the release, the petri dishes were detached therefrom to measure the numbers of living and dead insects of Ctenocephalides felis and blood-sucking individuals, and the mortality of insects was calculated according to the following equation.





Mortality of insects (%)={number of dead insects/(number of survived insects+number of dead insects)}×100


As a result, compound 1-20 exhibited a mortality of 100%.


Test Example 27 Pest Control Test of Coptotermes formosanus

A filter paper was allowed to be soaked in a drug solution of the compound of the present invention at a predetermined concentration, which had been prepared with acetone. The filter paper was sufficiently blow-dried and then put into a plastic petri dish, and 5 insects of Coptotermes formosanus (worker ant) were each released thereto. Thereafter, the insects were left to stand in a thermostatic chamber (16 hours of light period-8 hours of dark period) at 25° C. Seven days after the release, the insects were observed for survival or death, and the mortality of insects was calculated by the following equation. The test was performed in duplicate.





Mortality of insects (%)={number of dead insects/(number of survived insects+number of dead insects)}×100


As a result, compound 1-20 exhibited insecticidal activity having a mortality of 100% in the rate at 0.5 μg/cm2.


The biological activities of the preferred compounds of this invention were described in Tables 57 and 58.









TABLE 57







(foliar treatment)















Compound
Compound
Compound
Compound
Compound




1-20
1-21
3-20
4-20
5-20



Concentration
%
%
%
%
%


Test Example
(ppm)
Mortality
Mortality
Mortality
Mortality
Mortality
















Test Example1
100
100
80
55
100
100



Plutella

20
100
10
0
70
100



xylostella

5
50



20


Test Example2
100
90
55
30
20
60



Spodoptera litura



Test Example3
100
100
100
100
100



Aphis gossypii

20
100
100
100



5
100
100
100
100
100



1.25
75
100
100
100
55



0.313

55
15


Test Example4
5
100



Aulacophora

1.25
100



femoralis



Test Example5
100
100



Callosobruchus

10
100



chinensis



Test Example6
1.25
95



Laodelphax




striatella



Test Example7
100
80
90
45
60
50



Frankliniella

20
50
80



occidentalis



Test Example8
50
100
100
100
100



Trigonotylus

10
100
100
100
100
17



caelestialium

2
50
67
50
33
















TABLE 58







soil irrigation treatment















Compound
Compound
Compound
Compound
Compound




1-20
1-21
3-20
4-20
5-20



Concentration
%
%
%
%
%


Test Example
(mg/pot)
Mortality
Mortality
Mortality
Mortality
Mortality
















Test Example10
0.05
100
100
90
100
95



Laodelphax

0.01
91
20

100
52



striatella

0.005
75


35
26


Test Example11
0.01
88



Sogatella

0.005
53



furcifera



Test Example12
0.05
100
85
100
100
100



Nilaparvata

0.01
85
10
100
96
90



lugens

0.005
80


Test Example14
0.01
100



Nephotettix

0.001
67



cincticeps

0.0001
67








Claims
  • 1-15. (canceled)
  • 16. A method for controlling pests by use of a nitrogen-containing heterocyclic derivative having a 2-imino group, which is represented by the following Formula (I), or salt thereof:
  • 17. The method according to claim 16, wherein Y is a hydrogen atom, a halogen atom or a cyano group.
  • 18. The method according to claim 16, wherein the nitrogen-containing heterocyclic derivative having the 2-imino-group is N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroethanethioamide.
  • 19. The method according to claim 16, comprising: treating seeds, roots, tubers, bulbs and rhizomes of plants, germinated plants, seedlings, soil, a nutrient solution in nutrient solution culture, a solid medium in nutrient solution culture or a simple body that grows plants with the nitrogen-containing heterocyclic derivative or salt thereof having the 2-imino group to penetrate and migrate the compound into the plants.
  • 20. The method according to claim 16, wherein the pest is an agricultural and horticultural pest.
  • 21. The method according to claim 16, wherein the pest is an animal parasitic pest.
  • 23. The method according to claim 16, wherein the pest is a drug resistant pest.
Priority Claims (1)
Number Date Country Kind
2012-043743 Feb 2012 JP national
Divisions (1)
Number Date Country
Parent 14381001 Aug 2014 US
Child 15730611 US